,datetime,title,source,link,sentiment_class,sentiment_score
0,10/26/2016 12:08:20 AM,BRIEF-Edwards Lifesciences sees new product launches lifting growth (EW),Reuters,http://www.businessinsider.com/r-brief-edwards-lifesciences-sees-new-product-launches-lifting-growth-2016-10,positive,0.8845229744911194
1,11/28/2016 2:16:18 PM,BRIEF-Edwards enters into agreement to acquire Valtech Cardio (EW),Reuters,http://www.businessinsider.com/r-brief-edwards-enters-into-agreement-to-acquire-valtech-cardio-2016-11,positive,0.5544425845146179
2,11/28/2016 3:16:07 PM,Edwards Lifesciences to buy Israel's Valtech for up to $690 mln (EW),Reuters,http://www.businessinsider.com/r-edwards-lifesciences-to-buy-israels-valtech-for-up-to-690-mln-2016-11,neutral,0.7234453558921814
3,11/28/2016 4:04:06 PM,UPDATE 1-Edwards Lifesciences to buy Israel's Valtech for up to $690 mln (EW),Reuters,http://www.businessinsider.com/r-update-1-edwards-lifesciences-to-buy-israels-valtech-for-up-to-690-mln-2016-11,positive,0.504868745803833
4,12/8/2016 2:40:15 PM,BRIEF-Edwards Lifesciences sees 2017 global sales of $3.0 bln to $3.4 bln (EW),Reuters,http://www.businessinsider.com/r-brief-edwards-lifesciences-sees-2017-global-sales-of-30-bln-to-34-bln-2016-12,neutral,0.8026097416877747
5,2/1/2017 10:30:50 PM,BRIEF-Edwards Lifesciences Corp Q4 EPS $0.73 (EW),Reuters,http://www.businessinsider.com/r-brief-edwards-lifesciences-corp-q4-eps-073-2017-2,neutral,0.7940788269042969
6,2/1/2017 10:33:03 PM,Edwards Lifesciences Corp. Bottom Line Rises 13% In Q4,RTTNews,/news/stocks/edwards-lifesciences-corp-bottom-line-rises-13-in-q4-1001715259,positive,0.9379391670227051
7,2/2/2017 6:22:10 PM,"Edwards Lifesciences Under Pressure Despite Upbeat Q4 Results, Guidance ",RTTNews,/news/stocks/edwards-lifesciences-under-pressure-despite-upbeat-q4-results-guidance-1001719012,negative,0.6105371117591858
8,2/23/2017 4:16:12 PM,"US STOCKS-S&P, Dow hit record highs as oil prices rally (XOM, CVX, HPQ, BSX, EW, CRI, NVDA)",Reuters,http://www.businessinsider.com/r-us-stocks-sp-dow-hit-record-highs-as-oil-prices-rally-2017-2,positive,0.8520277142524719
9,2/23/2017 6:04:14 PM,"US STOCKS-Wall St reverses as tech losses outweigh oil gains (XOM, CVX, NVDA, BSX, EW)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-reverses-as-tech-losses-outweigh-oil-gains-2017-2,negative,0.9184073805809021
10,2/23/2017 7:46:12 PM,"US STOCKS-Wall St recovers after Trump pledges to bring back jobs (NVDA, BSX, EW)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-recovers-after-trump-pledges-to-bring-back-jobs-2017-2,positive,0.8267431259155273
11,2/23/2017 9:42:12 PM,"US STOCKS-S&P 500 edges higher after Trump renews jobs pledge (NVDA, BSX, EW)",Reuters,http://www.businessinsider.com/r-us-stocks-sp-500-edges-higher-after-trump-renews-jobs-pledge-2017-2,positive,0.8595612645149231
12,2/24/2017 3:31:00 PM,"Covered Call reports for ARRIS Group Inc., Edwards Lifesciences, Hormel Foods Corporation, TJX and Wayfair Inc. include trade ideas that offer high returns.",PR Newswire,/news/stocks/covered-call-reports-for-arris-group-inc-edwards-lifesciences-hormel-foods-corporation-tjx-and-wayfair-inc-include-trade-ideas-that-offer-high-returns-1001781657,neutral,0.6540879011154175
13,3/9/2017 11:16:22 AM,"BRIEF-Boston Scientific receives favorable rulings in Edwards Lifesciences litigation (BSX, EW)",Reuters,http://www.businessinsider.com/r-brief-boston-scientific-receives-favorable-rulings-in-edwards-lifesciences-litigation-2017-3,positive,0.9443076848983765
14,3/9/2017 12:56:22 PM,"BRIEF-German patent court issues initial decision (EW, BSX)",Reuters,http://www.businessinsider.com/r-brief-german-patent-court-issues-initial-decision-2017-3,neutral,0.9248261451721191
15,3/17/2017 2:08:45 PM,"Medtronic heart valve replacement succeeds in intermediate-risk patients-study (MDT, EW)",Reuters,http://www.businessinsider.com/r-medtronic-heart-valve-replacement-succeeds-in-intermediate-risk-patients-study-2017-3,neutral,0.5179142355918884
16,3/24/2017 12:15:00 PM,"Medical Appliances Stocks Under Scanner -- Neovasc, Hologic, Edwards Lifesciences, and Sunshine Heart",PR Newswire,/news/stocks/medical-appliances-stocks-under-scanner-neovasc-hologic-edwards-lifesciences-and-sunshine-heart-1001865476,neutral,0.6168363690376282
17,4/10/2017 1:05:00 PM,"Edwards Lifesciences To Host Earnings Conference Call On April 25, 2017",PR Newswire,/news/stocks/edwards-lifesciences-to-host-earnings-conference-call-on-april-25-2017-550106,neutral,0.9459027647972107
18,4/18/2017 2:00:00 PM,LEVEL-5 Announces Global Release Date and New Name For The Latest Addition to the Professor Layton Series,PR Newswire,/news/stocks/level-5-announces-global-release-date-and-new-name-for-the-latest-addition-to-the-professor-layton-series-1001596508,neutral,0.9114418029785156
19,4/19/2017 2:30:00 PM,Edwards' Advanced Hemodynamic Monitoring Platform Receives FDA Clearance,PR Newswire,/news/stocks/edwards-advanced-hemodynamic-monitoring-platform-receives-fda-clearance-1001930608,positive,0.72602379322052
20,4/25/2017 10:15:00 PM,Edwards Lifesciences Reports First Quarter Results,PR Newswire,/news/stocks/edwards-lifesciences-reports-first-quarter-results-1001948489,neutral,0.8994984030723572
21,4/25/2017 10:24:04 PM,Edwards profit tops expectations on soaring heart valve sales (EW),Reuters,http://www.businessinsider.com/r-edwards-profit-tops-expectations-on-soaring-heart-valve-sales-2017-4,positive,0.9379621148109436
22,4/25/2017 10:36:41 PM,Edwards Lifesciences Corp. Profit Rises 31% In Q1,RTTNews,/news/stocks/edwards-lifesciences-corp-profit-rises-31-in-q1-1001948560,positive,0.9326334595680237
23,4/25/2017 11:39:08 PM,BRIEF-Edwards Lifesciences Q1 earnings per share $1.06 (EW),Reuters,http://www.businessinsider.com/r-brief-edwards-lifesciences-q1-earnings-per-share-106-2017-4,neutral,0.8227421045303345
24,4/25/2017 11:43:40 PM,Edwards Lifesciences Updates FY17 Guidance - Quick Facts ,RTTNews,/news/stocks/edwards-lifesciences-updates-fy17-guidance-quick-facts-1001948786,neutral,0.9442720413208008
25,4/26/2017 3:45:06 PM,BRIEF-East West Petroleum commences 2017 New Zealand drilling program (EW),Reuters,http://www.businessinsider.com/r-brief-east-west-petroleum-commences-2017-new-zealand-drilling-program-2017-4,neutral,0.9139775037765503
26,4/26/2017 4:15:06 PM,"US STOCKS-Wall St flat as Trump's tax plan eyed (BA, EW, WYNN, X)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-flat-as-trumps-tax-plan-eyed-2017-4,neutral,0.4928607940673828
27,4/26/2017 5:45:08 PM,"GLOBAL MARKETS-World stocks advance on earnings, tax hopes (TMO, EW)",Reuters,http://www.businessinsider.com/r-global-markets-world-stocks-advance-on-earnings-tax-hopes-2017-4,positive,0.9257233738899231
28,4/26/2017 5:53:06 PM,"US STOCKS-Wall St near record levels ahead of Trump tax plan (BA, PG, STX, EW)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-near-record-levels-ahead-of-trump-tax-plan-2017-4,positive,0.6606202125549316
29,4/26/2017 7:41:11 PM,"US STOCKS-Wall St flirts with record highs; tax plan in focus (TMO, EW, UTX, BA, PG)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-flirts-with-record-highs-tax-plan-in-focus-2017-4,neutral,0.5820672512054443
30,4/26/2017 8:35:06 PM,"GLOBAL MARKETS-Stocks advance on earnings; Canada dollar, Mexico peso weaken on NAFTA news (TMO, EW)",Reuters,http://www.businessinsider.com/r-global-markets-stocks-advance-on-earnings-canada-dollar-mexico-peso-weaken-on-nafta-news-2017-4,negative,0.47749730944633484
31,4/27/2017 3:20:00 PM,Edwards Lifesciences To Present At The Deutsche Bank 42nd Annual Health Care Conference,PR Newswire,/news/stocks/edwards-lifesciences-to-present-at-the-deutsche-bank-42nd-annual-health-care-conference-1001957264,neutral,0.9114567637443542
32,5/3/2017 12:40:00 PM,"Research Reports Initiation on Medical Equipment Stocks -- Edwards Lifesciences, Hologic, and Stryker",PR Newswire,/news/stocks/research-reports-initiation-on-medical-equipment-stocks-edwards-lifesciences-hologic-and-stryker-1001973753,neutral,0.9469138979911804
33,5/4/2017 4:45:00 PM,Edwards Lifesciences To Webcast Annual Meeting Of Stockholders,PR Newswire,/news/stocks/edwards-lifesciences-to-webcast-annual-meeting-of-stockholders-1001980436,neutral,0.9405838251113892
34,5/16/2017 3:30:00 PM,Real-World Evidence With Edwards SAPIEN 3 Transcatheter Valve Confirms Beneficial Patient Outcomes From Clinical Trials,PR Newswire,/news/stocks/real-world-evidence-with-edwards-sapien-3-transcatheter-valve-confirms-beneficial-patient-outcomes-from-clinical-trials-1002017406,positive,0.9549074769020081
35,5/17/2017 8:30:00 AM,Edwards' Novel Self-Expanding Transcatheter Heart Valve Demonstrates Excellent Early Patient Outcomes,PR Newswire,/news/stocks/edwards-novel-self-expanding-transcatheter-heart-valve-demonstrates-excellent-early-patient-outcomes-1002019427,positive,0.9465617537498474
36,6/5/2017 9:38:03 PM,BRIEF-FDA expands use of Sapien 3 artificial heart valve for high-risk patients‍​ (EW),Reuters,http://www.businessinsider.com/r-brief-fda-expands-use-of-sapien-3-artificial-heart-valve-for-high-risk-patients-2017-6,positive,0.7093296647071838
37,6/5/2017 10:30:00 PM,"Edwards SAPIEN 3 Valve Receives FDA Approval For Aortic, Mitral Valve-In-Valve Procedures",PR Newswire,/news/stocks/edwards-sapien-3-valve-receives-fda-approval-for-aortic-mitral-valve-in-valve-procedures-1002068490,positive,0.9372193217277527
38,6/5/2017 10:42:03 PM,UPDATE 1-FDA approves new use for Edwards' Sapien 3 heart valve (EW),Reuters,http://www.businessinsider.com/r-update-1-fda-approves-new-use-for-edwards-sapien-3-heart-valve-2017-6,positive,0.8752641081809998
39,6/5/2017 10:50:06 PM,"BRIEF-Edwards Lifesciences says SAPIEN 3 valve receives FDA approval for aortic, mitral valve-in-valve procedures (EW)",Reuters,http://www.businessinsider.com/r-brief-edwards-lifesciences-says-sapien-3-valve-receives-fda-approval-for-aortic-mitral-valve-in-valve-procedures-2017-6,positive,0.9410553574562073
40,6/16/2017 5:52:03 PM,BRIEF-Neovasc says German Court partially found in favor of Edwards Lifesciences in its case against co (EW),Reuters,http://www.businessinsider.com/r-brief-neovasc-says-german-court-partially-found-in-favor-of-edwards-lifesciences-in-its-case-against-co-2017-6,positive,0.8376306295394897
41,6/19/2017 12:25:00 PM,"Technical Reports on Medical Equipment Equities -- Hologic, Wright Medical, Globus Medical, and Edwards Lifesciences",PR Newswire,/news/stocks/technical-reports-on-medical-equipment-equities-hologic-wright-medical-globus-medical-and-edwards-lifesciences-1002102936,neutral,0.9449363350868225
42,7/5/2017 12:14:10 PM,"Israel tech exits at 5-year low of $2 billion in first half (EW, INTC)",Reuters,http://www.businessinsider.com/r-israel-tech-exits-at-5-year-low-of-2-billion-in-first-half-2017-7,negative,0.9581708908081055
43,7/5/2017 3:30:08 PM,BRIEF-Edwards' Inspiris Resilia valve receives FDA approval (EW),Reuters,http://www.businessinsider.com/r-brief-edwards-inspiris-resilia-valve-receives-fda-approval-2017-7,positive,0.8658713102340698
44,7/26/2017 10:15:00 PM,Edwards Lifesciences Reports Second Quarter Results,PR Newswire,/news/stocks/edwards-lifesciences-reports-second-quarter-results-523722,neutral,0.8527344465255737
45,7/26/2017 10:24:06 PM,Edwards Lifesciences raises 2017 forecast after strong quarter (EW),Reuters,http://www.businessinsider.com/r-edwards-lifesciences-raises-2017-forecast-after-strong-quarter-2017-7,positive,0.892534613609314
46,7/26/2017 10:29:25 PM,Edwards Lifesciences Corp. Profit Climbs 41% In Q2,RTTNews,/news/stocks/edwards-lifesciences-corp-profit-climbs-41-in-q2-1002207671,positive,0.9297656416893005
47,7/26/2017 10:38:06 PM,"BRIEF-Edwards Lifesciences Q2 shr $0.86 , Q2 adj shr $1.08 (EW)",Reuters,http://www.businessinsider.com/r-brief-edwards-lifesciences-q2-shr-086--q2-adj-shr-108-2017-7,neutral,0.9117645025253296
48,7/26/2017 11:32:29 PM,Edwards Lifesciences Raises 2017 Outlook - Quick Facts ,RTTNews,/news/stocks/edwards-lifesciences-raises-2017-outlook-quick-facts-1002207945,neutral,0.8051102757453918
49,8/28/2017 12:15:00 PM,"Technical Snapshots for These Medical Equipment Stocks -- Abbott Labs, Boston Scientific, Edwards Lifesciences, and Medtronic",PR Newswire,/news/stocks/technical-snapshots-for-these-medical-equipment-stocks-abbott-labs-boston-scientific-edwards-lifesciences-and-medtronic-1002287926,neutral,0.9427250623703003
50,8/31/2017 4:30:00 PM,Edwards Lifesciences To Present At The 12th Annual Wells Fargo Healthcare Conference,PR Newswire,/news/stocks/edwards-lifesciences-to-present-at-the-12th-annual-wells-fargo-healthcare-conference-1002299138,neutral,0.9211956262588501
51,9/21/2017 1:53:00 AM,East West Announces Completion of Workover and Initial Test Results from Romania,PR Newswire,/news/stocks/east-west-announces-completion-of-workover-and-initial-test-results-from-romania-489131,neutral,0.7760294079780579
52,9/24/2017 8:00:00 AM,Edwards Announces Key Events For PCR London Valves 2017,PR Newswire,/news/stocks/edwards-announces-key-events-for-pcr-london-valves-2017-1002476440,neutral,0.9329026341438293
53,9/26/2017 3:00:00 PM,Epicor Featured in CRN 2017 Cloud Partner Program Guide,PR Newswire,/news/stocks/epicor-featured-in-crn-2017-cloud-partner-program-guide-1002071122,neutral,0.7233629822731018
54,9/28/2017 6:39:00 PM,Cape Coral Leads Florida Recovery Efforts with Swift Action on Behalf of Homeowners Following Hurricane Irma,PR Newswire,/news/stocks/cape-coral-leads-florida-recovery-efforts-with-swift-action-on-behalf-of-homeowners-following-hurricane-irma-1001715188,positive,0.9126803278923035
55,10/3/2017 2:30:00 PM,East West Announces Change Of Directors,PR Newswire,/news/stocks/east-west-announces-change-of-directors-587808,neutral,0.7213552594184875
56,10/11/2017 9:05:00 PM,"Edwards Lifesciences To Host Earnings Conference Call On October 24, 2017",PR Newswire,/news/stocks/edwards-lifesciences-to-host-earnings-conference-call-on-october-24-2017-1003866954,neutral,0.9441174268722534
57,10/24/2017 10:15:00 PM,Edwards Lifesciences Reports Third Quarter Results,PR Newswire,/news/stocks/edwards-lifesciences-reports-third-quarter-results-1005488154,neutral,0.8796749114990234
58,10/24/2017 10:27:08 PM,Edwards 3rd-quarter results short of Street estimates; shares fall (EW),Reuters,http://www.businessinsider.com/r-edwards-3rd-quarter-results-short-of-street-estimates-shares-fall-2017-10,negative,0.9702817797660828
59,10/24/2017 10:46:50 PM,Edwards Lifesciences Corp. Bottom Line Advances 23% In Q3,RTTNews,/news/stocks/edwards-lifesciences-corp-bottom-line-advances-23-in-q3-1005490111,positive,0.9347254037857056
60,10/24/2017 10:47:14 PM,UPDATE 1-Edwards results fall short of Street estimates; shares tumble (EW),Reuters,http://www.businessinsider.com/r-update-1-edwards-results-fall-short-of-street-estimates-shares-tumble-2017-10,negative,0.9694441556930542
61,10/24/2017 11:27:04 PM,BRIEF-Edwards Lifesciences reports quarterly share of $0.79 (EW),Reuters,http://www.businessinsider.com/r-brief-edwards-lifesciences-reports-quarterly-share-of-079-2017-10,neutral,0.9259146451950073
62,10/26/2017 1:00:00 PM,"McCoy Global Inc. to Release Third Quarter 2017 Results on November 9, 2017",PR Newswire,/news/stocks/mccoy-global-inc-to-release-third-quarter-2017-results-on-november-9-2017-1001807212,neutral,0.9152787923812866
63,10/31/2017 6:40:00 PM,Edwards SAPIEN 3 Transcatheter Valve Demonstrates Significant Cost Savings Over Surgery In Intermediate Risk Patients,PR Newswire,/news/stocks/edwards-sapien-3-transcatheter-valve-demonstrates-significant-cost-savings-over-surgery-in-intermediate-risk-patients-1006334408,positive,0.9549650549888611
64,11/2/2017 11:45:00 AM,"WidePoint Corporation to Announce Third Quarter 2017 Financial Results on November 14, 2017",PR Newswire,/news/stocks/widepoint-corporation-to-announce-third-quarter-2017-financial-results-on-november-14-2017-1001819369,neutral,0.9394704699516296
65,12/6/2017 10:30:00 PM,Edwards Acquires Harpoon Medical,PR Newswire,/news/stocks/edwards-acquires-harpoon-medical-1010435641,neutral,0.9344203472137451
66,12/6/2017 10:52:04 PM,BRIEF-Edwards Lifesciences Corp Acquires Harpoon Medical (EW),Reuters,http://www.businessinsider.com/r-brief-edwards-lifesciences-corp-acquires-harpoon-medical-2017-12,neutral,0.9343831539154053
67,12/7/2017 7:58:14 AM,"MDGL Crossed $100 Mark, INSY Awaits FDA Decision In July, ODT IPO Today ",RTTNews,/news/stocks/mdgl-crossed-100-mark-insy-awaits-fda-decision-in-july-odt-ipo-today-1010466446,neutral,0.763900101184845
68,12/7/2017 1:00:00 PM,Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference,PR Newswire,/news/stocks/edwards-lifesciences-outlines-growth-strategy-at-annual-investor-conference-1010484785,neutral,0.9126447439193726
69,12/7/2017 1:01:00 PM,Edwards Lifesciences' Board Approves New $1 Billion Share Repurchase Program,PR Newswire,/news/stocks/edwards-lifesciences-board-approves-new-1-billion-share-repurchase-program-1010484802,positive,0.6860747933387756
70,12/7/2017 1:24:37 PM,"Edwards Lifesciences Backs FY17 View, Sees Higher FY18; To Buy Back $1 Bln Share ",RTTNews,/news/stocks/edwards-lifesciences-backs-fy17-view-sees-higher-fy18-to-buy-back-1-bln-share-1010486153,positive,0.9066740274429321
71,12/19/2017 2:00:00 PM,East West Announces Teremia Well Test Results and Operational Update for Romania,PR Newswire,/news/stocks/east-west-announces-teremia-well-test-results-and-operational-update-for-romania-1011641061,neutral,0.8403472900390625
72,1/16/2018 2:00:00 PM,OncoSec Appoints Veteran Biopharma Executive Gregory T. Mayes To Board Of Directors,PR Newswire,/news/stocks/oncosec-appoints-veteran-biopharma-executive-gregory-t-mayes-to-board-of-directors-1001672147,neutral,0.9041025638580322
73,1/16/2018 9:30:00 PM,Edwards Lifesciences Corporation -- Moody's upgrades Edwards Lifesciences to Baa2,Moodys,/news/bonds/edwards-lifesciences-corporation-moody-s-upgrades-edwards-lifesciences-to-baa2-1013124811,positive,0.8666363954544067
74,1/18/2018 4:05:00 PM,"Edwards Lifesciences To Host Earnings Conference Call On February 1, 2018",PR Newswire,/news/stocks/edwards-lifesciences-to-host-earnings-conference-call-on-february-1-2018-1013228101,neutral,0.9491609930992126
75,2/1/2018 10:15:00 PM,Edwards Lifesciences Reports Fourth Quarter Results,PR Newswire,/news/stocks/edwards-lifesciences-reports-fourth-quarter-results-1014836450,neutral,0.8619431257247925
76,2/1/2018 10:27:25 PM,Edwards Lifesciences Corp. Earnings Rise In Q4,RTTNews,/news/stocks/edwards-lifesciences-corp-earnings-rise-in-q4-1014836496,positive,0.9287888407707214
77,2/1/2018 10:47:25 PM,Edwards Lifesciences Updates FY18 Guidance - Quick Facts ,RTTNews,/news/stocks/edwards-lifesciences-updates-fy18-guidance-quick-facts-1014838202,neutral,0.9438573718070984
78,2/15/2018 2:00:00 PM,Edwards' Self-Expanding Transcatheter Heart Valve Receives CE Mark,PR Newswire,/news/stocks/edwards-self-expanding-transcatheter-heart-valve-receives-ce-mark-1015891344,positive,0.5608047246932983
79,3/6/2018 4:30:00 PM,Edwards Lifesciences To Present At The Cowen 38th Annual Health Care Conference,PR Newswire,/news/stocks/edwards-lifesciences-to-present-at-the-cowen-38th-annual-health-care-conference-1018143056,neutral,0.9231541752815247
80,3/9/2018 5:29:00 PM,Moody's: Outlook for US medical products and devices industry changed to positive,Moodys,/news/bonds/moody-s-outlook-for-us-medical-products-and-devices-industry-changed-to-positive-1018563273,positive,0.8155419230461121
81,3/19/2018 1:30:00 PM,Edwards' Acumen Hypotension Prediction Index Launches In The U.S.,PR Newswire,/news/stocks/edwards-acumen-hypotension-prediction-index-launches-in-the-u-s-1018916854,neutral,0.6578564047813416
82,3/21/2018 9:40:00 PM,"Edwards Completes Enrollment In PARTNER 3 Low-Risk CT Sub-Study, Updates Timeline For SAPIEN 3 Ultra System Launch In Europe",PR Newswire,/news/stocks/edwards-completes-enrollment-in-partner-3-low-risk-ct-sub-study-updates-timeline-for-sapien-3-ultra-system-launch-in-europe-1019014053,neutral,0.6984548568725586
83,3/22/2018 7:35:17 AM,"FENC On Fast Track, SPHS To Report Data In Q2, REGN, ALNY Team Up For NASH ",RTTNews,/news/stocks/fenc-on-fast-track-sphs-to-report-data-in-q2-regn-alny-team-up-for-nash-1019042163,neutral,0.609477162361145
84,3/23/2018 10:18:30 PM,BRIEF-Edwards Lifesciences Prevails In U.S. Patent Office Review,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/MUZfI5kmugw/brief-edwards-lifesciences-prevails-in-u-s-patent-office-review-idUSFWN1R50TT,neutral,0.7512544393539429
85,3/28/2018 11:28:18 AM,BRIEF-Boston Scientific says co prevails in UK Edwards Lifesciences Litigation​,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/k15msuKpCHI/brief-boston-scientific-says-co-prevails-in-uk-edwards-lifesciences-litigation-idUSFWN1RA0BH,positive,0.8842407464981079
86,3/28/2018 11:42:18 AM,Boston Scientific: U.K. Court Affirms Edwards Infringes Company's Patent ,RTTNews,/news/stocks/boston-scientific-u-k-court-affirms-edwards-infringes-company-s-patent-1019694457,negative,0.8800815939903259
87,3/29/2018 10:43:12 PM,BRIEF-Edwards Lifesciences Corp Says CEO Michael Mussallem's FY 2017 Total Compensation Was $10.8 Mln Vs $9.7 Mln In FY 2016,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/t6s_mO-m00I/brief-edwards-lifesciences-corp-says-ceo-michael-mussallems-fy-2017-total-compensation-was-10-8-mln-vs-9-7-mln-in-fy-2016-idUSFWN1RB0Z4,negative,0.8991811871528625
88,3/30/2018 2:00:00 PM,94 Percent of American Dogs Report They're Happiest In Monogamous Relationships,PR Newswire,/news/stocks/94-percent-of-american-dogs-report-they-re-happiest-in-monogamous-relationships-1002219719,neutral,0.8719631433486938
89,4/10/2018 4:05:00 PM,"Edwards Lifesciences To Host Earnings Conference Call On April 24, 2018",PR Newswire,/news/stocks/edwards-lifesciences-to-host-earnings-conference-call-on-april-24-2018-1021059356,neutral,0.9478735327720642
90,4/16/2018 10:53:12 PM,BRIEF-Boston Scientific Prevails In European Patent Dispute With Edwards Lifesciences,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/I78PvQYaUyg/brief-boston-scientific-prevails-in-european-patent-dispute-with-edwards-lifesciences-idUSFWN1RT0V9,negative,0.6003894805908203
91,4/24/2018 10:15:00 PM,Edwards Lifesciences Reports First Quarter Results,PR Newswire,/news/stocks/edwards-lifesciences-reports-first-quarter-results-1022162660,neutral,0.8994984030723572
92,4/24/2018 10:16:07 PM,Edwards Lifesciences reports 1.3 pct rise in quarterly sales,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/QWVDlx5jA0w/edwards-lifesciences-reports-1-3-pct-rise-in-quarterly-sales-idUSL3N1S166J,positive,0.9410471320152283
93,4/24/2018 10:25:21 PM,Edwards Lifesciences Corp. Q1 adjusted earnings Beat Estimates,RTTNews,/news/stocks/edwards-lifesciences-corp-q1-adjusted-earnings-beat-estimates-1022162674,positive,0.8828858137130737
94,4/24/2018 10:28:11 PM,BRIEF-Edwards Lifesciences Reports Q1 Earnings Of $0.96/Share,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/XMCruLcQMVI/brief-edwards-lifesciences-reports-q1-earnings-of-0-96-share-idUSB8N1LI03J,neutral,0.8700064420700073
95,4/24/2018 10:35:25 PM,"UPDATE 1-Edwards Lifesciences heart valve sales miss estimates, shares fall",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/IVmcfeg2Qhk/update-1-edwards-lifesciences-heart-valve-sales-miss-estimates-shares-fall-idUSL3N1S1688,negative,0.9670925140380859
96,4/30/2018 10:15:00 PM,Edwards Granted CE Mark For First Transcatheter Tricuspid Therapy,PR Newswire,/news/stocks/edwards-granted-ce-mark-for-first-transcatheter-tricuspid-therapy-1022927659,positive,0.7245562672615051
97,4/30/2018 11:25:04 PM,BRIEF-Edwards Lifesciences Says Entered Into Credit Agreement To Establish Multi-Currency Unsecured Revolving Credit Facility - SEC Filing,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/jDe43Sr1FXg/brief-edwards-lifesciences-says-entered-into-credit-agreement-to-establish-multi-currency-unsecured-revolving-credit-facility-sec-filing-idUSFWN1S71AB,positive,0.6987078189849854
98,5/1/2018 7:42:04 AM,"INGN Soars On Revised Outlook, MRK Faces FDA In Sep., KPTI Taken By STORM ",RTTNews,/news/stocks/ingn-soars-on-revised-outlook-mrk-faces-fda-in-sep-kpti-taken-by-storm-1022974414,negative,0.7852578163146973
99,5/1/2018 2:26:15 PM,BRIEF-Edwards Lifesciences Enters Into Accelerated Share Repurchase Agreement,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/N7pHXAyYbJM/brief-edwards-lifesciences-enters-into-accelerated-share-repurchase-agreement-idUSASC09YL3,neutral,0.8896379470825195
100,5/2/2018 2:30:00 PM,DocPanel Announces Partnership with the University of Southern California Keck School of Medicine,PR Newswire,/news/stocks/docpanel-announces-partnership-with-the-university-of-southern-california-keck-school-of-medicine-646736,positive,0.7558629512786865
101,5/14/2018 4:15:00 PM,Edwards Lifesciences To Webcast Annual Meeting Of Stockholders,PR Newswire,/news/stocks/edwards-lifesciences-to-webcast-annual-meeting-of-stockholders-1024449451,neutral,0.9405838251113892
102,5/21/2018 6:01:00 AM,Edwards Announces Key Events For EuroPCR 2018,PR Newswire,/news/stocks/edwards-announces-key-events-for-europcr-2018-1025062051,neutral,0.9391244649887085
103,5/22/2018 6:01:00 AM,East West Petroleum Announces Operational Update For Romania,PR Newswire,/news/stocks/east-west-petroleum-announces-operational-update-for-romania-1025077171,neutral,0.88172847032547
104,5/22/2018 3:03:00 PM,Real-World Evidence Confirms Clinical Trial Outcomes For Patients Treated With Edwards SAPIEN 3 Valve,PR Newswire,/news/stocks/real-world-evidence-confirms-clinical-trial-outcomes-for-patients-treated-with-edwards-sapien-3-valve-1025088972,positive,0.8645983338356018
105,5/24/2018 3:15:00 PM,Edwards Lifesciences To Present At The Bernstein 34th Annual Strategic Decisions Conference,PR Newswire,/news/stocks/edwards-lifesciences-to-present-at-the-bernstein-34th-annual-strategic-decisions-conference-715911,neutral,0.9180871248245239
106,6/14/2018 2:00:00 PM,SolAero Technologies Awarded Contract to Provide Solar Panels to SSL,PR Newswire,/news/stocks/solaero-technologies-awarded-contract-to-provide-solar-panels-to-ssl-1001802544,positive,0.9221005439758301
107,6/16/2018 12:27:00 AM,East West Petroleum Announces Change of Directors,PR Newswire,/news/stocks/east-west-petroleum-announces-change-of-directors-1027148082,neutral,0.7804712653160095
108,7/24/2018 3:02:12 PM,Edwards Lifesciences earnings preview: what Wall Street is expecting,Markets Insider Automation,/news/stocks/edwards_lifesciences-quarter-earnings-preview-q2-1027394115,neutral,0.9218891859054565
109,7/26/2018 10:26:05 PM,Edwards Lifesciences Corp. Q2 adjusted earnings Beat Estimates,RTTNews,/news/stocks/edwards-lifesciences-corp-q2-adjusted-earnings-beat-estimates-1027405095,positive,0.8774147629737854
110,7/26/2018 10:41:51 PM,Edwards Lifesciences Raises 2018 Adj. EPS Guidance - Quick Facts ,RTTNews,/news/stocks/edwards-lifesciences-raises-2018-adj-eps-guidance-quick-facts-1027405199,neutral,0.9245843887329102
111,10/9/2018 6:01:21 AM,"AFMD Bleeds On Clinical Hold, BHC Gets FDA Nod, MNLO Disappoints ",RTTNews,/news/stocks/afmd-bleeds-on-clinical-hold-bhc-gets-fda-nod-mnlo-disappoints-1027598700,negative,0.3958076238632202
112,10/22/2018 3:01:43 PM,Edwards Lifesciences earnings preview: what to expect,Markets Insider Automation,/news/stocks/edwards_lifesciences-stock-quarter-earnings-preview-q3-1027638966,neutral,0.9303550720214844
113,10/23/2018 2:11:27 PM,Boston Scientific Says Court Rules Edwards Lifesciences' Valve Infringes Patent ,RTTNews,/news/stocks/boston-scientific-says-court-rules-edwards-lifesciences-valve-infringes-patent-1027643838,negative,0.8539325594902039
114,10/23/2018 11:02:19 PM,Edwards Lifesciences Corp. Q3 adjusted earnings Beat Estimates,RTTNews,/news/stocks/edwards-lifesciences-corp-q3-adjusted-earnings-beat-estimates-1027646463,positive,0.8775575160980225
115,12/5/2018 4:05:02 PM,Edwards Lifesciences Reaffirms Financial Guidance ,RTTNews,/news/stocks/edwards-lifesciences-reaffirms-financial-guidance-1027783686,neutral,0.8486881256103516
116,1/15/2019 1:06:41 PM,"Boston Scientific, Edwards Lifesciences Agree To Settle All Patent Disputes ",RTTNews,/news/stocks/boston-scientific-edwards-lifesciences-agree-to-settle-all-patent-disputes-1027868271,neutral,0.5469019412994385
117,1/30/2019 3:02:21 PM,Here's what Wall Street expects from Edwards Lifesciences's earnings report,Markets Insider Automation,/news/stocks/edwards_lifesciences-stock-quarter-earnings-preview-q4-1027909177,neutral,0.9049685597419739
118,1/31/2019 10:16:20 PM,Edwards Lifesciences beats on revenue but forecast lags estimates,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/vf64ArRL3qU/edwards-lifesciences-beats-on-revenue-but-forecast-lags-estimates-idUSL3N1ZU5UP,negative,0.6401649117469788
119,1/31/2019 10:23:43 PM,Edwards Lifesciences Corp. Q4 adjusted earnings Inline With Estimates,RTTNews,/news/stocks/edwards-lifesciences-corp-q4-adjusted-earnings-inline-with-estimates-1027914719,neutral,0.580095648765564
120,2/1/2019 6:12:48 AM,"AVEO Crashes, FDA Approves 1st Generic Of ADVAIR DISKUS, 'Tis Advantage TTNP ",RTTNews,/news/stocks/aveo-crashes-fda-approves-1st-generic-of-advair-diskus-tis-advantage-ttnp-1027915260,positive,0.5829919576644897
121,2/12/2019 2:52:57 PM,Edwards Lifesciences To Buy CAS Medical Systems In $100 Mln Deal ,RTTNews,/news/stocks/edwards-lifesciences-to-buy-cas-medical-systems-in-100-mln-deal-1027945312,neutral,0.905882716178894
122,2/20/2019 6:13:18 AM,"FDA Nod For NVO's Hemophilia A Drug, ICPT's NASH Trial Hits Goal, NVTA Abuzz ",RTTNews,/news/stocks/fda-nod-for-nvo-s-hemophilia-a-drug-icpt-s-nash-trial-hits-goal-nvta-abuzz-1027966173,positive,0.8868405818939209
123,4/22/2019 3:01:36 PM,Edwards Lifesciences is about to announce its earnings — here's what Wall Street expects,Markets Insider Automation,/news/stocks/edwards_lifesciences-stock-price-q1-earnings-preview-1028126281,neutral,0.9329422116279602
124,4/23/2019 10:19:43 PM,Edwards Lifesciences Corp. Q1 adjusted earnings Beat Estimates,RTTNews,/news/stocks/edwards-lifesciences-corp-q1-adjusted-earnings-beat-estimates-1028131713,positive,0.8828858137130737
125,5/7/2019 2:36:19 PM,Edwards: Aortic Valve Study Shows Positive Outcomes With RESILIA Platform ,RTTNews,/news/stocks/edwards-aortic-valve-study-shows-positive-outcomes-with-resilia-platform-1028176361,positive,0.951530396938324
126,6/24/2019 10:40:00 PM,Edwards Lifesciences Corporation -- Moody's announces completion of a periodic review of ratings of Edwards Lifesciences Corporation,Moodys,/news/bonds/edwards-lifesciences-corporation-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-edwards-lifesciences-corporation-1028303427,neutral,0.8869621753692627
127,7/22/2019 3:01:34 PM,Edwards Lifesciences is about to announce its earnings — here's what Wall Street expects,Markets Insider Automation,/news/stocks/edwards_lifesciences-q2-quarterly-earnings-preview-stock-1028371800,neutral,0.9329422116279602
128,7/23/2019 10:50:59 PM,"Edwards Lifesciences Increases 2019 Sales, EPS Guidance - Quick Facts ",RTTNews,/news/stocks/edwards-lifesciences-increases-2019-sales-eps-guidance-quick-facts-1028377949,positive,0.7819986343383789
129,8/16/2019 7:29:49 PM,"Edwards Lifesciences, Medtronic heart valves win FDA approval for expanded use",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/aum41V_eA5I/edwards-lifesciences-medtronic-heart-valves-win-fda-approval-for-expanded-use-idUSL4N25C357,positive,0.9200960993766785
130,8/17/2019 12:26:57 AM,"UPDATE 1-Edwards Lifesciences, Medtronic heart valves win U.S. approval for expanded use",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/s6m_Pz9LK8A/update-1-edwards-lifesciences-medtronic-heart-valves-win-u-s-approval-for-expanded-use-idUSL4N25C3N0,positive,0.9187406897544861
131,8/19/2019 8:00:41 PM,3 Beautiful Breakout Stocks to Buy,InvestorPlace,/news/stocks/3-beautiful-breakout-stocks-to-buy-1028457710,neutral,0.8525016903877258
132,8/22/2019 5:46:35 PM,Edwards Lifesciences recalls delivery system for Sapien heart valves,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/XMfItwbBzSY/edwards-lifesciences-recalls-delivery-system-for-sapien-heart-valves-idUSL4N25I3NY,neutral,0.7582896947860718
133,8/22/2019 8:47:32 PM,UPDATE 1-FDA classifies Edwards Lifesciences Sapien delivery system recall as severest,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/4Ixj9p56MUk/update-1-fda-classifies-edwards-lifesciences-sapien-delivery-system-recall-as-severest-idUSL4N25I3OU,negative,0.928037703037262
134,8/22/2019 11:58:06 PM,UPDATE 2-FDA pegs Edwards Lifesciences Sapien delivery system recall as severest,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/3C2dA0SQ3xM/update-2-fda-pegs-edwards-lifesciences-sapien-delivery-system-recall-as-severest-idUSL4N25I3OU,negative,0.9606521725654602
135,10/23/2019 10:59:23 PM,Edwards Lifesciences Corp. Reports Advance In Q3 Earnings,RTTNews,/news/stocks/edwards-lifesciences-corp-reports-advance-in-q3-earnings-1028625070,positive,0.8563783764839172
136,10/23/2019 11:21:10 PM,Edwards Lifesciences Raises Earnings Guidance - Quick Facts ,RTTNews,/news/stocks/edwards-lifesciences-raises-earnings-guidance-quick-facts-1028625139,neutral,0.7573201656341553
137,10/25/2019 2:57:46 PM,"Healthcare Stocks On The Move (EW, NVO, BBI…) ",RTTNews,/news/stocks/healthcare-stocks-on-the-move-ew-nvo-bbi-1028631420,neutral,0.9144319295883179
138,12/5/2019 1:47:24 PM,Edwards Lifesciences Issues FY20 Guidance; Affirms 2019 Outlook ,RTTNews,/news/stocks/edwards-lifesciences-issues-fy20-guidance-affirms-2019-outlook-1028740446,neutral,0.563806414604187
139,1/29/2020 3:02:11 PM,Here's what Wall Street expects from Edwards Lifesciences's earnings,Markets Insider Automation,/news/stocks/edwards_lifesciences-stock-price-quarter-earnings-preview-q4-1028855437,neutral,0.9278062582015991
140,1/30/2020 10:31:58 PM,Edwards Lifesciences Corp. Q4 adjusted earnings Miss Estimates,RTTNews,/news/stocks/edwards-lifesciences-corp-q4-adjusted-earnings-miss-estimates-1028861588,negative,0.9571582078933716
141,2/4/2020 4:49:26 PM,3 Healthcare Stocks to Buy This Week Ahead of Earnings,InvestorPlace,/news/stocks/3-healthcare-stocks-to-buy-after-earnings-1028873201,neutral,0.8996131420135498
142,3/5/2020 12:37:07 PM,New sell-side coverage - healthcare,Seeking Alpha,https://seekingalpha.com/news/3548949-new-sell-side-coverage-healthcare?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8478835821151733
143,3/20/2020 5:43:00 PM,FDA relaxes standards for remote vital sign monitoring,Seeking Alpha,https://seekingalpha.com/news/3553898-fda-relaxes-standards-for-remote-vital-sign-monitoring?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7739486694335938
144,3/28/2020 2:47:02 PM,Edwards pauses enrollment in key trials amid Covid-19,Seeking Alpha,https://seekingalpha.com/news/3556072-edwards-pauses-enrollment-in-key-trials-amid-covidminus-19?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8914085030555725
145,3/30/2020 5:32:01 AM,Edwards Lifesciences Says SAPIEN 3 Valve Shows Excellent Results At 2 Years ,RTTNews,/news/stocks/edwards-lifesciences-says-sapien-3-valve-shows-excellent-results-at-2-years-1029042782,positive,0.9414069652557373
146,4/17/2020 11:18:06 AM,Benchmark likes Regeneron in premarket analyst action,Seeking Alpha,https://seekingalpha.com/news/3561611-benchmark-likes-regeneron-in-premarket-analyst-action?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8388407230377197
147,4/22/2020 3:01:37 PM,Edwards Lifesciences earnings: here's what to expect,Markets Insider Automation,/news/stocks/edwards_lifesciences-q1-quarterly-earnings-preview-stock-1029117610,neutral,0.9386208057403564
148,4/22/2020 9:35:11 PM,Edwards Lifesciences Q1 2020 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3563188-edwards-lifesciences-q1-2020-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.865103006362915
149,4/22/2020 9:35:28 PM,Notable earnings after Thursday's close,Seeking Alpha,https://seekingalpha.com/news/3563165-notable-earnings-after-thursdays-close?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8900271058082581
150,4/23/2020 10:26:55 PM,Edwards Lifesciences Corp. Q1 adjusted earnings Beat Estimates,RTTNews,/news/stocks/edwards-lifesciences-corp-q1-adjusted-earnings-beat-estimates-1029124737,positive,0.8828858137130737
151,4/23/2020 10:49:19 PM,Edwards Substantially Reduces 2020 Guidance Due To Effects Of COVID-19 ,RTTNews,/news/stocks/edwards-substantially-reduces-2020-guidance-due-to-effects-of-covid-19-1029124805,negative,0.9661239385604858
152,4/24/2020 7:43:19 AM,"SAVA Gets Funding For AD Drug, JNJ Hits All-time High, ENZ On Watch ",RTTNews,/news/stocks/sava-gets-funding-for-ad-drug-jnj-hits-all-time-high-enz-on-watch-1029125551,positive,0.8711331486701965
153,4/27/2020 10:30:10 PM,Edwards’ HemoSphere Platform Receives Expanded Use Indication From Health Canada in Treatment of COVID-19 Patients,GlobeNewswire,/news/stocks/edwards-hemosphere-platform-receives-expanded-use-indication-from-health-canada-in-treatment-of-covid-19-patients-1029134695,positive,0.9050009846687317
154,4/28/2020 11:32:55 AM,Wells softens view on Edwards Lifesciences in premarket analyst action,Seeking Alpha,https://seekingalpha.com/news/3565181-wells-softens-view-on-edwards-lifesciences-in-premarket-analyst-action?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7519422769546509
155,5/19/2020 10:01:00 PM,Edwards Lifesciences Corporation -- Moody's announces completion of a periodic review of ratings of Edwards Lifesciences Corporation,Moodys,/news/bonds/edwards-lifesciences-corporation-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-edwards-lifesciences-corporation-1029217082,neutral,0.8869621753692627
156,6/8/2020 3:28:01 PM,Edwards Sapien 3 valve OK'd in China,Seeking Alpha,https://seekingalpha.com/news/3581179-edwards-sapien-3-valve-okd-in-china?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7610204219818115
157,7/15/2020 2:43:57 PM,Edwards Announces FDA Approval For KONECT RESILIA Aortic Valved Conduit - Quick Facts ,RTTNews,/news/stocks/edwards-announces-fda-approval-for-konect-resilia-aortic-valved-conduit-quick-facts-1029397085,neutral,0.5080118775367737
158,7/22/2020 3:01:36 PM,Edwards Lifesciences earnings preview: what Wall Street is expecting,Markets Insider Automation,/news/stocks/edwards_lifesciences-stock-quarter-earnings-preview-q2-1029420063,neutral,0.9218891859054565
159,7/23/2020 10:33:50 PM,Edwards Lifesciences Corp. Q2 adjusted earnings Beat Estimates,RTTNews,/news/stocks/edwards-lifesciences-corp-q2-adjusted-earnings-beat-estimates-1029426756,positive,0.8774147629737854
160,7/23/2020 10:41:06 PM,Edwards Lifesciences Raises 2020 Adj. EPS Guidance; Reiterates Sales Outlook ,RTTNews,/news/stocks/edwards-lifesciences-raises-2020-adj-eps-guidance-reiterates-sales-outlook-1029426782,neutral,0.8732666969299316
161,10/20/2020 3:01:35 PM,Here's what Wall Street expects from Edwards Lifesciences's earnings,Markets Insider Automation,/news/stocks/edwards_lifesciences-q3-earnings-preview-stock-1029698763,neutral,0.9278062582015991
162,10/20/2020 6:01:46 PM,Edwards Lifesciences Q3 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3623848-edwards-lifesciences-q3-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.874144434928894
163,10/20/2020 9:35:00 PM,Notable earnings after Wednesday's close,Seeking Alpha,https://seekingalpha.com/news/3623755-notable-earnings-after-wednesdays-close?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8919200301170349
164,10/21/2020 8:39:26 PM,"Edwards Lifesciences Q3 sales up 4%, earnings up 18%",Seeking Alpha,https://seekingalpha.com/news/3624518-edwards-lifesciences-q3-sales-up-4-earnings-up-18?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9526076912879944
165,10/21/2020 10:22:58 PM,Edwards Lifesciences Corp. Q3 adjusted earnings Beat Estimates,RTTNews,/news/stocks/edwards-lifesciences-corp-q3-adjusted-earnings-beat-estimates-1029707091,positive,0.8775575160980225
166,11/4/2020 5:12:44 PM,Healthcare rallies as Presidential vote count continues,Seeking Alpha,https://seekingalpha.com/news/3631239-healthcare-rallies-presidential-vote-count-continues?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5205032825469971
167,11/30/2020 10:46:26 AM,7 ESG Investing Ideas That Could Add to Your Wallet and to Your Soul,InvestorPlace,/news/stocks/7-esg-investing-ideas-that-could-add-to-your-wallet-and-to-your-soul-1029848245,neutral,0.8763432502746582
168,12/10/2020 4:00:56 PM,Edwards Lifesciences Sees FY21 Adj. EPS Below View ,RTTNews,/news/stocks/edwards-lifesciences-sees-fy21-adj-eps-below-view-1029881923,neutral,0.9392392635345459
169,12/18/2020 8:30:47 PM,Expanded use of Edwards' Sapien 3 valve OK'd in Canada,Seeking Alpha,https://seekingalpha.com/news/3645899-expanded-use-of-edwards-sapien-3-valve-okd-in-canada?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6861026287078857
170,12/23/2020 2:30:53 PM,"The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut",Benzinga,/news/stocks/the-daily-biotech-pulse-supernus-issues-positive-adhd-readout-sorrento-files-for-emergency-use-authorization-for-rapid-covid-19-test-inhibikase-to-make-wall-street-debut-1029916943,positive,0.7712023854255676
171,12/29/2020 2:09:37 PM,"The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica",Benzinga,/news/stocks/the-daily-biotech-pulse-fda-nod-for-amphastar-s-generic-glucagon-arcturus-sinks-on-vaccine-data-decision-day-for-osmotica-1029923067,neutral,0.8028444051742554
172,12/30/2020 2:08:28 PM,"The Daily Biotech Pulse: Osmotica Faces Second FDA Rejection, UK Conditionally Approves AstraZeneca's Vaccine Candidate, Hepion NASH Data",Benzinga,/news/stocks/the-daily-biotech-pulse-osmotica-faces-second-fda-rejection-uk-conditionally-approves-astrazeneca-s-vaccine-candidate-hepion-nash-data-1029925168,neutral,0.47888410091400146
173,1/23/2021 3:14:04 PM,"The Week Ahead In Biotech (Jan 24-30): J&J, Lilly to Kickstart Big Pharma Earnings, Amgen FDA Decision and More",Benzinga,/news/stocks/the-week-ahead-in-biotech-jan-24-30-j-j-lilly-to-kickstart-big-pharma-earnings-amgen-fda-decision-and-more-1029996049,positive,0.6939172744750977
174,1/25/2021 3:01:29 PM,Here's what Wall Street expects from Edwards Lifesciences's earnings,Markets Insider Automation,/news/stocks/edwards_lifesciences-q4-quarterly-earnings-preview-1029999382,neutral,0.9278062582015991
175,1/26/2021 10:30:50 PM,Edwards Lifesciences Q4 2020 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3654444-edwards-lifesciences-q4-2020-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8838546872138977
176,1/26/2021 10:35:07 PM,Notable earnings after Wednesday's close,Seeking Alpha,https://seekingalpha.com/news/3654434-notable-earnings-after-wednesdays-close?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8919200301170349
177,1/27/2021 1:35:59 PM,"The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement",Benzinga,/news/stocks/the-daily-biotech-pulse-sorrento-immutep-surge-on-covid-19-study-data-t2-biosystems-sinks-on-preannouncement-1030009241,neutral,0.834762454032898
178,1/27/2021 10:34:43 PM,Edwards Lifesciences Corp. Q4 adjusted earnings Miss Estimates,RTTNews,/news/stocks/edwards-lifesciences-corp-q4-adjusted-earnings-miss-estimates-1030011974,negative,0.9571582078933716
179,1/27/2021 11:22:19 PM,13 Stocks Moving In Wednesday's After-Hours Session,Benzinga,/news/stocks/13-stocks-moving-in-wednesday-s-after-hours-session-1030012164,negative,0.6677055954933167
180,1/28/2021 2:03:49 PM,"The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO",Benzinga,/news/stocks/the-daily-biotech-pulse-decision-day-for-amgen-zymeworks-sinks-on-data-ortho-clinical-diagnostics-ipo-1030014922,neutral,0.9371458292007446
181,1/28/2021 3:20:31 PM,"Edwards Lifesciences  topline up 2%, misses Q4 profit consensus",Seeking Alpha,https://seekingalpha.com/news/3655616-edwards-lifesciences-topline-up-2-misses-q4-profit-consensus?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.930611252784729
182,2/1/2021 1:57:16 AM,Edwards' Resilia Tissue Aortic Valve Shows Favorable Safety And Efficacy At Five Years ,RTTNews,/news/stocks/edwards-resilia-tissue-aortic-valve-shows-favorable-safety-and-efficacy-at-five-years-1030024104,positive,0.9456368088722229
183,2/1/2021 8:19:35 PM,Edwards Lifesciences’ Resilia tissue aortic valve shows favorable safety and efficacy,Seeking Alpha,https://seekingalpha.com/news/3656849-edwards-lifesciences-resilia-tissue-aortic-valve-shows-favorable-safety-and-efficacy?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9478327631950378
184,3/2/2021 2:22:58 PM,"Cramer Shares His Thoughts On Penn National Gaming, Snap, More",Benzinga,/news/stocks/cramer-shares-his-thoughts-on-penn-national-gaming-snap-more-1030140427,neutral,0.9379293918609619
185,4/5/2021 1:03:01 PM,Focus on equipment makers as Citi unveils positive catalyst watch; Invitae upgraded on Softbank investment and more in today’s analyst action,Seeking Alpha,https://seekingalpha.com/news/3679123-equipment-makers-on-watch-invitae-upgraded-on-softbank-investment?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8823693990707397
186,4/5/2021 3:06:05 PM,Edwards Lifesciences is not getting the credit it deserves: Evercore ISI,Seeking Alpha,https://seekingalpha.com/news/3679200-edwards-lifesciences-is-not-getting-the-credit-it-deserves-evercore-isi?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8694518804550171
187,4/5/2021 4:03:33 PM,"Benzinga's Top Ratings Upgrades, Downgrades For April 5, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-april-5-2021-1030273989,negative,0.5280468463897705
188,4/9/2021 10:04:00 PM,Edwards Lifesciences Corporation -- Moody's announces completion of a periodic review of ratings of Edwards Lifesciences Corporation,Moodys,/news/bonds/edwards-lifesciences-corporation-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-edwards-lifesciences-corporation-1030290301,neutral,0.8869621753692627
189,4/15/2021 3:04:25 PM,Edwards Lifesciences Corp. hosts conference call for investors,Markets Insider Automation,/news/stocks/edwards_lifesciences_conference-1029937344,neutral,0.9470229148864746
190,4/15/2021 4:03:31 PM,"Benzinga's Top Ratings Upgrades, Downgrades For April 15, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-april-15-2021-1030308913,negative,0.5670157670974731
191,4/18/2021 3:01:24 PM,Edwards Lifesciences earnings: here's what Wall Street expects,Markets Insider Automation,/news/stocks/edwards_lifesciences-q1-earnings-preview-stock-1030315037,neutral,0.9300240874290466
192,4/19/2021 9:35:36 PM,Edwards Lifesciences Q1 2021 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3683089-edwards-lifesciences-q1-2021-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8256014585494995
193,4/19/2021 9:35:53 PM,Notable earnings after Tuesday's close,Seeking Alpha,https://seekingalpha.com/news/3683045-notable-earnings-after-tuesdays-close?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8953563570976257
194,4/20/2021 2:06:58 PM,"The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex",Benzinga,/news/stocks/the-daily-biotech-pulse-q1-beat-from-johnson-johnson-kalvista-study-placed-on-hold-european-label-expansion-for-gw-pharma-s-epidiolex-1030322640,neutral,0.7906162738800049
195,4/20/2021 10:24:10 PM,Edwards Lifesciences Corp. Q1 adjusted earnings Beat Estimates,RTTNews,/news/stocks/edwards-lifesciences-corp-q1-adjusted-earnings-beat-estimates-1030325334,positive,0.8828858137130737
196,4/20/2021 11:04:41 PM,8 Stocks Moving In Tuesday's After-Hours Session,Benzinga,/news/stocks/8-stocks-moving-in-tuesday-s-after-hours-session-1030325456,negative,0.6977605819702148
197,4/20/2021 11:14:11 PM,Edwards Lifesciences Q1 Results Beat Street View; Lifts Outlook ,RTTNews,/news/stocks/edwards-lifesciences-q1-results-beat-street-view-lifts-outlook-1030325459,positive,0.9336956143379211
198,4/21/2021 1:05:19 PM,24 Stocks Moving in Wednesday's Pre-Market Session,Benzinga,/news/stocks/24-stocks-moving-in-wednesday-s-pre-market-session-1030327808,neutral,0.7507777810096741
199,4/21/2021 1:31:27 PM,"The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue",Benzinga,/news/stocks/the-daily-biotech-pulse-moderna-to-supply-variant-specific-vaccine-to-israel-roche-s-diagnostics-business-comes-to-rescue-1030327873,neutral,0.651543915271759
200,4/21/2021 6:00:17 PM,Edwards Lifesciences hits new all-time high buoyed by strong Q1 results,Seeking Alpha,https://seekingalpha.com/news/3684113-edwards-lifesciences-hits-new-all-time-high-buoyed-by-strong-q1-results?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9377025365829468
201,4/21/2021 6:03:10 PM,33 Stocks Moving In Wednesday's Mid-Day Session,Benzinga,/news/stocks/33-stocks-moving-in-wednesday-s-mid-day-session-1030329572,negative,0.6970771551132202
202,4/22/2021 11:03:54 AM,48 Biggest Movers From Yesterday,Benzinga,/news/stocks/48-biggest-movers-from-yesterday-1030332063,neutral,0.8529891967773438
203,4/22/2021 2:08:59 PM,"The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs",Benzinga,/news/stocks/the-daily-biotech-pulse-kempharm-receives-10m-milestone-payment-zymergen-neuropace-debut-on-nasdaq-renalytix-wins-us-government-contract-2-ipos-1030332968,positive,0.795148491859436
204,4/23/2021 1:28:48 PM,"The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs",Benzinga,/news/stocks/the-daily-biotech-pulse-quidel-slides-on-negative-pre-announcement-roche-gets-positive-ema-committee-recommendation-3-ipos-1030338292,negative,0.6960055232048035
205,5/18/2021 9:08:07 PM,Edwards releases real-world data on transcatheter aortic valve replacement,Seeking Alpha,https://seekingalpha.com/news/3698034-edwards-releases-real-world-data-on-transcatheter-aortic-valve-replacement?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9260801672935486
206,5/21/2021 1:26:12 PM,"The Daily Biotech Pulse: Moderna's Vaccine Authorized In Japan, Neovasc's Adverse Ruling In Germany, Metacrine Rallies On Insider Buying",Benzinga,/news/stocks/the-daily-biotech-pulse-moderna-s-vaccine-authorized-in-japan-neovasc-s-adverse-ruling-in-germany-metacrine-rallies-on-insider-buying-1030454685,neutral,0.755637526512146
207,5/25/2021 4:02:44 PM,"Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-may-25-2021-1030463045,negative,0.5758826732635498
208,5/25/2021 6:07:34 PM,"Barclays sees ""renaissance"" in medical device industry",Seeking Alpha,https://seekingalpha.com/news/3699979-barclays-sees-renaissance-in-medical-device-industry?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7192387580871582
209,6/1/2021 8:23:47 PM,Edwards Lifesciences gets FDA clearance for hypotension prediction index software,Seeking Alpha,https://seekingalpha.com/news/3702056-edwards-lifesciences-gets-fda-clearance-for-hypotension-prediction-index-software?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8360487222671509
210,6/3/2021 12:35:35 PM,"Amazon, IBM highlight Credit Suisse's 'Top of the Crop' picks: At the Open",Seeking Alpha,https://seekingalpha.com/news/3702860-amazon-ibm-highlight-credit-suisses-top-of-the-crop-picks?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8129107356071472
211,6/12/2021 9:36:53 PM,Top stocks with pricing power for a sputtering reflation trade: Alpha Tactics,Seeking Alpha,https://seekingalpha.com/news/3705786-top-stocks-with-pricing-power-for-a-sputtering-reflation-trade?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8027105927467346
212,6/15/2021 2:07:38 PM,"The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda",Benzinga,/news/stocks/the-daily-biotech-pulse-astrazeneca-biogen-face-clinical-trial-disappointments-novavax-studies-coronavirus-flu-combo-vaccine-decision-day-for-takeda-1030523320,neutral,0.9001524448394775
213,6/16/2021 2:20:39 PM,"The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO",Benzinga,/news/stocks/the-daily-biotech-pulse-regeneron-covid-19-antibody-cocktail-data-fda-nod-for-mallinckrodt-molecular-partners-ipo-1030527915,neutral,0.9316365122795105
214,6/22/2021 2:12:07 PM,"The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal",Benzinga,/news/stocks/the-daily-biotech-pulse-sanofi-translate-bio-start-early-stage-seasonal-flu-vaccine-study-dr-reddy-s-launches-generic-vascepa-halozyme-strikes-licensing-deal-1030542723,neutral,0.8023732900619507
215,6/23/2021 1:35:16 PM,"The Daily Biotech Pulse: Gemini Sinks On Data, Amgen's Migraine Drug Approved In Japan, Liver Congress Gets Underway",Benzinga,/news/stocks/the-daily-biotech-pulse-gemini-sinks-on-data-amgen-s-migraine-drug-approved-in-japan-liver-congress-gets-underway-1030546471,neutral,0.8094767928123474
216,6/24/2021 2:12:04 PM,"The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO",Benzinga,/news/stocks/the-daily-biotech-pulse-lilly-spikes-on-alzheimer-s-drug-regulatory-filing-plan-applied-genetics-arcus-issue-data-readouts-adcom-test-awaits-incyte-monte-rosa-prices-ipo-1030550889,neutral,0.93064284324646
217,6/25/2021 1:32:32 PM,"The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs",Benzinga,/news/stocks/the-daily-biotech-pulse-roche-gets-authorization-for-covid-19-treatment-nods-for-sanofi-regeneron-in-europe-osmotica-divestment-2-ipos-1030554577,positive,0.7482125759124756
218,6/28/2021 9:37:16 PM,"4 Top Stock Trades for Tuesday: NIO, FB, EW, TXN",InvestorPlace,/news/stocks/4-top-stock-trades-for-tuesday-nio-fb-ew-txn-1030560721,neutral,0.9221511483192444
219,7/1/2021 12:29:40 PM,Caterpillar moves into Credit Suisse's 'Top of the Crop' list: At the Open,Seeking Alpha,https://seekingalpha.com/news/3711767-caterpillar-moves-into-credit-suisses-top-of-the-crop-list?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.838917076587677
220,7/8/2021 1:45:17 PM,"The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test",Benzinga,/news/stocks/the-daily-biotech-pulse-priority-review-for-amgen-s-asthma-treatment-evaxion-reports-positive-skin-cancer-readout-quidel-recalls-lyra-covid-19-test-1030589266,neutral,0.5796161890029907
221,7/9/2021 1:36:16 PM,"The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO",Benzinga,/news/stocks/the-daily-biotech-pulse-lilly-morphic-s-positive-data-at-ecco-humanigen-s-covid-treatment-gets-expedited-review-in-uk-transcode-ipo-1030592766,neutral,0.6329366564750671
222,7/22/2021 1:05:00 PM,"Edwards Lifesciences To Host Earnings Conference Call On July 29, 2021",PR Newswire,/news/stocks/edwards-lifesciences-to-host-earnings-conference-call-on-july-29-2021-1030634418,neutral,0.9513744115829468
223,7/22/2021 9:15:00 PM,"Study Data Presented at TVT on the Economics of Minimalist TAVR, PARTNER 3 Bicuspid TAVR",PR Newswire,/news/stocks/study-data-presented-at-tvt-on-the-economics-of-minimalist-tavr-partner-3-bicuspid-tavr-1030636637,neutral,0.8999937772750854
224,7/25/2021 3:26:31 PM,"The Week Ahead In Biotech: Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More",Benzinga,/news/stocks/the-week-ahead-in-biotech-july-25-31-big-pharma-earnings-iterum-fda-decision-alzheimer-s-conference-ipos-and-more-1030641744,neutral,0.9177685976028442
225,7/27/2021 3:02:14 PM,Here's what Wall Street expects from Edwards Lifesciences's earnings,Markets Insider Automation,/news/stocks/edwards_lifesciences-stock-quarter-earnings-preview-q2-1030650739,neutral,0.9278062582015991
226,7/28/2021 9:35:02 PM,Notable earnings after Thursday's close,Seeking Alpha,https://seekingalpha.com/news/3720530-notable-earnings-after-thursdays-close?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8900271058082581
227,7/29/2021 2:18:48 PM,"The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs",Benzinga,/news/stocks/the-daily-biotech-pulse-merck-s-disappointing-q2-atreca-falls-on-data-fda-nod-for-viatris-nuvalent-icosavax-ipos-1030662210,negative,0.9680227041244507
228,7/29/2021 8:20:47 PM,"Edwards Lifesciences EPS beats by $0.09, beats on revenue",Seeking Alpha,https://seekingalpha.com/news/3721886-edwards-lifesciences-eps-beats-0_09-beats-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7948797941207886
229,7/29/2021 10:15:00 PM,Edwards Lifesciences Reports Second Quarter Results,PR Newswire,/news/stocks/edwards-lifesciences-reports-second-quarter-results-1030664365,neutral,0.8527344465255737
230,7/29/2021 10:49:56 PM,Edwards Lifesciences Corp. Q2 adjusted earnings Beat Estimates,RTTNews,/news/stocks/edwards-lifesciences-corp-q2-adjusted-earnings-beat-estimates-1030664610,positive,0.8774147629737854
231,7/30/2021 12:08:42 AM,Edwards Lifesciences Lifts FY21 Outlook ,RTTNews,/news/stocks/edwards-lifesciences-lifts-fy21-outlook-1030664888,positive,0.8803500533103943
232,7/30/2021 1:53:58 PM,"The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs",Benzinga,/news/stocks/the-daily-biotech-pulse-erytech-jumps-on-fast-track-designation-glaxosmithkline-fda-nod-alnylam-s-clinical-collaboration-4-ipos-1030667906,positive,0.7937847971916199
233,7/30/2021 2:13:53 PM,"Edwards Lifesciences Beats Q2 Earnings On Demand Recovery, Boosts FY2021 Guidance; Analysts Raise Price Target",Benzinga,/news/stocks/edwards-lifesciences-beats-q2-earnings-on-demand-recovery-boosts-fy2021-guidance-analysts-raise-price-target-1030668029,positive,0.9312945604324341
234,7/30/2021 6:14:25 PM,What 16 Analyst Ratings Have To Say About Edwards Lifesciences,Benzinga,/news/stocks/what-16-analyst-ratings-have-to-say-about-edwards-lifesciences-1030668940,neutral,0.9436067938804626
235,8/2/2021 1:51:01 PM,10 Biggest Price Target Changes For Monday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-monday-1030675837,neutral,0.7998326420783997
236,8/2/2021 7:20:57 PM,Expert Ratings for Edwards Lifesciences,Benzinga,/news/stocks/expert-ratings-for-edwards-lifesciences-1030677534,neutral,0.8712101578712463
237,8/4/2021 12:31:18 PM,Credit Suisse's latest 'Top of the Crop' list down to two names: At the Open,Seeking Alpha,https://seekingalpha.com/news/3724833-credit-suisses-latest-top-of-the-crop-list-down-to-two-names?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9133922457695007
238,8/5/2021 2:07:56 PM,"The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO",Benzinga,/news/stocks/the-daily-biotech-pulse-merck-reports-positive-keytruda-readout-moderna-slips-despite-q2-beat-bayer-to-buy-vividion-for-up-to-2b-glycomimetics-gets-new-ceo-1030695873,positive,0.8679100871086121
239,8/6/2021 1:42:39 PM,"The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO",Benzinga,/news/stocks/the-daily-biotech-pulse-dicerna-slips-on-data-novavax-tightlipped-on-us-vaccine-approval-adagio-ipo-1030701132,negative,0.6754711866378784
240,8/10/2021 1:55:36 PM,"The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts",Benzinga,/news/stocks/the-daily-biotech-pulse-arcturus-soars-on-covid-19-vaccine-updates-merck-s-keytruda-on-track-for-more-label-expansions-eliem-debuts-1030712978,positive,0.804527997970581
241,8/10/2021 3:54:54 PM,"MedTech, hospital stocks slump after Texas Governor asked to delay elective procedures (Updated)",Seeking Alpha,https://seekingalpha.com/news/3728313-medtech-stocks-slump-after-texas-governor-urged-hospitals-to-delay-elective-procedures?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9571396112442017
242,8/18/2021 1:37:56 PM,"The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline",Benzinga,/news/stocks/the-daily-biotech-pulse-azurrx-jumps-on-data-agios-regulatory-application-for-mitapivat-accepted-for-priority-review-fda-nod-for-glaxosmithkline-1030741574,positive,0.5053825378417969
243,8/20/2021 1:45:43 PM,"The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data",Benzinga,/news/stocks/the-daily-biotech-pulse-j-j-announces-ceo-transition-fibrogen-s-roxadustat-approved-in-europe-geovax-sorrento-announce-covid-19-vaccine-data-1030748705,neutral,0.8679836392402649
244,8/21/2021 6:30:51 PM,Where Edwards Lifesciences Stands With Analysts,Benzinga,/news/stocks/where-edwards-lifesciences-stands-with-analysts-1030750285,neutral,0.9225320816040039
245,8/24/2021 2:09:21 PM,"The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal",Benzinga,/news/stocks/the-daily-biotech-pulse-cara-s-korsuva-greenlighted-by-fda-clinical-trial-disappointments-for-novartis-theravance-vertex-inks-crispr-licensing-deal-1030754775,neutral,0.5257495641708374
246,8/26/2021 9:46:00 PM,Edwards Lifesciences Corporation -- Moody's affirms Edwards Lifesciences Baa2 senior unsecured rating; outlook is stable,Moodys,/news/bonds/edwards-lifesciences-corporation-moody-s-affirms-edwards-lifesciences-baa2-senior-unsecured-rating-outlook-is-stable-1030761984,positive,0.8747735023498535
247,9/3/2021 1:31:13 PM,"The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself",Benzinga,/news/stocks/the-daily-biotech-pulse-cellect-jumps-on-first-apograft-transplantation-astrazeneca-european-commission-bury-legal-hatchet-cassava-defends-itself-1030779479,neutral,0.7601718306541443
248,9/8/2021 1:32:08 PM,"The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod",Benzinga,/news/stocks/the-daily-biotech-pulse-macrogenics-clinical-trial-disappointment-sanofi-to-buy-kadmon-alector-loses-2-key-executives-adma-s-fda-nod-1030786678,neutral,0.5691118240356445
249,9/9/2021 2:17:07 PM,"The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization",Benzinga,/news/stocks/the-daily-biotech-pulse-proqr-lilly-r-d-partnership-sanofi-s-pemphigus-trial-disappointment-humanigen-s-covid-19-drug-denied-emergency-use-authorization-1030789942,neutral,0.9088907241821289
250,10/24/2021 5:45:47 PM,"The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More",Benzinga,/news/stocks/the-week-ahead-in-biotech-oct-24-30-eyenovia-ani-pharma-clearside-medical-fda-decisions-merck-bristol-myers-squibb-earnings-ipos-and-more-1030891741,neutral,0.9414970874786377
251,10/25/2021 3:02:03 PM,Edwards Lifesciences earnings preview: what Wall Street is expecting,Markets Insider Automation,/news/stocks/edwards_lifesciences-q3-earnings-preview-stock-1030894697,neutral,0.9218891859054565
252,10/26/2021 9:35:59 PM,Notable earnings after Wednesday's close,Seeking Alpha,https://seekingalpha.com/news/3758173-notable-earnings-after-wednesdays-close?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8919200301170349
253,10/27/2021 10:25:08 PM,Edwards Lifesciences Corp. Q3 adjusted earnings Beat Estimates,RTTNews,/news/stocks/edwards-lifesciences-corp-q3-adjusted-earnings-beat-estimates-1030906937,positive,0.8775575160980225
254,10/28/2021 2:26:10 PM,"The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug",Benzinga,/news/stocks/the-daily-biotech-pulse-merck-reports-beat-and-raise-quarter-pfizer-biontech-snag-orders-for-additional-vaccine-doses-hcw-cleared-for-phase-1-study-of-pancreatic-cancer-drug-1030910260,positive,0.8363469839096069
255,10/28/2021 6:23:04 PM,Expert Ratings For Edwards Lifesciences,Benzinga,/news/stocks/expert-ratings-for-edwards-lifesciences-1030911399,neutral,0.8712101578712463
256,11/4/2021 11:50:01 AM,Credit Suisse highlights 9 'Top of the Crop' picks for November: At the Open,Seeking Alpha,https://seekingalpha.com/news/3765048-credit-suisse-highlights-8-top-of-the-crop-picks-for-november?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8836307525634766
257,12/3/2021 1:12:11 PM,Microsoft gets a 'Top of the Crop' nod from Credit Suisse: At the Open,Seeking Alpha,https://seekingalpha.com/news/3776836-microsoft-gets-a-top-of-the-crop-nod-from-credit-suisse?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.839984118938446
258,12/6/2021 4:05:46 PM,"Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-december-6-2021-1031026544,negative,0.5734044909477234
259,12/6/2021 9:45:19 PM,Edwards upgraded to overweight at Wells Fargo on transcatheter aortic valve growth,Seeking Alpha,https://seekingalpha.com/news/3777552-edwards-upgraded-to-overweight-at-wells-fargo-on-transcatheter-aortic-valve-growth?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8847494721412659
260,12/8/2021 2:50:31 PM,Edwards Lifesciences projects $5.5 - $6.0 billion global sales in 2022,Seeking Alpha,https://seekingalpha.com/news/3778288-edwards-lifesciences-projects-55-60-billion-global-sales-in-2022?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7615893483161926
261,12/9/2021 4:28:22 PM,10 Biggest Price Target Changes For Thursday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-thursday-1031036160,neutral,0.7969077229499817
262,12/10/2021 1:51:08 PM,10 Biggest Price Target Changes For Friday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-friday-1031038563,neutral,0.791632354259491
263,12/10/2021 6:41:32 PM,"Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-december-10-2021-1031039422,negative,0.6048890352249146
264,12/15/2021 1:26:03 PM,10 Biggest Price Target Changes For Wednesday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-wednesday-1031046876,neutral,0.8142688870429993
265,12/15/2021 4:05:47 PM,"Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-december-15-2021-1031047709,negative,0.5827964544296265
266,12/17/2021 4:17:57 PM,"Benzinga's Top Ratings Upgrades, Downgrades For December 17, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-december-17-2021-1031053650,negative,0.5951844453811646
267,12/17/2021 7:42:39 PM,Edwards Lifesciences upgraded at JP Morgan despite recent outperformance,Seeking Alpha,https://seekingalpha.com/news/3781418-edwards-lifesciences-upgraded-at-jp-morgan-despite-recent-outperformance?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9386242628097534
268,12/20/2021 2:11:20 PM,"Jim Cramer Shares His Thoughts On Medtronic, Peloton Interactive And More",Benzinga,/news/stocks/jim-cramer-shares-his-thoughts-on-medtronic-peloton-interactive-and-more-1031056203,neutral,0.9407474994659424
269,12/20/2021 3:29:35 PM,Edwards Gets FDA Approval For SAPIEN 3 With Alterra For Transcatheter Pulmonic Valve Replacement ,RTTNews,/news/stocks/edwards-gets-fda-approval-for-sapien-3-with-alterra-for-transcatheter-pulmonic-valve-replacement-1031056505,positive,0.8520662784576416
270,12/20/2021 3:55:57 PM,Edwards Lifesciences wins approval for Sapien 3 with Altera prestent,Seeking Alpha,https://seekingalpha.com/news/3781717-edwards-lifesciences-wins-approval-for-sapien-3-with-altera-prestent?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9160712957382202
271,12/24/2021 9:37:35 PM,COVID uptick to hurt MedTech firms and healthcare providers in early 2022 - Goldman Sachs,Seeking Alpha,https://seekingalpha.com/news/3783326-covid-uptick-to-hurt-medtech-firms-and-healthcare-providers-in-early-2022-goldman-sachs?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7903520464897156
272,1/3/2022 4:28:09 PM,"Abbott, Baxter among MedTech favorites at Raymond James for early 2022",Seeking Alpha,https://seekingalpha.com/news/3784631-abbott-baxter-among-medtech-favorites-at-raymond-james-for-early-2022?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8172067999839783
273,1/7/2022 7:02:18 PM,Where Edwards Lifesciences Stands With Analysts,Benzinga,/news/stocks/where-edwards-lifesciences-stands-with-analysts-1031088263,neutral,0.9225320816040039
274,1/25/2022 3:01:13 PM,Edwards Lifesciences is about to announce its earnings — here's what Wall Street expects,Markets Insider Automation,/news/stocks/edwards_lifesciences-stock-q4-earnings-preview-1031126428,neutral,0.9329422116279602
275,1/25/2022 10:35:17 PM,Edwards Lifesciences Q4 2021 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3791308-edwards-lifesciences-q4-2021-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8582025170326233
276,1/25/2022 10:35:19 PM,Notable earnings after Wednesday's close,Seeking Alpha,https://seekingalpha.com/news/3791276-notable-earnings-after-wednesdays-close?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8919200301170349
277,1/26/2022 2:29:25 PM,"The Daily Biotech Pulse: Gilead's Blood Cancer Studies Placed On Partial Clinical Hold, Immunocore Gets FDA Nod, NRx Touts Positive COVID-19 Data",Benzinga,/news/stocks/the-daily-biotech-pulse-gilead-s-blood-cancer-studies-placed-on-partial-clinical-hold-immunocore-gets-fda-nod-nrx-touts-positive-covid-19-data-1031130804,neutral,0.8202437162399292
278,1/26/2022 9:17:28 PM,"Edwards Lifesciences Non-GAAP EPS of $0.51 misses by $0.04, revenue of $1.33B misses by $20M",Seeking Alpha,https://seekingalpha.com/news/3792092-edwards-lifesciences-non-gaap-eps-of-0_51-misses-0_04-revenue-of-1_33b-misses-20m?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5491252541542053
279,1/26/2022 10:26:06 PM,"Edwards Lifesciences Corp. Q4 Profit Increases, but misses estimates",RTTNews,/news/stocks/edwards-lifesciences-corp-q4-profit-increases-but-misses-estimates-1031132630,positive,0.9047290682792664
280,1/26/2022 11:11:39 PM,Edwards Lifesciences down 5% postmarket follow top and bottom line quarterly misses,Seeking Alpha,https://seekingalpha.com/news/3792224-edwards-lifesciences-down-5-postmarket-follow-top-and-bottom-line-quarterly-misses?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9718902111053467
281,1/27/2022 7:02:13 PM,Where Edwards Lifesciences Stands With Analysts,Benzinga,/news/stocks/where-edwards-lifesciences-stands-with-analysts-1031136727,neutral,0.9225320816040039
282,1/27/2022 8:46:51 PM,Edwards Lifesciences at a seven-month low as analysts react to earnings miss,Seeking Alpha,https://seekingalpha.com/news/3792679-edwards-lifesciences-at-a-seven-month-low-as-analysts-react-to-earnings-miss?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9695367217063904
283,1/31/2022 2:20:54 PM,"The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News",Benzinga,/news/stocks/the-week-ahead-in-biotech-jan-31-feb-5-merck-bristol-myers-squibb-lilly-novartis-headline-large-cap-biopharma-earnings-news-1031144306,neutral,0.9110234975814819
284,2/2/2022 4:05:51 PM,"Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-february-2-2022-1031154681,negative,0.4918740391731262
285,2/2/2022 5:33:12 PM,Edwards Lifesciences upgraded at UBS on prospects in TAVR market,Seeking Alpha,https://seekingalpha.com/news/3795028-edwards-lifesciences-upgraded-at-ubs-on-prospects-in-tavr-market?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8708482980728149
286,2/8/2022 12:04:35 PM,"UBS debuts tactical screen for selloff opportunities, cuts Meta off two lists",Seeking Alpha,https://seekingalpha.com/news/3796135-ubs-debuts-tactical-screen-for-selloff-opportunities-cuts-meta-off-two-lists?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9269717931747437
287,3/8/2022 6:13:23 PM,Medtech negatively impacted by rising energy costs- Hammerstone Markets,Seeking Alpha,https://seekingalpha.com/news/3810746-medtech-negatively-impacted-by-rising-energy-costs-hammerstone-markets?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6233038902282715
288,3/16/2022 4:07:50 PM,"Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-march-16-2022-1031285835,negative,0.504859983921051
289,3/16/2022 7:09:38 PM,Analyst Ratings For Edwards Lifesciences,Benzinga,/news/stocks/analyst-ratings-for-edwards-lifesciences-1031286343,neutral,0.9268762469291687
290,3/16/2022 9:02:18 PM,What 9 Analyst Ratings Have To Say About Edwards Lifesciences,Benzinga,/news/stocks/what-9-analyst-ratings-have-to-say-about-edwards-lifesciences-1031286552,neutral,0.9436009526252747
291,3/23/2022 4:17:58 PM,Medical equipment makers drag healthcare sector,Seeking Alpha,https://seekingalpha.com/news/3816537-medical-equipment-makers-drag-healthcare-sector?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7234999537467957
292,4/4/2022 2:10:57 PM,Baxter cut to Sell as Goldman Sachs flags macro risks in MedTech space,Seeking Alpha,https://seekingalpha.com/news/3820395-baxter-cut-to-sell-as-goldman-sachs-flags-macro-concerns-on-medtech-space?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8837200999259949
293,4/5/2022 11:46:42 AM,7 Medical Device Stocks to Buy as Covid-19 Fears Fade,InvestorPlace,/news/stocks/7-medical-device-stocks-to-buy-as-covid-19-fears-fade-1031332907,negative,0.45163992047309875
294,4/11/2022 11:48:55 AM,Goldman screens companies with best and worst pricing power into earnings season,Seeking Alpha,https://seekingalpha.com/news/3822185-godlman-screens-companies-with-best-and-worst-pricing-power-into-earnings-season?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9079514741897583
295,4/13/2022 4:01:57 PM,"Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-april-13-2022-1031353831,neutral,0.5246440172195435
296,4/13/2022 7:02:48 PM,Expert Ratings for Edwards Lifesciences,Benzinga,/news/stocks/expert-ratings-for-edwards-lifesciences-1031354394,neutral,0.8712101578712463
297,4/19/2022 6:55:51 PM,"Abiomed, AtriCure draw bullish views at Piper on proposed Medicare rates",Seeking Alpha,https://seekingalpha.com/news/3824436-abmd-atrc-stocks-draw-bullish-views-at-piper-on-proposed-medicare-rates?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8464428186416626
298,4/25/2022 3:01:13 PM,Edwards Lifesciences is about to announce earnings — here's what Wall Street expects,Markets Insider Automation,/news/stocks/edwards_lifesciences-stock-price-q1-earnings-preview-1031380071,neutral,0.933809220790863
299,4/25/2022 9:35:11 PM,Edwards Lifesciences Q1 2022 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3826333-edwards-lifesciences-q1-2022-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9024057984352112
300,4/25/2022 9:35:27 PM,Notable earnings after Tuesday's close,Seeking Alpha,https://seekingalpha.com/news/3826203-notable-earnings-after-tuesdays-close?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8953563570976257
301,4/26/2022 8:17:06 PM,"Edwards Lifesciences Non-GAAP EPS of $0.60 beats by $0.03, revenue of $1.34B beats by $30M",Seeking Alpha,https://seekingalpha.com/news/3827156-edwards-lifesciences-non-gaap-eps-of-0_60-beats-0_03-revenue-of-1_34b-beats-30m?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5773857831954956
302,4/26/2022 9:19:34 PM,"Despite top and bottom line earnings beat, Edwards Lifesciences falls 4%",Seeking Alpha,https://seekingalpha.com/news/3827269-despite-top-and-bottom-line-earnings-beat-edwards-lifesciences-falls-4?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9631662964820862
303,4/26/2022 10:31:07 PM,"Edwards Lifesciences Corp. Q1 Profit Increases, beats estimates",RTTNews,/news/stocks/edwards-lifesciences-corp-q1-profit-increases-beats-estimates-1031386675,positive,0.9340653419494629
304,4/27/2022 2:38:09 PM,Edwards Lifesciences Clocks 10% Top-Line Growth In Q1; Forecasts Lower Than Expected Q2 Sales,Benzinga,/news/stocks/edwards-lifesciences-clocks-10-top-line-growth-in-q1-forecasts-lower-than-expected-q2-sales-1031391037,negative,0.8371808528900146
305,5/3/2022 1:47:40 PM,Why Jim Cramer Prefers These 2 Semiconductor Stocks,Benzinga,/news/stocks/why-jim-cramer-prefers-these-2-semiconductor-stocks-1031413237,neutral,0.9349565505981445
306,5/6/2022 2:50:26 PM,"Cramer Gives His Opinion On CoreCivic, SGHC And More",Benzinga,/news/stocks/cramer-gives-his-opinion-on-corecivic-sghc-and-more-1031430970,neutral,0.9499825239181519
307,5/17/2022 1:49:20 PM,7 Growth Stocks That Analysts Love Right Now,InvestorPlace,/news/stocks/7-growth-stocks-that-analysts-love-right-now-1031468936,neutral,0.9026117920875549
308,5/17/2022 10:32:04 PM,Where Edwards Lifesciences Stands With Analysts,Benzinga,/news/stocks/where-edwards-lifesciences-stands-with-analysts-1031469923,neutral,0.9225320816040039
309,6/22/2022 3:03:11 PM,"Jim Cramer Shares His Takes On Marathon Oil, T Rowe Price Group And More",Benzinga,/news/stocks/jim-cramer-shares-his-takes-on-marathon-oil-t-rowe-price-group-and-more-1031543321,neutral,0.9408597946166992
310,7/18/2022 10:53:41 PM,Expert Ratings for Edwards Lifesciences,Benzinga,/news/stocks/expert-ratings-for-edwards-lifesciences-1031595106,neutral,0.8712101578712463
311,7/27/2022 3:01:13 PM,Edwards Lifesciences earnings preview: what to expect,Markets Insider Automation,/news/stocks/edwards_lifesciences-stock-q2-earnings-preview-1031620549,neutral,0.9303550720214844
312,7/27/2022 9:35:06 PM,Notable earnings after Thursday's close,Seeking Alpha,https://seekingalpha.com/news/3861399-notable-earnings-after-thursdays-close?utm_source=businessinsider&utm_medium=referral,positive,0.8900271058082581
313,7/27/2022 9:35:54 PM,Edwards Lifesciences Q2 2022 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3861617-edwards-lifesciences-q2-2022-earnings-preview?utm_source=businessinsider&utm_medium=referral,neutral,0.9069837331771851
314,7/28/2022 8:22:56 PM,"Edwards Lifesciences Non-GAAP EPS of $0.63 misses by $0.01, revenue of $1.37B misses by $30M",Seeking Alpha,https://seekingalpha.com/news/3862729-edwards-lifesciences-non-gaap-eps-of-0_63-misses-0_01-revenue-of-1_37b-misses-30m?utm_source=businessinsider&utm_medium=referral,neutral,0.5472267270088196
315,7/28/2022 8:51:00 PM,"Edwards Lifesciences stock down ~6% after hours on Q2 results miss, slashed FY guidance",Seeking Alpha,https://seekingalpha.com/news/3862805-edwards-lifesciences-stock-down-6-after-hours-on-q2-results-miss-slashed-fy-guidance?utm_source=businessinsider&utm_medium=referral,negative,0.9717707633972168
316,7/28/2022 10:23:24 PM,"Edwards Lifesciences Corp. Q2 Profit Decreases, misses estimates",RTTNews,/news/stocks/edwards-lifesciences-corp-q2-profit-decreases-misses-estimates-1031627315,negative,0.9732015132904053
317,7/29/2022 11:22:35 AM,Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday,InvestorPlace,/news/stocks/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-july-29-1031629706,neutral,0.5049089193344116
318,7/29/2022 12:31:03 PM,"BABA, BILI and FMS among pre market losers",Seeking Alpha,https://seekingalpha.com/news/3863128-baba-bili-and-fms-among-pre-market-losers?utm_source=businessinsider&utm_medium=referral,neutral,0.9162664413452148
319,7/29/2022 4:31:04 PM,"Benzinga's Top Ratings Upgrades, Downgrades For July 29, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-july-29-2022-1031630399,neutral,0.533697783946991
320,9/15/2022 2:32:07 PM,Edwards Lifesciences wins FDA approval for PASCAL transcatheter valve repair system,Seeking Alpha,https://seekingalpha.com/news/3883119-edwards-lifesciences-wins-fda-approval-for-pascal-transcatheter-valve-repair-system?utm_source=businessinsider&utm_medium=referral,positive,0.9268574714660645
321,9/16/2022 12:47:03 AM,"Important Biotech Catalysts For September 15, 2022 - End Of The Day Summary",Benzinga,/news/stocks/important-biotech-catalysts-for-september-15-2022---end-of-the-day-summary-1031746992,neutral,0.9436883330345154
322,9/19/2022 10:10:56 AM,Analysts Offer Insights on Healthcare Companies: Alcon (ALC) and Edwards Lifesciences (EW),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-alcon-alc-and-edwards-lifesciences-ew-1031750239,neutral,0.9055880308151245
323,9/22/2022 2:20:59 PM,HC Wainwright Cuts Price Target On This Stock By 50%? Also This Analyst Slashes PT On Cisco,Benzinga,/news/stocks/hc-wainwright-cuts-price-target-on-this-stock-by-50-also-this-analyst-slashes-pt-on-cisco-1031759168,negative,0.5651688575744629
324,9/22/2022 3:18:51 PM,What 8 Analyst Ratings Have To Say About Edwards Lifesciences,Benzinga,/news/stocks/what-8-analyst-ratings-have-to-say-about-edwards-lifesciences-1031759472,neutral,0.9451578855514526
325,10/12/2022 4:02:53 PM,"Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-october-12-2022-1031799955,neutral,0.527388334274292
326,10/12/2022 4:13:22 PM,Where Edwards Lifesciences Stands With Analysts,Benzinga,/news/stocks/where-edwards-lifesciences-stands-with-analysts-1031800045,neutral,0.9225320816040039
327,10/14/2022 2:58:03 PM,Microsoft To $325? Plus This Analyst Sees BlackRock Dropping By 15%,Benzinga,/news/stocks/microsoft-to-325-plus-this-analyst-sees-blackrock-dropping-by-15-1031806192,negative,0.9676775336265564
328,10/18/2022 4:21:58 PM,"Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-october-18-2022-1031813984,neutral,0.4930570423603058
329,10/26/2022 3:01:13 PM,What Wall Street expects from Edwards Lifesciences's earnings,Markets Insider Automation,/news/stocks/edwards_lifesciences-q3-earnings-preview-1031838133,neutral,0.9170252084732056
330,10/26/2022 4:07:48 PM,"Benzinga's Top Ratings Upgrades, Downgrades For October 26, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-october-26-2022-1031838805,neutral,0.4896215796470642
331,10/26/2022 9:35:41 PM,Edwards Lifesciences Q3 2022 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3895620-edwards-lifesciences-q3-2022-earnings-preview?utm_source=businessinsider&utm_medium=referral,neutral,0.8973557353019714
332,10/27/2022 8:24:29 PM,"Edwards Lifesciences Non-GAAP EPS of $0.61 misses by $0.01, revenue of $1.32B misses by $10M",Seeking Alpha,https://seekingalpha.com/news/3896846-edwards-lifesciences-non-gaap-eps-of-0_61-misses-0_01-revenue-of-1_32b-misses-10m?utm_source=businessinsider&utm_medium=referral,neutral,0.54509437084198
333,10/27/2022 10:14:21 PM,"Edwards Lifesciences down 11% after Q3 misses, revised 2022 EPS guidance",Seeking Alpha,https://seekingalpha.com/news/3897003-edwards-lifesciences-down-11-after-q3-misses-revised-2022-eps-guidance?utm_source=businessinsider&utm_medium=referral,negative,0.9725766777992249
334,10/27/2022 11:02:13 PM,"Edwards Lifesciences Corp. Q3 Profit Increases, but misses estimates",RTTNews,/news/stocks/edwards-lifesciences-corp-q3-profit-increases-but-misses-estimates-1031845438,positive,0.911952018737793
335,10/27/2022 11:43:00 PM,Edwards Lifesciences Cuts FY22 Outlook; Shares Tank 10% ,RTTNews,/news/stocks/edwards-lifesciences-cuts-fy22-outlook-shares-tank-10-1031845554,negative,0.9556320905685425
336,10/28/2022 4:25:09 AM,BTIG Sticks to Their Hold Rating for Edwards Lifesciences (EW),TipRanks,/news/stocks/btig-sticks-to-their-hold-rating-for-edwards-lifesciences-ew-1031845966,neutral,0.8570407629013062
337,10/28/2022 11:31:11 AM,Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday,InvestorPlace,/news/stocks/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-oct-28-1031848051,neutral,0.5049089193344116
338,10/28/2022 12:14:33 PM,Why Pinterest Shares Are Trading Higher; Here Are 27 Stocks Moving Premarket,Benzinga,/news/stocks/why-pinterest-shares-are-trading-higher-here-are-27-stocks-moving-premarket-1031847746,neutral,0.8411549925804138
339,10/28/2022 12:24:11 PM,"Amazon.com, Pinduoduo, JD.com among premarket losers' pack",Seeking Alpha,https://seekingalpha.com/news/3897206-amazoncom-pinduoduo-jdcom-among-premarket-losers-pack?utm_source=businessinsider&utm_medium=referral,neutral,0.9054520726203918
340,10/28/2022 12:42:54 PM,"Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), West Pharmaceutical Services (WST) and Argenx Se (ARGX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-edwards-lifesciences-ew-west-pharmaceutical-services-wst-and-argenx-se-argx-1031848376,neutral,0.9109487533569336
341,10/28/2022 1:03:49 PM,"Analysts’ Top Healthcare Picks: Edwards Lifesciences (EW), Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-top-healthcare-picks-edwards-lifesciences-ew-vertex-pharmaceuticals-vrtx-1031848550,positive,0.7616164684295654
342,10/28/2022 2:02:57 PM,"Nuvalent, DexCom top healthcare gainers; DaVita, LeMaitre lead losers' pack",Seeking Alpha,https://seekingalpha.com/news/3897287-nuvalent-dexcom-top-healthcare-gainers-davita-lemaitre-lead-losers-pack?utm_source=businessinsider&utm_medium=referral,positive,0.8436352610588074
343,10/28/2022 4:12:35 PM,"Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-october-28-2022-1031848725,neutral,0.4888375699520111
344,10/28/2022 4:27:31 PM,US Stocks Mostly Higher; Dow Surges 300 Points,Benzinga,/news/stocks/us-stocks-mostly-higher-dow-surges-300-points-1031848790,positive,0.7758517265319824
345,10/28/2022 4:36:39 PM,Morgan Stanley Keeps Their Buy Rating on Edwards Lifesciences (EW),TipRanks,/news/stocks/morgan-stanley-keeps-their-buy-rating-on-edwards-lifesciences-ew-1031849117,neutral,0.9212889075279236
346,10/28/2022 4:53:24 PM,BDTX and TCRX among mid-day movers,Seeking Alpha,https://seekingalpha.com/news/3897376-bdtx-and-tcrx-among-mid-day-movers?utm_source=businessinsider&utm_medium=referral,neutral,0.8749073147773743
347,10/28/2022 5:57:24 PM,Dow Jumps 600 Points; Crude Oil Down Over 1%,Benzinga,/news/stocks/dow-jumps-600-points-crude-oil-down-over-1-1031849022,negative,0.9159544706344604
348,10/28/2022 6:12:36 PM,Why Edwards Lifesciences Shares Are Trading Lower By Around 17%? Here Are 47 Stocks Moving In Friday's Mid-Day Session,Benzinga,/news/stocks/why-edwards-lifesciences-shares-are-trading-lower-by-around-17-here-are-47-stocks-moving-in-friday-s-mid-day-session-1031849053,negative,0.791652500629425
349,10/28/2022 8:35:31 PM,Nasdaq Climbs 275 Points; S&P 500 Rises Over 2%,Benzinga,/news/stocks/nasdaq-climbs-275-points-s-p-500-rises-over-2-1031849315,positive,0.8829936385154724
350,10/31/2022 1:20:34 AM,Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW) and Dr Reddy’s Laboratories (RDY),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-edwards-lifesciences-ew-and-dr-reddy-s-laboratories-rdy-1031850800,neutral,0.895889937877655
351,10/31/2022 9:13:01 AM,Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday,Benzinga,/news/stocks/why-pinterest-shares-jumped-around-14-here-are-69-biggest-movers-from-friday-1031852696,neutral,0.9106787443161011
352,10/31/2022 10:44:18 AM,"Weibo, XPeng, Li Auto And Other Big Losers From Friday",Benzinga,/news/stocks/weibo-xpeng-li-auto-and-other-big-losers-from-friday-1031852866,negative,0.6121727228164673
353,10/31/2022 12:22:29 PM,Honeywell To $194? Plus Citigroup Slashes PT On This Stock By Over 93%,Benzinga,/news/stocks/honeywell-to-194-plus-citigroup-slashes-pt-on-this-stock-by-over-93-1031853127,negative,0.863725483417511
354,10/31/2022 4:01:53 PM,7 Stocks to Buy at the ‘Midterm Elections’ Bottom,InvestorPlace,/news/stocks/7-stocks-to-buy-at-midterm-elections-bottom-1031854352,neutral,0.8731608986854553
355,11/1/2022 1:16:15 PM,Edwards Lifesciences executes $750M accelerated share repurchase,Seeking Alpha,https://seekingalpha.com/news/3898525-edwards-lifesciences-executes-750m-accelerated-share-repurchase?utm_source=businessinsider&utm_medium=referral,neutral,0.8734431266784668
356,11/1/2022 2:31:40 PM,Edwards Lifesciences Announces $750 Mln Buyback ,RTTNews,/news/stocks/edwards-lifesciences-announces-750-mln-buyback-1031858632,neutral,0.9001708030700684
357,11/1/2022 8:30:10 PM,Quant Ratings Updated on 113 Stocks,InvestorPlace,/news/stocks/20221101-quant-ratings-1031860320,neutral,0.9265337586402893
358,11/3/2022 1:06:27 PM,Cramer's Take On This Stock That's Down 53% Year-To-Date: 'I Think Long-Term. I Don't Want To Own It',Benzinga,/news/stocks/cramer-s-take-on-this-stock-that-s-down-53-year-to-date-i-think-long-term-i-don-t-want-to-own-it-1031870171,negative,0.8992704749107361
359,11/3/2022 4:40:18 PM,"Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), United Therapeutics (UTHR) and Ultragenyx Pharmaceutical (RARE)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-edwards-lifesciences-ew-united-therapeutics-uthr-and-ultragenyx-pharmaceutical-rare-1031871748,neutral,0.9159085154533386
360,11/4/2022 1:15:13 AM,Credit Suisse Sticks to Its Hold Rating for Edwards Lifesciences (EW),TipRanks,/news/stocks/credit-suisse-sticks-to-its-hold-rating-for-edwards-lifesciences-ew-1031873102,neutral,0.7382323741912842
361,11/11/2022 8:16:39 PM,"Healthcare stocks come off lows, worst performing sector among defensive losers (update)",Seeking Alpha,https://seekingalpha.com/news/3906637-healthcare-stocks-fall-across-the-board-as-traders-move-out-of-defensive-sectors?utm_source=businessinsider&utm_medium=referral,negative,0.8541240692138672
362,11/28/2022 2:34:34 AM,Edwards Announces Positive Data On Transfemoral Transcatheter Tricuspid Valve Replacement ,RTTNews,/news/stocks/edwards-announces-positive-data-on-transfemoral-transcatheter-tricuspid-valve-replacement-1031938800,positive,0.9417548775672913
363,11/28/2022 3:06:09 PM,15 Analysts Have This to Say About Edwards Lifesciences,Benzinga,/news/stocks/15-analysts-have-this-to-say-about-edwards-lifesciences-1031939963,neutral,0.9336784482002258
364,11/28/2022 3:14:24 PM,Reata Pharmaceuticals To Jump 220%? Plus JP Morgan Predicts $51 For Las Vegas Sands,Benzinga,/news/stocks/reata-pharmaceuticals-to-jump-220-plus-jp-morgan-predicts-51-for-las-vegas-sands-1031939997,positive,0.8867543935775757
365,11/28/2022 4:05:23 PM,Expert Ratings for Edwards Lifesciences,Benzinga,/news/stocks/expert-ratings-for-edwards-lifesciences-1031940109,neutral,0.8712101578712463
366,12/2/2022 4:00:50 PM,"Benzinga's Top Ratings Upgrades, Downgrades For December 2, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-december-2-2022-1031950556,neutral,0.5192335844039917
367,12/6/2022 1:46:00 PM,JPMorgan To Rally Around 17%? Here Are 10 Other Price Target Changes For Tuesday,Benzinga,/news/stocks/jpmorgan-to-rally-around-17-here-are-10-other-price-target-changes-for-tuesday-1031955153,neutral,0.9244601726531982
368,12/6/2022 3:26:38 PM,Edwards Lifesciences cut to Hold at Stifel on TAVR market outlook,Seeking Alpha,https://seekingalpha.com/news/3914359-ew-stock-cut-to-hold-stifel-tavr-market-outlook?utm_source=businessinsider&utm_medium=referral,negative,0.5336319804191589
369,12/6/2022 4:05:04 PM,"Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-december-6-2022-1031955691,neutral,0.5029000043869019
370,12/8/2022 1:28:42 PM,Edwards Lifesciences CEO Michael Mussallem to retire,Seeking Alpha,https://seekingalpha.com/news/3915261-edwards-lifesciences-ceo-michael-mussallem-to-retire?utm_source=businessinsider&utm_medium=referral,neutral,0.8635313510894775
371,12/8/2022 2:11:57 PM,Edwards Lifesciences: Bernard Zovighian To Succeed Michael Mussallem As CEO ,RTTNews,/news/stocks/edwards-lifesciences-bernard-zovighian-to-succeed-michael-mussallem-as-ceo-1031960332,neutral,0.92225182056427
372,12/8/2022 2:25:07 PM,BTIG Reaffirms Their Hold Rating on Edwards Lifesciences (EW),TipRanks,/news/stocks/btig-reaffirms-their-hold-rating-on-edwards-lifesciences-ew-1031960803,neutral,0.8089757561683655
373,12/13/2022 1:45:15 AM,RBC Capital Remains a Buy on Edwards Lifesciences (EW),TipRanks,/news/stocks/rbc-capital-remains-a-buy-on-edwards-lifesciences-ew-1031967963,neutral,0.9438652396202087
374,12/13/2022 12:30:23 PM,"Analysts Conflicted on These Healthcare Names: Amgen (AMGN), Edwards Lifesciences (EW) and Horizon Therapeutics (HZNP)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-amgen-amgn-edwards-lifesciences-ew-and-horizon-therapeutics-hznp-1031968908,negative,0.6572074890136719
375,12/16/2022 12:34:33 PM,"Jim Cramer Recommends These 5 Healthcare Stocks For 2023: 'Biggest Winners Were Boring, Consistent Operators'",Benzinga,/news/stocks/jim-cramer-recommends-these-5-healthcare-stocks-for-2023-biggest-winners-were-boring-consistent-operators-1031976997,neutral,0.8001697063446045
376,12/17/2022 11:38:17 PM,Citi lists the contrarian bull and bear stock calls for 2023,Seeking Alpha,https://seekingalpha.com/news/3918107-citi-lists-the-contrarian-bull-and-bear-stock-calls-for-2023?utm_source=businessinsider&utm_medium=referral,neutral,0.9323194026947021
377,1/6/2023 4:26:30 PM,Edwards Lifesciences (EW) Receives a Buy from Morgan Stanley,TipRanks,/news/stocks/edwards-lifesciences-ew-receives-a-buy-from-morgan-stanley-1032004647,positive,0.6059368848800659
378,1/13/2023 1:57:02 AM,Edwards Lifesciences (EW) Gets a Buy from RBC Capital,TipRanks,/news/stocks/edwards-lifesciences-ew-gets-a-buy-from-rbc-capital-1032016256,neutral,0.7262666821479797
379,1/16/2023 3:23:03 PM,Goldman picks 50 top return-on-equity stocks for a tough ROE year,Seeking Alpha,https://seekingalpha.com/news/3924725-goldman-picks-50-top-return-on-equity-stocks-for-a-tough-roe-year?utm_source=businessinsider&utm_medium=referral,neutral,0.8135861754417419
380,1/30/2023 12:24:04 PM,Edwards Lifesciences slips as Piper downgrades on challenging setup,Seeking Alpha,https://seekingalpha.com/news/3929293-ew-stock-slips-as-piper-sandler-downgrades-edwards-lifesciences?utm_source=businessinsider&utm_medium=referral,negative,0.9692133069038391
381,1/30/2023 1:44:41 PM,Amazon To Rally Around 29%? Here Are 10 Other Analyst Forecasts For Monday,Benzinga,/news/stocks/amazon-to-rally-around-29-here-are-10-other-analyst-forecasts-for-monday-1032050669,neutral,0.9044280052185059
382,1/30/2023 3:01:13 PM,Edwards Lifesciences earnings preview: what Wall Street is expecting,Markets Insider Automation,/news/stocks/edwards_lifesciences-stock-quarter-earnings-preview-q4-1032050952,neutral,0.9218891859054565
383,1/30/2023 4:00:50 PM,"Benzinga's Top Ratings Upgrades, Downgrades For January 30, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-january-30-2023-1032051242,negative,0.5226986408233643
384,1/30/2023 10:00:58 PM,What 8 Analyst Ratings Have To Say About Edwards Lifesciences,Benzinga,/news/stocks/what-8-analyst-ratings-have-to-say-about-edwards-lifesciences-1032051902,neutral,0.9451578855514526
385,1/30/2023 10:35:25 PM,Notable earnings after Tuesday's close,Seeking Alpha,https://seekingalpha.com/news/3929403-notable-earnings-after-tuesdays-close?utm_source=businessinsider&utm_medium=referral,positive,0.8953563570976257
386,1/30/2023 10:35:45 PM,Edwards Lifesciences Q4 2022 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3929487-edwards-lifesciences-q4-2022-earnings-preview?utm_source=businessinsider&utm_medium=referral,neutral,0.9119400382041931
387,1/31/2023 1:10:11 PM,"Analysts Are Bullish on These Healthcare Stocks: Edwards Lifesciences (EW), Envista Holdings (NVST)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-edwards-lifesciences-ew-envista-holdings-nvst-1032054069,neutral,0.6933616995811462
388,1/31/2023 9:21:08 PM,"Edwards Lifesciences Non-GAAP EPS of $0.64 beats by $0.03, revenue of $1.35B beats by $20M",Seeking Alpha,https://seekingalpha.com/news/3930127-edwards-lifesciences-non-gaap-eps-of-0_64-beats-0_03-revenue-of-1_35b-beats-20m?utm_source=businessinsider&utm_medium=referral,neutral,0.5125897526741028
389,1/31/2023 10:22:45 PM,"Edwards Lifesciences Corp. Q4 Profit Increases, beats estimates",RTTNews,/news/stocks/edwards-lifesciences-corp-q4-profit-increases-beats-estimates-1032055735,positive,0.9376407861709595
390,2/1/2023 1:45:43 PM,Edwards Lifesciences (EW) Receives a Hold from BTIG,TipRanks,/news/stocks/edwards-lifesciences-ew-receives-a-hold-from-btig-1032058794,neutral,0.8885552287101746
391,2/1/2023 1:57:10 PM,Stifel Nicolaus Remains a Hold on Edwards Lifesciences (EW),TipRanks,/news/stocks/stifel-nicolaus-remains-a-hold-on-edwards-lifesciences-ew-1032058713,neutral,0.9221562147140503
392,2/1/2023 1:57:45 PM,Bank of America Securities Sticks to Their Hold Rating for Edwards Lifesciences (EW),TipRanks,/news/stocks/bank-of-america-securities-sticks-to-their-hold-rating-for-edwards-lifesciences-ew-1032059237,neutral,0.8992408514022827
393,2/1/2023 1:59:09 PM,"Analysts Are Bullish on These Healthcare Stocks: Edwards Lifesciences (EW), Alpine Immune Sciences (ALPN)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-edwards-lifesciences-ew-alpine-immune-sciences-alpn-1032059207,neutral,0.5254297852516174
394,2/2/2023 10:54:14 AM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN), Bio-Rad Laboratories (BIO) and Edwards Lifesciences (EW)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-amgen-amgn-bio-rad-laboratories-bio-and-edwards-lifesciences-ew-1032062083,negative,0.6319912075996399
395,2/2/2023 11:10:31 AM,"Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Humana (HUM) and Thermo Fisher (TMO)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-edwards-lifesciences-ew-humana-hum-and-thermo-fisher-tmo-1032062137,neutral,0.9080888628959656
396,2/4/2023 1:50:24 AM,"Analysts Are Bullish on Top Healthcare Stocks: Edwards Lifesciences (EW), Humana (HUM)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-edwards-lifesciences-ew-humana-hum-1032067276,positive,0.5106948614120483
397,2/6/2023 4:01:32 PM,"Benzinga's Top Ratings Upgrades, Downgrades For February 6, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-february-6-2023-1032070686,negative,0.5190939903259277
398,2/6/2023 4:15:26 PM,Edwards Lifesciences downgraded to market perform at Raymond James on growth challenges,Seeking Alpha,https://seekingalpha.com/news/3932357-edwards-lifesciences-downgraded-to-market-perform-at-raymond-james-on-growth-challenges?utm_source=businessinsider&utm_medium=referral,negative,0.8949730396270752
399,2/7/2023 1:15:04 AM,Credit Suisse Keeps Their Hold Rating on Edwards Lifesciences (EW),TipRanks,/news/stocks/credit-suisse-keeps-their-hold-rating-on-edwards-lifesciences-ew-1032071710,neutral,0.9154864549636841
400,2/25/2023 9:00:00 PM,"Pharmas, medtechs dominate list of innovation leaders thanks to patents",Seeking Alpha,https://seekingalpha.com/news/3940793-pharmas-medtechs-dominate-list-of-innovation-leaders-thanks-to-patents?utm_source=businessinsider&utm_medium=referral,neutral,0.6739815473556519
401,3/2/2023 5:35:01 PM,Stocks that thrive and struggle the most as rates rise - BofA,Seeking Alpha,https://seekingalpha.com/news/3943181-stocks-helped-and-hit-hard-by-rising-rates?utm_source=businessinsider&utm_medium=referral,neutral,0.5202492475509644
402,3/3/2023 1:45:08 PM,Jefferies Reaffirms Their Buy Rating on Edwards Lifesciences (EW),TipRanks,/news/stocks/jefferies-reaffirms-their-buy-rating-on-edwards-lifesciences-ew-1032143825,neutral,0.8305209279060364
403,3/4/2023 1:55:25 AM,Edwards Lifesciences (EW) Receives a Buy from RBC Capital,TipRanks,/news/stocks/edwards-lifesciences-ew-receives-a-buy-from-rbc-capital-1032145054,neutral,0.5992449522018433
404,3/8/2023 12:30:30 PM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Edwards Lifesciences (EW), Prophase Labs (PRPH) and Seres Therapeutics (MCRB)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-edwards-lifesciences-ew-prophase-labs-prph-and-seres-therapeutics-mcrb-1032153320,negative,0.9126917123794556
405,3/8/2023 1:01:42 PM,Edwards Lifesciences downgraded at Wells Fargo on growth concerns,Seeking Alpha,https://seekingalpha.com/news/3945290-edwards-lifesciences-downgraded-at-wells-fargo-on-growth-concerns?utm_source=businessinsider&utm_medium=referral,negative,0.9329724311828613
406,3/8/2023 3:00:40 PM,Expert Ratings for Edwards Lifesciences,Benzinga,/news/stocks/expert-ratings-for-edwards-lifesciences-1032153821,neutral,0.8712101578712463
407,3/8/2023 4:00:34 PM,"Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-march-8-2023-1032154041,negative,0.49161553382873535
408,3/29/2023 4:01:15 PM,The Latest Analyst Ratings for Edwards Lifesciences,Benzinga,/news/stocks/the-latest-analyst-ratings-for-edwards-lifesciences-1032200728,neutral,0.942221999168396
409,3/29/2023 5:00:39 PM,"Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-march-29-2023-1032200913,negative,0.49505260586738586
410,4/3/2023 10:15:10 AM,Citigroup Reaffirms Their Buy Rating on Edwards Lifesciences (EW),TipRanks,/news/stocks/citigroup-reaffirms-their-buy-rating-on-edwards-lifesciences-ew-1032210149,neutral,0.8503695130348206
411,4/6/2023 12:25:52 PM,Piper Sandler Remains a Hold on Edwards Lifesciences (EW),TipRanks,/news/stocks/piper-sandler-remains-a-hold-on-edwards-lifesciences-ew-1032218955,neutral,0.9007685780525208
412,4/24/2023 12:25:16 PM,Jefferies Sticks to Its Buy Rating for Edwards Lifesciences (EW),TipRanks,/news/stocks/jefferies-sticks-to-its-buy-rating-for-edwards-lifesciences-ew-1032253963,neutral,0.8274935483932495
413,4/24/2023 10:01:15 PM,The Latest Analyst Ratings for Edwards Lifesciences,Benzinga,/news/stocks/the-latest-analyst-ratings-for-edwards-lifesciences-1032255416,neutral,0.942221999168396
414,4/25/2023 1:53:57 PM,eBay To Rally Around 30%? Here Are 10 Other Analyst Forecasts For Tuesday,Benzinga,/news/stocks/ebay-to-rally-around-30-here-are-10-other-analyst-forecasts-for-tuesday-1032257974,neutral,0.9193334579467773
415,4/25/2023 9:35:21 PM,Edwards Lifesciences Q1 2023 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3959956-edwards-lifesciences-q1-2023-earnings-preview?utm_source=businessinsider&utm_medium=referral,neutral,0.8981328010559082
416,4/26/2023 3:01:13 PM,Edwards Lifesciences earnings preview: what Wall Street is expecting,Markets Insider Automation,/news/stocks/edwards_lifesciences-stock-price-q1-earnings-preview-1032263477,neutral,0.9218891859054565
417,4/26/2023 8:23:27 PM,"Edwards Lifesciences Non-GAAP EPS of $0.60 misses by $0.01, revenue of $1.46B beats by $70M",Seeking Alpha,https://seekingalpha.com/news/3960877-edwards-lifesciences-non-gaap-eps-of-0_60-misses-0_01-revenue-of-1_46b-beats-70m?utm_source=businessinsider&utm_medium=referral,neutral,0.5301595330238342
418,4/26/2023 10:05:41 PM,"Edwards Lifesciences non-GAAP EPS of $0.62 beats by $0.01, revenue of $1.46B beats by $70M",Seeking Alpha,https://seekingalpha.com/news/3960877-edwards-lifesciences-non-gaap-eps-of-062-beats-001-revenue-of-146b-beats-70m?utm_source=businessinsider&utm_medium=referral,neutral,0.5618621110916138
419,4/26/2023 10:46:16 PM,"Edwards Lifesciences Corp. Q1 Profit Decreases, but beats estimates",RTTNews,/news/stocks/edwards-lifesciences-corp-q1-profit-decreases-but-beats-estimates-1032265262,negative,0.966817319393158
420,4/27/2023 3:45:05 AM,BTIG Sticks to Its Hold Rating for Edwards Lifesciences (EW),TipRanks,/news/stocks/btig-sticks-to-its-hold-rating-for-edwards-lifesciences-ew-1032265772,neutral,0.8261594176292419
421,4/27/2023 11:20:32 AM,"Analysts Are Bullish on Top Healthcare Stocks: Edwards Lifesciences (EW), Humana (HUM)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-edwards-lifesciences-ew-humana-hum-1032268206,positive,0.5106948614120483
422,4/27/2023 12:26:27 PM,Edwards Lifesciences (EW) Gets a Hold from Piper Sandler,TipRanks,/news/stocks/edwards-lifesciences-ew-gets-a-hold-from-piper-sandler-1032268514,neutral,0.872122049331665
423,4/27/2023 1:01:01 PM,"Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Eli Lilly & Co (LLY) and Universal Health (UHS)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-edwards-lifesciences-ew-eli-lilly-co-lly-and-universal-health-uhs-1032269007,neutral,0.9226823449134827
424,4/27/2023 7:00:43 PM,Piper Sandler Maintains Neutral Rating for Edwards Lifesciences: Here's What You Need To Know,Benzinga,/news/stocks/piper-sandler-maintains-neutral-rating-for-edwards-lifesciences-here-s-what-you-need-to-know-1032269890,neutral,0.924716055393219
425,4/28/2023 8:31:31 AM,"Analysts Conflicted on These Healthcare Names: Edwards Lifesciences (EW), Gilead Sciences (GILD) and Revance Therapeutics (RVNC)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-edwards-lifesciences-ew-gilead-sciences-gild-and-revance-therapeutics-rvnc-1032272731,negative,0.6772834658622742
426,5/4/2023 4:25:48 PM,RBC Capital Keeps Their Buy Rating on Edwards Lifesciences (EW),TipRanks,/news/stocks/rbc-capital-keeps-their-buy-rating-on-edwards-lifesciences-ew-1032293649,neutral,0.9204249978065491
427,5/5/2023 1:15:06 AM,Credit Suisse Sticks to Its Hold Rating for Edwards Lifesciences (EW),TipRanks,/news/stocks/credit-suisse-sticks-to-its-hold-rating-for-edwards-lifesciences-ew-1032294657,neutral,0.7382323741912842
428,5/8/2023 4:52:45 AM,Edwards:Aortic Valve With Resilia Tissue Shows Favorable Durability& Efficacy Outcomes In 7-yrs Data ,RTTNews,/news/stocks/edwards-aortic-valve-with-resilia-tissue-shows-favorable-durability-efficacy-outcomes-in-7-yrs-data-1032299929,positive,0.9565122723579407
429,5/30/2023 8:01:59 PM,The Latest Analyst Ratings for Edwards Lifesciences,Benzinga,/news/stocks/the-latest-analyst-ratings-for-edwards-lifesciences-1032359080,neutral,0.942221999168396
430,6/2/2023 2:32:37 PM,"Illumina names Hologic CEO as chair, elects Edwards CFO to board",Seeking Alpha,https://seekingalpha.com/news/3977158-illumina-names-hologic-ceo-as-chair-elects-edwards-cfo-to-board?utm_source=businessinsider&utm_medium=referral,neutral,0.9450439810752869
431,6/7/2023 9:01:18 AM,"Analysts Offer Insights on Healthcare Companies: Bristol Myers (BMY), Edwards Lifesciences (EW) and Amedisys (AMED)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-bristol-myers-bmy-edwards-lifesciences-ew-and-amedisys-amed-1032375205,neutral,0.9114871621131897
432,6/10/2023 10:55:00 PM,Best oversold stocks and worst crowded shorts from Citi's quant team,Seeking Alpha,https://seekingalpha.com/news/3977936-best-oversold-stocks-and-worst-crowded-shorts-from-citis-quant-team?utm_source=businessinsider&utm_medium=referral,negative,0.8676583766937256
433,6/27/2023 12:30:38 PM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Regeneron (REGN), Edwards Lifesciences (EW) and Tonix Pharma (TNXP)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-regeneron-regn-edwards-lifesciences-ew-and-tonix-pharma-tnxp-1032412234,negative,0.9335933327674866
434,6/27/2023 8:00:40 PM,Analyst Ratings for Edwards Lifesciences,Benzinga,/news/stocks/analyst-ratings-for-edwards-lifesciences-1032413259,neutral,0.9268762469291687
435,7/9/2023 4:00:00 PM,Goldman Sachs sees rays of hope in underperforming health sector,Seeking Alpha,https://seekingalpha.com/news/3986286-goldman-sachs-sees-hope-underperforming-health-sector?utm_source=businessinsider&utm_medium=referral,positive,0.9371913075447083
436,7/14/2023 11:00:59 PM,Where Edwards Lifesciences Stands With Analysts,Benzinga,/news/stocks/where-edwards-lifesciences-stands-with-analysts-1032448437,neutral,0.9225320816040039
437,7/15/2023 12:20:05 AM,Wall Street Analysts Are Bullish on Top Healthcare Picks,TipRanks,/news/stocks/wall-street-analysts-are-bullish-on-top-healthcare-picks-1032448501,positive,0.552167534828186
438,7/15/2023 1:46:48 AM,RBC Capital Keeps Their Buy Rating on Edwards Lifesciences (EW),TipRanks,/news/stocks/rbc-capital-keeps-their-buy-rating-on-edwards-lifesciences-ew-1032448572,neutral,0.9204249978065491
439,7/17/2023 2:25:20 AM,Truist Financial Sticks to Its Buy Rating for Edwards Lifesciences (EW),TipRanks,/news/stocks/truist-financial-sticks-to-its-buy-rating-for-edwards-lifesciences-ew-1032449268,positive,0.5672964453697205
440,7/19/2023 5:00:50 PM,"Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-july-19-2023-1032459612,neutral,0.48795682191848755
441,7/23/2023 4:00:31 PM,Johnson & Johnson’s Q2 is positive for MedTech - Baird,Seeking Alpha,https://seekingalpha.com/news/3989880-johnson-johnson-q2-positive-medtech-baird?utm_source=businessinsider&utm_medium=referral,positive,0.9131311178207397
442,7/25/2023 12:30:54 PM,"Analysts’ Top Healthcare Picks: Alnylam Pharma (ALNY), Biogen (BIIB)",TipRanks,/news/stocks/analysts-top-healthcare-picks-alnylam-pharma-alny-biogen-biib-1032474293,positive,0.6176849603652954
443,7/25/2023 3:01:13 PM,Here's what Wall Street expects from Edwards Lifesciences's earnings report,Markets Insider Automation,/news/stocks/edwards_lifesciences-q2-quarterly-earnings-preview-1032474382,neutral,0.9049685597419739
444,7/25/2023 9:35:17 PM,Edwards Lifesciences Q2 2023 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3990694-edwards-lifesciences-q2-2023-earnings-preview?utm_source=businessinsider&utm_medium=referral,neutral,0.8999811410903931
445,7/25/2023 9:35:43 PM,Notable earnings after Wednesday's close,Seeking Alpha,https://seekingalpha.com/news/3990588-notable-earnings-after-wednesdays-close?utm_source=businessinsider&utm_medium=referral,positive,0.8919200301170349
446,7/26/2023 7:25:10 AM,Mizuho Securities Keeps Their Buy Rating on Edwards Lifesciences (EW),TipRanks,/news/stocks/mizuho-securities-keeps-their-buy-rating-on-edwards-lifesciences-ew-1032478179,neutral,0.9110602140426636
447,7/26/2023 8:17:15 PM,"Edwards Lifesciences Non-GAAP EPS of $0.66 beats by $0.01, revenue of $1.53B beats by $20M",Seeking Alpha,https://seekingalpha.com/news/3991559-edwards-lifesciences-non-gaap-eps-of-0_66-beats-0_01-revenue-of-1_53b-beats-20m?utm_source=businessinsider&utm_medium=referral,neutral,0.5460073351860046
448,7/26/2023 9:47:14 PM,"Edwards Lifesciences down 6% despite earnings beat, 2023 guidance",Seeking Alpha,https://seekingalpha.com/news/3991734-edwards-lifesciences-down-6-despite-earnings-beat-guidance?utm_source=businessinsider&utm_medium=referral,negative,0.972502589225769
449,7/26/2023 10:24:50 PM,"Edwards Lifesciences Corp. Q2 Profit Decreases, but beats estimates",RTTNews,/news/stocks/edwards-lifesciences-corp-q2-profit-decreases-but-beats-estimates-1032481351,negative,0.9661444425582886
450,7/27/2023 9:15:23 AM,Bank of America Securities Remains a Hold on Edwards Lifesciences (EW),TipRanks,/news/stocks/bank-of-america-securities-remains-a-hold-on-edwards-lifesciences-ew-1032483550,neutral,0.8900853991508484
451,7/27/2023 10:04:48 AM,"Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Quest Diagnostics (DGX) and Molina Healthcare (MOH)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-edwards-lifesciences-ew-quest-diagnostics-dgx-and-molina-healthcare-moh-1032483746,neutral,0.9170411229133606
452,7/27/2023 10:05:20 AM,Barclays Remains a Buy on Edwards Lifesciences (EW),TipRanks,/news/stocks/barclays-remains-a-buy-on-edwards-lifesciences-ew-1032483744,neutral,0.9387277364730835
453,7/27/2023 12:38:02 PM,"YELL, PKX and ELBM among pre-market losers",Seeking Alpha,https://seekingalpha.com/news/3992072-yell-pkx-and-elbm-among-pre-market-losers?utm_source=businessinsider&utm_medium=referral,neutral,0.9221838116645813
454,7/27/2023 12:47:50 PM,"eBay, Barclays, Edwards Lifesciences And Other Big Stocks Moving Lower In Thursday's Pre-Market Session",Benzinga,/news/stocks/ebay-barclays-edwards-lifesciences-and-other-big-stocks-moving-lower-in-thursday-s-pre-market-session-1032483882,negative,0.9663214087486267
455,7/27/2023 6:53:15 PM,Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session,Benzinga,/news/stocks/why-willis-towers-watson-shares-are-trading-lower-by-9-here-are-other-stocks-moving-in-thursday-s-mid-day-session-1032485817,negative,0.8242227435112
456,7/31/2023 9:50:22 AM,"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Icon (ICLR) and Edwards Lifesciences (EW)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-amgen-amgn-icon-iclr-and-edwards-lifesciences-ew-1032494583,neutral,0.915432333946228
457,8/1/2023 5:00:28 PM,Where Edwards Lifesciences Stands With Analysts,Benzinga,/news/stocks/where-edwards-lifesciences-stands-with-analysts-1032501745,neutral,0.9225320816040039
458,8/2/2023 9:02:06 AM,Wall Street Analysts Are Bullish on Top Healthcare Picks,TipRanks,/news/stocks/wall-street-analysts-are-bullish-on-top-healthcare-picks-1032505660,positive,0.552167534828186
459,8/2/2023 12:25:10 PM,RBC Capital Remains a Buy on Edwards Lifesciences (EW),TipRanks,/news/stocks/rbc-capital-remains-a-buy-on-edwards-lifesciences-ew-1032506471,neutral,0.9438652396202087
460,8/3/2023 1:15:11 AM,Credit Suisse Reaffirms Their Hold Rating on Edwards Lifesciences (EW),TipRanks,/news/stocks/credit-suisse-reaffirms-their-hold-rating-on-edwards-lifesciences-ew-1032509128,neutral,0.7937955260276794
461,8/5/2023 8:00:22 PM,Medtech set for banner year after significant boost in H1 device approvals,Seeking Alpha,https://seekingalpha.com/news/3997951-medtech-banner-year-significant-boost-h1-device-approvals?utm_source=businessinsider&utm_medium=referral,positive,0.9480461478233337
462,8/5/2023 11:13:50 PM,"Barron's Weekend Stock Picks: PayPal, Nikola And Icahn Enterprises' Challenges",Benzinga,/news/stocks/barron-s-weekend-stock-picks-paypal-nikola-and-icahn-enterprises-challenges-1032519709,neutral,0.941493034362793
463,8/17/2023 10:35:21 AM,RBC Capital Remains a Buy on Edwards Lifesciences (EW),TipRanks,/news/stocks/rbc-capital-remains-a-buy-on-edwards-lifesciences-ew-1032562697,neutral,0.9438652396202087
464,8/17/2023 7:00:52 PM,Analyst Ratings for Edwards Lifesciences,Benzinga,/news/stocks/analyst-ratings-for-edwards-lifesciences-1032564319,neutral,0.9268762469291687
465,8/29/2023 5:29:41 PM,JPMorgan says time to buy MedTech based on past,Seeking Alpha,https://seekingalpha.com/news/4007211-jpmorgan-says-buy-medtech-stocks?utm_source=businessinsider&utm_medium=referral,neutral,0.9078741073608398
466,8/30/2023 4:26:41 PM,Beyond Pills: 3 Non-Pharma Healthcare Stocks for Healthy Gains,InvestorPlace,/news/stocks/beyond-pills-3-non-pharma-healthcare-stocks-for-healthy-gains-1032593841,positive,0.9417311549186707
467,9/4/2023 4:00:00 PM,AI to represent 11% of healthcare budgets in 2024 - Morgan Stanley,Seeking Alpha,https://seekingalpha.com/news/4008712-ai-eleven-percent-healthcare-budgets-2024-morgan-stanley?utm_source=businessinsider&utm_medium=referral,neutral,0.8714701533317566
468,9/4/2023 4:21:00 PM,"Despite a slower Q2, Needham sees medtech market growing 7% in 2023",Seeking Alpha,https://seekingalpha.com/news/4008713-despite-slower-q2-needham-sees-medtech-market-growing-7-percent-2023?utm_source=businessinsider&utm_medium=referral,positive,0.9523437023162842
469,9/5/2023 8:30:55 PM,Quant Ratings Updated on 87 Stocks,InvestorPlace,/news/stocks/090523-quant-ratings-1032606869,neutral,0.92836993932724
470,9/8/2023 7:00:19 PM,Expert Ratings for Edwards Lifesciences,Benzinga,/news/stocks/expert-ratings-for-edwards-lifesciences-1032616965,neutral,0.8712101578712463
471,9/18/2023 10:15:55 AM,Edwards Lifesciences (EW) Gets a Hold from Bank of America Securities,TipRanks,/news/stocks/edwards-lifesciences-ew-gets-a-hold-from-bank-of-america-securities-1032636361,neutral,0.9157263040542603
472,9/26/2023 5:01:15 PM,"Benzinga's Top Ratings Upgrades, Downgrades For September 26, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-september-26-2023-1032656763,neutral,0.4882463812828064
473,9/26/2023 9:00:56 PM,"Edwards Lifesciences Commits to Fair Competition Amid Regulatory Scrutiny, Analyst Upgrades Stock",Benzinga,/news/stocks/edwards-lifesciences-commits-to-fair-competition-amid-regulatory-scrutiny-analyst-upgrades-stock-1032657292,positive,0.87337327003479
474,9/27/2023 9:21:23 AM,"Analysts Conflicted on These Healthcare Names: Edwards Lifesciences (EW), Immunovant (IMVT) and Cigna (CI)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-edwards-lifesciences-ew-immunovant-imvt-and-cigna-ci-1032658589,negative,0.6920607089996338
475,9/27/2023 1:30:34 PM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Generation Bio (GBIO), Teladoc (TDOC) and Edwards Lifesciences (EW)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-generation-bio-gbio-teladoc-tdoc-and-edwards-lifesciences-ew-1032659585,negative,0.7992101311683655
476,10/2/2023 12:55:57 PM,Promising Financial Outlook and Expected Return Spur Buy Rating for Edwards Lifesciences’ Stock – An Analyst Report by Joanne Wuensch,TipRanks,/news/stocks/promising-financial-outlook-and-expected-return-spur-buy-rating-for-edwards-lifesciences-stock-–-an-analyst-report-by-joanne-wuensch-1032670262,positive,0.5020747780799866
477,10/2/2023 8:00:26 PM,Expert Ratings for Edwards Lifesciences,Benzinga,/news/stocks/expert-ratings-for-edwards-lifesciences-1032671508,neutral,0.8712101578712463
478,10/17/2023 8:30:51 PM,Quant Ratings Updated on 92 Stocks,InvestorPlace,/news/stocks/101723-quant-ratings-1032714183,neutral,0.9286938905715942
479,10/20/2023 8:40:07 AM,"Analysts Offer Insights on Healthcare Companies: Royalty Pharma (RPRX), Bristol-Myers Squibb (BMY) and Edwards Lifesciences (EW)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-royalty-pharma-rprx-bristol-myers-squibb-bmy-and-edwards-lifesciences-ew-1032723592,neutral,0.913282573223114
480,10/24/2023 12:47:07 PM,Edwards Lifesciences: Strong Q3 Growth and Future Prospects Justify Buy Rating,TipRanks,/news/stocks/edwards-lifesciences-strong-q3-growth-and-future-prospects-justify-buy-rating-1032735415,positive,0.9261901378631592
481,10/24/2023 3:01:13 PM,Here's what to expect from Edwards Lifesciences's earnings report,Markets Insider Automation,/news/stocks/edwards_lifesciences-quarter-earnings-preview-q3-1032733453,neutral,0.9317857623100281
482,10/25/2023 10:01:31 AM,"Analysts Are Neutral on Top Healthcare Stocks: American Well (AMWL), Edwards Lifesciences (EW)",TipRanks,/news/stocks/analysts-are-neutral-on-top-healthcare-stocks-american-well-amwl-edwards-lifesciences-ew-1032740683,negative,0.5727237462997437
483,10/25/2023 11:09:17 AM,Piper Sandler Sticks to Their Hold Rating for Edwards Lifesciences (EW),TipRanks,/news/stocks/piper-sandler-sticks-to-their-hold-rating-for-edwards-lifesciences-ew-1032740741,neutral,0.8857382535934448
484,10/25/2023 12:50:22 PM,"Analysts Offer Insights on Healthcare Companies: HCA Healthcare (HCA), Edwards Lifesciences (EW) and Milestone Pharmaceuticals (MIST)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-hca-healthcare-hca-edwards-lifesciences-ew-and-milestone-pharmaceuticals-mist-1032740869,neutral,0.9176058769226074
485,10/25/2023 7:26:17 PM,"US Stocks Sink On Tech-Led Selloff, Treasury Yields Surge Again: What's Driving Markets Wednesday?",Benzinga,/news/etf/us-stocks-sink-on-tech-led-selloff-treasury-yields-surge-again-what-s-driving-markets-wednesday-1032740019,negative,0.8893340826034546
486,10/25/2023 10:25:49 PM,"Edwards Lifesciences Corp. Q3 Profit Increases, Inline With Estimates",RTTNews,/news/stocks/edwards-lifesciences-corp-q3-profit-increases-inline-with-estimates-1032740399,positive,0.9385327696800232
487,10/26/2023 2:45:42 AM,Hold Rating on Edwards Lifesciences Amidst Q3 Results and Market Uncertainties,TipRanks,/news/stocks/hold-rating-on-edwards-lifesciences-amidst-q3-results-and-market-uncertainties-1032744779,neutral,0.5925926566123962
488,10/26/2023 5:46:15 AM,Buy Rating Affirmed for Edwards Lifesciences: Consistent Performance and Potential Growth Drive Positive Analyst Recommendation,TipRanks,/news/stocks/buy-rating-affirmed-for-edwards-lifesciences-consistent-performance-and-potential-growth-drive-positive-analyst-recommendation-1032745258,positive,0.9459431767463684
489,10/26/2023 9:44:54 AM,"Hold Rating on Edwards Lifesciences: Evaluating TAVR Growth Potential, Margin Expansion, and Revised Price Objective",TipRanks,/news/stocks/hold-rating-on-edwards-lifesciences-evaluating-tavr-growth-potential-margin-expansion-and-revised-price-objective-1032745788,positive,0.7465748190879822
490,10/26/2023 10:41:09 AM,Edwards Lifesciences’ Strong Market Position and Potential Growth Despite Slowdown: An Optimistic Outlook,TipRanks,/news/stocks/edwards-lifesciences-strong-market-position-and-potential-growth-despite-slowdown-an-optimistic-outlook-1032745817,positive,0.8711875081062317
491,10/26/2023 10:43:49 AM,Wall Street Analysts Are Bullish on Top Healthcare Picks,TipRanks,/news/stocks/wall-street-analysts-are-bullish-on-top-healthcare-picks-1032745878,positive,0.552167534828186
492,10/26/2023 10:48:04 AM,Edwards Lifesciences’ Promising Growth Trends Elicit ‘Buy’ Rating Despite Setbacks,TipRanks,/news/stocks/edwards-lifesciences-promising-growth-trends-elicit-buy-rating-despite-setbacks-1032745874,positive,0.9436313509941101
493,10/26/2023 11:42:04 AM,Hold Rating on Edwards Lifesciences Due to Lower Revenue Estimates and Increased Market Competition,TipRanks,/news/stocks/hold-rating-on-edwards-lifesciences-due-to-lower-revenue-estimates-and-increased-market-competition-1032745924,negative,0.9594952464103699
494,10/26/2023 11:54:05 AM,"Analysts Offer Insights on Healthcare Companies: Conmed (CNMD), Edwards Lifesciences (EW) and Prothena (PRTA)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-conmed-cnmd-edwards-lifesciences-ew-and-prothena-prta-1032745950,neutral,0.9106742739677429
495,10/27/2023 7:10:07 AM,Analysts Offer Insights on Healthcare Companies: Halozyme (HALO) and Edwards Lifesciences (EW),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-halozyme-halo-and-edwards-lifesciences-ew-1032749725,neutral,0.9103573560714722
496,11/3/2023 12:14:07 PM,Oppenheimer Sticks to Their Buy Rating for Edwards Lifesciences (EW),TipRanks,/news/stocks/oppenheimer-sticks-to-their-buy-rating-for-edwards-lifesciences-ew-1032777980,neutral,0.8800579905509949
497,11/28/2023 8:25:58 AM,Edwards Lifesciences Sell Rating: Anticipating Market Headwinds and Margin Pressures,TipRanks,/news/stocks/edwards-lifesciences-sell-rating-anticipating-market-headwinds-and-margin-pressures-1032856246,negative,0.9591334462165833
498,11/28/2023 10:46:41 AM,Edwards Lifesciences (EW) Gets a Buy from J.P. Morgan,TipRanks,/news/stocks/edwards-lifesciences-ew-gets-a-buy-from-j-p-morgan-1032856519,positive,0.6344268918037415
499,11/28/2023 11:47:37 AM,"Zscaler Posts Q1 Results, Joins argenx, Cool Company And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session",Benzinga,/news/stocks/zscaler-posts-q1-results-joins-argenx-cool-company-and-other-big-stocks-moving-lower-in-tuesday-s-pre-market-session-1032854099,negative,0.9631522297859192
500,11/28/2023 2:00:49 PM,Analyst Expectations for Edwards Lifesciences's Future,Benzinga,/news/stocks/analyst-expectations-for-edwards-lifesciences-s-future-1032854545,positive,0.7918892502784729
501,12/1/2023 11:29:36 AM,Buy Rating on Edwards Lifesciences: Resilience and Growth Potential Underscored by Stable TAVR Market Position,TipRanks,/news/stocks/buy-rating-on-edwards-lifesciences-resilience-and-growth-potential-underscored-by-stable-tavr-market-position-1032867770,positive,0.9484483003616333
502,12/4/2023 12:16:45 PM,RBC Capital Keeps Their Buy Rating on Edwards Lifesciences (EW),TipRanks,/news/stocks/rbc-capital-keeps-their-buy-rating-on-edwards-lifesciences-ew-1032872224,neutral,0.9204249978065491
503,12/7/2023 8:07:03 AM,Edwards Lifesciences: Strong Buy Amid Market Leadership and Growth Potential,TipRanks,/news/stocks/edwards-lifesciences-strong-buy-amid-market-leadership-and-growth-potential-1032883430,positive,0.9417218565940857
504,12/7/2023 11:05:41 PM,BTIG Sticks to Its Hold Rating for Edwards Lifesciences (EW),TipRanks,/news/stocks/btig-sticks-to-its-hold-rating-for-edwards-lifesciences-ew-1032885092,neutral,0.8261594176292419
505,12/8/2023 2:02:14 AM,Analysts Offer Insights on Healthcare Companies: Biohaven Ltd. (BHVN) and Edwards Lifesciences (EW),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-biohaven-ltd-bhvn-and-edwards-lifesciences-ew-1032885672,neutral,0.9101055860519409
506,12/8/2023 2:15:22 AM,Edwards Lifesciences To Spin-off Of Critical Care Unit; To Buy Back Additional $1 Bln Of Shares ,RTTNews,/news/stocks/edwards-lifesciences-to-spin-off-of-critical-care-unit-to-buy-back-additional-1-bln-of-shares-1032883964,neutral,0.8257898092269897
507,12/8/2023 4:35:24 AM,Edwards Lifesciences: Strong Buy Recommendation on Stable Growth and Strategic ‘Goldilocks Guidance’,TipRanks,/news/stocks/edwards-lifesciences-strong-buy-recommendation-on-stable-growth-and-strategic-goldilocks-guidance-1032886325,positive,0.9188910722732544
508,12/8/2023 10:30:15 AM,Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Edwards Lifesciences (EW),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-amgen-amgn-and-edwards-lifesciences-ew-1032886934,neutral,0.9092161059379578
509,12/8/2023 10:56:32 AM,Maintaining Hold on Edwards Lifesciences Amidst In-Line 2024 Guidance and Promising 2025 Growth Outlook,TipRanks,/news/stocks/maintaining-hold-on-edwards-lifesciences-amidst-in-line-2024-guidance-and-promising-2025-growth-outlook-1032886945,positive,0.9374238848686218
510,12/8/2023 12:36:04 PM,Piper Sandler Reaffirms Their Hold Rating on Edwards Lifesciences (EW),TipRanks,/news/stocks/piper-sandler-reaffirms-their-hold-rating-on-edwards-lifesciences-ew-1032887047,neutral,0.8381720781326294
511,12/8/2023 12:40:31 PM,Wall Street Analysts Are Bullish on Top Healthcare Picks,TipRanks,/news/stocks/wall-street-analysts-are-bullish-on-top-healthcare-picks-1032887030,positive,0.552167534828186
512,12/8/2023 12:46:14 PM,Canaccord Genuity Issues Hold Rating on Edwards Lifesciences Amid TAVR Market Uncertainties and Strategic Focus Shifts,TipRanks,/news/stocks/canaccord-genuity-issues-hold-rating-on-edwards-lifesciences-amid-tavr-market-uncertainties-and-strategic-focus-shifts-1032887065,negative,0.8804295659065247
513,12/11/2023 7:15:27 AM,Edwards Lifesciences: Strategic Focus on TAVR Amid Hold Rating Due to Mixed Financial Outlook,TipRanks,/news/stocks/edwards-lifesciences-strategic-focus-on-tavr-amid-hold-rating-due-to-mixed-financial-outlook-1032890778,negative,0.7918791770935059
514,12/12/2023 1:46:01 AM,RBC Capital Sticks to Its Buy Rating for Edwards Lifesciences (EW),TipRanks,/news/stocks/rbc-capital-sticks-to-its-buy-rating-for-edwards-lifesciences-ew-1032893204,neutral,0.7209327816963196
515,12/13/2023 12:58:03 PM,Wells Fargo Reaffirms Their Hold Rating on Edwards Lifesciences (EW),TipRanks,/news/stocks/wells-fargo-reaffirms-their-hold-rating-on-edwards-lifesciences-ew-1032899088,neutral,0.8220694661140442
516,12/14/2023 11:06:02 AM,"Analysts Offer Insights on Healthcare Companies: Lucid Diagnostics (LUCD), Edwards Lifesciences (EW) and BeiGene (BGNE)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-lucid-diagnostics-lucd-edwards-lifesciences-ew-and-beigene-bgne-1032903019,neutral,0.9082992672920227
517,12/14/2023 11:06:49 AM,Buy Rating for Edwards Lifesciences on Strength of Market Position and Growth Potential,TipRanks,/news/stocks/buy-rating-for-edwards-lifesciences-on-strength-of-market-position-and-growth-potential-1032903017,positive,0.8980305194854736
518,12/22/2023 4:01:19 PM,Deep Dive Into Edwards Lifesciences Stock: Analyst Perspectives (14 Ratings),Benzinga,/news/stocks/deep-dive-into-edwards-lifesciences-stock-analyst-perspectives-14-ratings-1032922729,neutral,0.8390365839004517
519,1/2/2024 2:23:15 PM,BTIG Sticks to Their Hold Rating for Edwards Lifesciences (EW),TipRanks,/news/stocks/btig-sticks-to-their-hold-rating-for-edwards-lifesciences-ew-1032938342,neutral,0.8570407629013062
520,1/12/2024 10:00:44 PM,Assessing Edwards Lifesciences: Insights From 14 Financial Analysts,Benzinga,/news/stocks/assessing-edwards-lifesciences-insights-from-14-financial-analysts-1032964939,neutral,0.8630402684211731
521,1/24/2024 6:27:56 AM,Edwards Lifesciences: A Balanced Outlook Amidst Slowing TAVR Growth and Market Competition,TipRanks,/news/stocks/edwards-lifesciences-a-balanced-outlook-amidst-slowing-tavr-growth-and-market-competition-1032991419,positive,0.756153404712677
522,1/31/2024 8:33:55 PM,"Stryker, Boston Scientific fuel MedTech gains",Seeking Alpha,https://seekingalpha.com/news/4060880-stryker-stock-boston-scientific-stock-lift-medtech?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9037370085716248
523,2/2/2024 3:51:42 PM,Edwards gets FDA okay for Evoque tricuspid valve replacement system,Seeking Alpha,https://seekingalpha.com/news/4062220-edwards-gets-fda-okay-for-evoque-tricuspid-valve-replacement-system?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8315778374671936
524,2/2/2024 5:00:38 PM,Expert Ratings For Edwards Lifesciences,Benzinga,/news/stocks/expert-ratings-for-edwards-lifesciences-1033025868,neutral,0.8712101578712463
525,2/2/2024 5:05:26 PM,"Edwards Lifesciences Earns ‘Buy’ Rating Following Early FDA Approval of Evoque System, with Raised Price Target to $90",TipRanks,/news/stocks/edwards-lifesciences-earns-buy-rating-following-early-fda-approval-of-evoque-system-with-raised-price-target-to-90-1033026455,positive,0.9404909014701843
526,2/2/2024 5:20:25 PM,"Edwards stock jumps 8% on FDA approval, Wells Fargo upgrade",Seeking Alpha,https://seekingalpha.com/news/4062258-edwards-stock-jumps-on-fda-approval-wells-fargo-upgrade?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9136337041854858
527,2/3/2024 6:06:32 PM,Maintaining Hold on Edwards Lifesciences Amidst EVOQUE Approval and Emerging Competition,TipRanks,/news/stocks/maintaining-hold-on-edwards-lifesciences-amidst-evoque-approval-and-emerging-competition-1033026824,positive,0.9079070687294006
528,2/5/2024 9:50:09 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Healthequity (HQY), Adverum Biotechnologies (ADVM) and Edwards Lifesciences (EW)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-healthequity-hqy-adverum-biotechnologies-advm-and-edwards-lifesciences-ew-1033029795,negative,0.9381601810455322
529,2/5/2024 3:01:13 PM,Here's what Wall Street expects from Edwards Lifesciences's earnings report,Markets Insider Automation,/news/stocks/edwards_lifesciences-q4-earnings-preview-stock-1033030229,neutral,0.9049685597419739
530,2/5/2024 3:07:48 PM,Balancing Positives and Uncertainties: Hold Rating on Edwards Lifesciences,TipRanks,/news/stocks/balancing-positives-and-uncertainties-hold-rating-on-edwards-lifesciences-1033031436,neutral,0.9092907309532166
531,2/5/2024 10:05:31 PM,Edwards Lifesciences Q4 2023 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/4062640-edwards-lifesciences-q4-2023-earnings-preview?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9095425605773926
532,2/5/2024 10:35:34 PM,Notable earnings after Tuesday's close,Seeking Alpha,https://seekingalpha.com/news/4062589-notable-earnings-after-tuesdays-close?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8953563570976257
533,2/6/2024 1:10:51 PM,"Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Astria Therapeutics (ATXS) and Inspire Medical Systems (INSP)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-edwards-lifesciences-ew-astria-therapeutics-atxs-and-inspire-medical-systems-insp-1033036086,neutral,0.9102658629417419
534,2/6/2024 8:24:05 PM,"Tech Slides, Chinese Stocks Rebound, New York Community Bancorp Tumbles: What's Driving Markets Tuesday?",Benzinga,/news/etf/tech-slides-chinese-stocks-rebound-new-york-community-bancorp-tumbles-what-s-driving-markets-tuesday-1033036589,negative,0.8938384652137756
535,2/6/2024 9:20:14 PM,"Edwards Lifesciences Non-GAAP EPS of $0.64 in-line, revenue of $1.53B beats by $30M",Seeking Alpha,https://seekingalpha.com/news/4063453-edwards-lifesciences-non-gaap-eps-of-0_64-in-line-revenue-of-1_53b-beats-30m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7826377749443054
536,2/6/2024 10:22:47 PM,"Edwards Lifesciences Corp. Q4 Profit Drops, Inline With Estimates",RTTNews,/news/stocks/edwards-lifesciences-corp-q4-profit-drops-inline-with-estimates-1033036852,negative,0.9731383323669434
537,2/7/2024 11:40:11 AM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Arrowhead Pharmaceuticals (ARWR), Edwards Lifesciences (EW) and Doximity (DOCS)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-arrowhead-pharmaceuticals-arwr-edwards-lifesciences-ew-and-doximity-docs-1033041237,negative,0.7844913601875305
538,2/7/2024 12:31:00 PM,"Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Edwards Lifesciences (EW) and Omnicell (OMCL)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-gilead-sciences-gild-edwards-lifesciences-ew-and-omnicell-omcl-1033041817,neutral,0.9096051454544067
539,2/7/2024 12:56:14 PM,Edwards Lifesciences (EW) Receives a Buy from Oppenheimer,TipRanks,/news/stocks/edwards-lifesciences-ew-receives-a-buy-from-oppenheimer-1033041882,neutral,0.625199019908905
540,2/7/2024 1:28:23 PM,Maintaining Hold on Edwards Lifesciences Amid Balanced Growth and Adequate Valuation,TipRanks,/news/stocks/maintaining-hold-on-edwards-lifesciences-amid-balanced-growth-and-adequate-valuation-1033042131,positive,0.8107205033302307
541,2/7/2024 1:41:22 PM,"Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Qiagen (QGEN) and Inspire Medical Systems (INSP)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-edwards-lifesciences-ew-qiagen-qgen-and-inspire-medical-systems-insp-1033042093,neutral,0.9069743752479553
542,2/7/2024 6:15:56 PM,Buy Rating Affirmed for Edwards Lifesciences on Evoque TTVR System’s FDA Approval and Promising Trial Results,TipRanks,/news/stocks/buy-rating-affirmed-for-edwards-lifesciences-on-evoque-ttvr-system-s-fda-approval-and-promising-trial-results-1033042822,positive,0.9510795474052429
543,2/7/2024 6:30:57 PM,These Analysts Boost Their Forecasts On Edwards Lifesciences Following Q4 Results,Benzinga,/news/stocks/these-analysts-boost-their-forecasts-on-edwards-lifesciences-following-q4-results-1033042378,positive,0.9205259084701538
544,2/8/2024 11:27:41 AM,Barclays Remains a Buy on Edwards Lifesciences (EW),TipRanks,/news/stocks/barclays-remains-a-buy-on-edwards-lifesciences-ew-1033046733,neutral,0.9387277364730835
545,2/12/2024 10:47:14 AM,Wells Fargo Reaffirms Their Buy Rating on Edwards Lifesciences (EW),TipRanks,/news/stocks/wells-fargo-reaffirms-their-buy-rating-on-edwards-lifesciences-ew-1033056912,neutral,0.8233293294906616
546,2/14/2024 11:41:19 AM,"Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Edwards Lifesciences (EW) and Coya Therapeutics, Inc. (COYA)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-edwards-lifesciences-ew-and-coya-therapeutics-inc-coya-1033066810,neutral,0.918390691280365
547,2/26/2024 11:32:05 AM,Edwards Lifesciences (EW) Gets a Buy from Wells Fargo,TipRanks,/news/stocks/edwards-lifesciences-ew-gets-a-buy-from-wells-fargo-1033102848,positive,0.7469812631607056
548,3/4/2024 1:05:52 PM,Buy Rating on Edwards Lifesciences Amidst Strong TAVR Business and Promising TMTT Expansion,TipRanks,/news/stocks/buy-rating-on-edwards-lifesciences-amidst-strong-tavr-business-and-promising-tmtt-expansion-1033129451,positive,0.9535549879074097
549,3/7/2024 1:00:20 PM,What 9 Analyst Ratings Have To Say About Edwards Lifesciences,Benzinga,/news/stocks/what-9-analyst-ratings-have-to-say-about-edwards-lifesciences-1033141686,neutral,0.9436009526252747
550,3/7/2024 7:12:00 PM,"BofA upgrades Edwards to buy, says double-digit growth is back",Seeking Alpha,https://seekingalpha.com/news/4077323-bofa-upgrades-edwards-to-buy-says-double-digit-growth-is-back?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9290301203727722
551,3/13/2024 8:15:35 AM,Buy Rating on Edwards Lifesciences Amid Expanding TAVR Market and Positive SMART Trial Outlook,TipRanks,/news/stocks/buy-rating-on-edwards-lifesciences-amid-expanding-tavr-market-and-positive-smart-trial-outlook-1033158976,positive,0.9506128430366516
552,3/14/2024 10:40:16 AM,"Analysts’ Top Healthcare Picks: Edwards Lifesciences (EW), Arrowhead Pharmaceuticals (ARWR)",TipRanks,/news/stocks/analysts-top-healthcare-picks-edwards-lifesciences-ew-arrowhead-pharmaceuticals-arwr-1033164131,positive,0.75758296251297
553,3/18/2024 11:50:07 AM,"Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS), Edwards Lifesciences (EW) and Aveanna Healthcare Holdings (AVAH)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-ionis-pharmaceuticals-ions-edwards-lifesciences-ew-and-aveanna-healthcare-holdings-avah-1033172754,neutral,0.9119763970375061
554,3/20/2024 11:44:44 AM,"Fund managers risk appetite at 2-year high, but 40% see an AI bubble",Seeking Alpha,https://seekingalpha.com/news/4081381-fund-managers-risk-appetite-at-3-year-high-but-40-see-an-ai-bubble?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.49843648076057434
555,3/21/2024 12:01:55 PM,"Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), Edwards Lifesciences (EW) and Innovent Biologics (OtherIVBXF)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-biontech-se-bntx-edwards-lifesciences-ew-and-innovent-biologics-otherivbxf-1033185621,neutral,0.8976751565933228
556,3/26/2024 5:00:33 PM,The Latest Analyst Ratings For Edwards Lifesciences,Benzinga,/news/stocks/the-latest-analyst-ratings-for-edwards-lifesciences-1033197899,neutral,0.942221999168396
557,3/27/2024 2:24:23 PM,Medtronic wins FDA OK for heart valve implant,Seeking Alpha,https://seekingalpha.com/news/4084402-medtronic-stock-gains--fda-ok-evolut-fx?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8424063920974731
558,3/28/2024 7:00:00 PM,"Catalyst Watch: Tesla deliveries, Disney board vote, DJT drama and Fortinet event",Seeking Alpha,https://seekingalpha.com/news/4084622-catalyst-watch-tesla-deliveries-disney-board-vote-djt-drama-and-fortinet-event?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9371159076690674
559,3/30/2024 4:13:00 PM,Eli Lilly tops S&P 500 healthcare sector in Q1 as weight loss frenzy continues,Seeking Alpha,https://seekingalpha.com/news/4084974-eli-lilly-tops-the-growth-chart-for-the-sp-500-index-in-q1-as-the-sector-gains-momentum?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.653032124042511
560,4/5/2024 4:16:01 AM,Evercore ISI Remains a Hold on Edwards Lifesciences (EW),TipRanks,/news/stocks/evercore-isi-remains-a-hold-on-edwards-lifesciences-ew-1033224622,neutral,0.8145594000816345
561,4/10/2024 6:17:00 AM,Revising Edwards Lifesciences Price Target Post-Medtronic’s SMART Study: A Hold Rating Amidst Competitive Pressures,TipRanks,/news/stocks/revising-edwards-lifesciences-price-target-post-medtronic-s-smart-study-a-hold-rating-amidst-competitive-pressures-1033236284,neutral,0.6766188144683838
562,4/10/2024 6:56:07 PM,Top 10 best performing S&P 500 health care stocks of 2024,Seeking Alpha,https://seekingalpha.com/news/4088691-top-10-best-performing-sp-500-health-care-stocks-of-2024?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8458036780357361
563,4/11/2024 11:50:10 AM,"Analysts Offer Insights on Healthcare Companies: Evogene (EVGN), Edwards Lifesciences (EW) and Nurix Therapeutics (NRIX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-evogene-evgn-edwards-lifesciences-ew-and-nurix-therapeutics-nrix-1033241758,neutral,0.9029660820960999
564,4/11/2024 7:00:24 PM,What Analysts Are Saying About Edwards Lifesciences Stock,Benzinga,/news/stocks/what-analysts-are-saying-about-edwards-lifesciences-stock-1033242168,neutral,0.9433876872062683
565,4/17/2024 8:01:11 AM,Truist Financial Reaffirms Their Buy Rating on Edwards Lifesciences (EW),TipRanks,/news/stocks/truist-financial-reaffirms-their-buy-rating-on-edwards-lifesciences-ew-1033257327,neutral,0.7873767614364624
566,4/24/2024 3:01:13 PM,Here's what Wall Street expects from Edwards Lifesciences's earnings,Markets Insider Automation,/news/stocks/edwards_lifesciences-q1-earnings-preview-stock-1033282020,neutral,0.9278062582015991
567,4/24/2024 9:20:27 PM,Edwards Lifesciences Q1 2024 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/4093441-edwards-lifesciences-q1-2024-earnings-preview?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8996816873550415
568,4/25/2024 8:18:53 PM,"Edwards Lifesciences Non-GAAP EPS of $0.66 beats by $0.02, revenue of $1.6B beats by $30M",Seeking Alpha,https://seekingalpha.com/news/4094508-edwards-lifesciences-non-gaap-eps-of-0_66-beats-0_02-revenue-of-1_6b-beats-30m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.48167139291763306
569,4/25/2024 10:49:58 PM,"Edwards Lifesciences Corp. Q1 Profit Increases, beats estimates",RTTNews,/news/stocks/edwards-lifesciences-corp-q1-profit-increases-beats-estimates-1033290447,positive,0.9340653419494629
570,4/26/2024 12:53:32 AM,"EW Stock Earnings: Edwards Lifesciences Beats EPS, Beats Revenue for Q1 2024",InvestorPlace,/news/stocks/ew-stock-earnings-edwards-lifesciences-for-q1-of-2024-1033290821,positive,0.664929986000061
571,4/26/2024 8:48:00 AM,Barclays Reaffirms Their Buy Rating on Edwards Lifesciences (EW),TipRanks,/news/stocks/barclays-reaffirms-their-buy-rating-on-edwards-lifesciences-ew-1033293615,neutral,0.8241811394691467
572,4/26/2024 9:46:50 AM,Buy Rating Justified: Edwards Lifesciences Exceeds Q1 Expectations with Strong Sales and Market Growth Prospects,TipRanks,/news/stocks/buy-rating-justified-edwards-lifesciences-exceeds-q1-expectations-with-strong-sales-and-market-growth-prospects-1033294003,positive,0.9559286236763
573,4/26/2024 10:36:12 AM,Edwards Lifesciences (EW) Receives a Buy from RBC Capital,TipRanks,/news/stocks/edwards-lifesciences-ew-receives-a-buy-from-rbc-capital-1033294231,neutral,0.5992449522018433
574,4/26/2024 11:47:20 AM,Edwards Lifesciences (EW) Receives a Hold from Stifel Nicolaus,TipRanks,/news/stocks/edwards-lifesciences-ew-receives-a-hold-from-stifel-nicolaus-1033294954,neutral,0.8014072179794312
575,4/26/2024 11:52:30 AM,Piper Sandler Sticks to Their Hold Rating for Edwards Lifesciences (EW),TipRanks,/news/stocks/piper-sandler-sticks-to-their-hold-rating-for-edwards-lifesciences-ew-1033294893,neutral,0.8857382535934448
576,4/26/2024 12:16:32 PM,Strong Q1 Performance and Positive Market Trends Reinforce Buy Rating for Edwards Lifesciences,TipRanks,/news/stocks/strong-q1-performance-and-positive-market-trends-reinforce-buy-rating-for-edwards-lifesciences-1033295049,positive,0.9555752277374268
577,4/27/2024 4:20:11 AM,"Analysts Are Neutral on These Healthcare Stocks: Edwards Lifesciences (EW), Gilead Sciences (GILD)",TipRanks,/news/stocks/analysts-are-neutral-on-these-healthcare-stocks-edwards-lifesciences-ew-gilead-sciences-gild-1033295986,neutral,0.8280479311943054
578,4/29/2024 11:52:14 AM,Truist Financial Reaffirms Their Buy Rating on Edwards Lifesciences (EW),TipRanks,/news/stocks/truist-financial-reaffirms-their-buy-rating-on-edwards-lifesciences-ew-1033301145,neutral,0.7873767614364624
579,4/29/2024 11:53:00 AM,"Analysts’ Top Healthcare Picks: AbbVie (ABBV), Wave Life Sciences (WVE)",TipRanks,/news/stocks/analysts-top-healthcare-picks-abbvie-abbv-wave-life-sciences-wve-1033301142,positive,0.6223708987236023
580,4/30/2024 6:12:11 AM,"Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), BioMarin Pharmaceutical (BMRN) and Hookipa Pharma (HOOK)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-edwards-lifesciences-ew-biomarin-pharmaceutical-bmrn-and-hookipa-pharma-hook-1033304876,neutral,0.9060637354850769
581,4/30/2024 6:49:10 AM,Maintaining Buy Rating on Edwards Lifesciences Amid Mixed TAVR Performance and Strong TMTT Growth,TipRanks,/news/stocks/maintaining-buy-rating-on-edwards-lifesciences-amid-mixed-tavr-performance-and-strong-tmtt-growth-1033305026,positive,0.9372562170028687
582,4/30/2024 6:55:33 AM,Hold Rating Justified for Edwards Lifesciences Amid TAVR Segment Uncertainties,TipRanks,/news/stocks/hold-rating-justified-for-edwards-lifesciences-amid-tavr-segment-uncertainties-1033305013,negative,0.682110071182251
583,4/30/2024 7:20:50 AM,"Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Bristol-Myers Squibb (BMY) and Laboratory (LH)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-edwards-lifesciences-ew-bristol-myers-squibb-bmy-and-laboratory-lh-1033305216,neutral,0.9157887697219849
584,5/7/2024 12:21:56 AM,"Analysts Offer Insights on Healthcare Companies: Gossamer Bio (GOSS), RxSight (RXST) and Edwards Lifesciences (EW)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-gossamer-bio-goss-rxsight-rxst-and-edwards-lifesciences-ew-1033335813,neutral,0.9087927937507629
585,5/7/2024 6:00:15 PM,Assessing Edwards Lifesciences: Insights From 11 Financial Analysts,Benzinga,/news/stocks/assessing-edwards-lifesciences-insights-from-11-financial-analysts-1033341077,neutral,0.8581908345222473
586,5/13/2024 3:11:20 PM,India's Meril files EU antitrust complaint against Edwards: report,Seeking Alpha,https://seekingalpha.com/news/4105258-indias-meril-files-eu-antitrust-complaint-against-edwards-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6456825733184814
587,5/14/2024 1:15:53 PM,Edwards Lifesciences: A Buy Rating with Strong Growth Prospects and Positive Market Dynamics,TipRanks,/news/stocks/edwards-lifesciences-a-buy-rating-with-strong-growth-prospects-and-positive-market-dynamics-1033378035,positive,0.9265886545181274
588,5/20/2024 9:47:12 AM,Robust Growth and R&D Focus Solidify Buy Rating for Edwards Lifesciences,TipRanks,/news/stocks/robust-growth-and-r-d-focus-solidify-buy-rating-for-edwards-lifesciences-1033403240,positive,0.927332878112793
589,5/22/2024 5:55:06 PM,"Citi upgrades Edwards, Tandem; cuts Nevro, Establishment Labs",Seeking Alpha,https://seekingalpha.com/news/4109467-citi-upgrades-edwards-tandem-cuts-nevro-establishment-labs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7632619142532349
590,5/30/2024 8:27:39 AM,Buy Rating Affirmed for Edwards Lifesciences on Growth and Market Positioning Prospects,TipRanks,/news/stocks/buy-rating-affirmed-for-edwards-lifesciences-on-growth-and-market-positioning-prospects-1033435737,positive,0.7418431639671326
591,5/30/2024 2:00:29 PM,What Analysts Are Saying About Edwards Lifesciences Stock,Benzinga,/news/stocks/what-analysts-are-saying-about-edwards-lifesciences-stock-1033435770,neutral,0.9433876872062683
592,5/31/2024 6:51:03 PM,Wall Street Analysts Are Bullish on Top Healthcare Picks,TipRanks,/news/stocks/wall-street-analysts-are-bullish-on-top-healthcare-picks-1033442734,positive,0.552167534828186
593,6/3/2024 10:50:43 AM,BD to buy Edwards Life Critical Care unit for $4.2B in cash,Seeking Alpha,https://seekingalpha.com/news/4112225-bd-to-buy-edwards-life-critical-care-unit-for-42b-in-cash?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9168686270713806
594,6/3/2024 11:00:42 AM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Corbus Pharmaceuticals (CRBP), Edwards Lifesciences (EW) and Kymera Therapeutics (KYMR)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-corbus-pharmaceuticals-crbp-edwards-lifesciences-ew-and-kymera-therapeutics-kymr-1033446305,negative,0.771032452583313
595,6/3/2024 12:55:56 PM,Edwards Lifesciences Stock Up With BD Deal To Buy Critical Care Product Unit For $4.2 Bln Cash ,RTTNews,/news/stocks/edwards-lifesciences-stock-up-with-bd-deal-to-buy-critical-care-product-unit-for-4-2-bln-cash-1033445142,positive,0.7420020699501038
596,6/3/2024 7:19:23 PM,"Goldman Sachs adds 5 stocks, including 2 solar names, to its U.S. 'conviction list'",Seeking Alpha,https://seekingalpha.com/news/4112430-goldman-sachs-adds-5-stocks-including-2-solar-names-to-its-us-conviction-list?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9054940342903137
597,6/4/2024 2:20:45 AM,"Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Rhythm Pharmaceuticals (RYTM) and Healthequity (HQY)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-edwards-lifesciences-ew-rhythm-pharmaceuticals-rytm-and-healthequity-hqy-1033447881,neutral,0.9064896702766418
598,6/4/2024 10:36:14 AM,Maintaining Hold Rating on Edwards Lifesciences Following Critical Care Divestiture,TipRanks,/news/stocks/maintaining-hold-rating-on-edwards-lifesciences-following-critical-care-divestiture-1033449649,neutral,0.9201037287712097
599,6/4/2024 11:15:21 AM,Truist Financial Reaffirms Their Buy Rating on Edwards Lifesciences (EW),TipRanks,/news/stocks/truist-financial-reaffirms-their-buy-rating-on-edwards-lifesciences-ew-1033450119,neutral,0.7873767614364624
600,6/5/2024 3:21:33 PM,The most crowded longs and shorts in U.S. Med-Tech for May - UBS,Seeking Alpha,https://seekingalpha.com/news/4113240-the-most-crowded-longs-and-shorts-in-us-med-tech-for-may-ubs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8358548879623413
601,6/6/2024 8:15:42 AM,TD Cowen Sticks to Their Buy Rating for Edwards Lifesciences (EW),TipRanks,/news/stocks/td-cowen-sticks-to-their-buy-rating-for-edwards-lifesciences-ew-1033456989,neutral,0.8542608022689819
602,6/6/2024 10:14:18 AM,Edwards Lifesciences Hold Rating: Strategic Divestiture Amid Growth Prospects and Caution,TipRanks,/news/stocks/edwards-lifesciences-hold-rating-strategic-divestiture-amid-growth-prospects-and-caution-1033457579,neutral,0.7943242788314819
603,6/6/2024 10:40:15 AM,"Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Jazz Pharmaceuticals (JAZZ) and Neurocrine (NBIX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-edwards-lifesciences-ew-jazz-pharmaceuticals-jazz-and-neurocrine-nbix-1033457654,neutral,0.9163671135902405
604,6/7/2024 12:22:06 PM,"Analysts Offer Insights on Healthcare Companies: Geron (GERN), Moderna (MRNA) and Edwards Lifesciences (EW)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-geron-gern-moderna-mrna-and-edwards-lifesciences-ew-1033461885,neutral,0.9135932922363281
605,6/18/2024 3:06:42 PM,AtriCure gains amid report of Edwards Lifesciences interest,Seeking Alpha,https://seekingalpha.com/news/4117051-atricure-gains-amid-report-of-edwards-lifesciences-interest?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7259639501571655
606,6/21/2024 9:48:53 AM,Buy Rating Affirmed for Edwards Lifesciences on Promising Evoque Technology and TAVR Market Growth Prospects,TipRanks,/news/stocks/buy-rating-affirmed-for-edwards-lifesciences-on-promising-evoque-technology-and-tavr-market-growth-prospects-1033495883,positive,0.9484289288520813
607,6/21/2024 9:49:30 AM,Edwards Lifesciences (EW) Receives a Hold from BTIG,TipRanks,/news/stocks/edwards-lifesciences-ew-receives-a-hold-from-btig-1033495880,neutral,0.8885552287101746
608,6/21/2024 10:55:34 AM,Piper Sandler Keeps Their Hold Rating on Edwards Lifesciences (EW),TipRanks,/news/stocks/piper-sandler-keeps-their-hold-rating-on-edwards-lifesciences-ew-1033496129,neutral,0.9154956340789795
609,6/25/2024 1:46:47 AM,Edwards Lifesciences (EW) Gets a Buy from RBC Capital,TipRanks,/news/stocks/edwards-lifesciences-ew-gets-a-buy-from-rbc-capital-1033502085,neutral,0.7262666821479797
610,6/27/2024 10:31:32 AM,Robbie Marcus Reiterates Buy Rating on Edwards Lifesciences Citing Growth and Clinical Outcomes,TipRanks,/news/stocks/robbie-marcus-reiterates-buy-rating-on-edwards-lifesciences-citing-growth-and-clinical-outcomes-1033511545,neutral,0.7998793125152588
611,7/1/2024 1:25:47 PM,Deutsche Numis Sticks to Their Buy Rating for Edwards Lifesciences (EW),TipRanks,/news/stocks/deutsche-numis-sticks-to-their-buy-rating-for-edwards-lifesciences-ew-1033520638,neutral,0.8273479342460632
612,7/2/2024 8:02:22 PM,The Analyst Landscape: 13 Takes On Edwards Lifesciences,Benzinga,/news/stocks/the-analyst-landscape-13-takes-on-edwards-lifesciences-1033524241,neutral,0.936229944229126
613,7/12/2024 7:15:22 AM,Maintaining Hold on Edwards Lifesciences Amid TAVR Market Caution and Forecasted Sales Dip,TipRanks,/news/stocks/maintaining-hold-on-edwards-lifesciences-amid-tavr-market-caution-and-forecasted-sales-dip-1033549895,positive,0.7359921932220459
614,7/15/2024 1:27:22 PM,Edwards Lifesciences acquires early-stage TMVR company Innovalve,Seeking Alpha,https://seekingalpha.com/news/4124264-edwards-lifesciences-acquires-early-stage-tmvr-company-innovalve?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9044357538223267
615,7/15/2024 3:10:03 PM,Edwards Lifesciences To Acquire Innovalve Bio Medical - Quick Facts ,RTTNews,/news/stocks/edwards-lifesciences-to-acquire-innovalve-bio-medical-quick-facts-1033555339,neutral,0.9319798350334167
616,7/16/2024 10:21:58 AM,Maintaining Hold on Edwards Lifesciences Amid Strategic Expansion and Product Development,TipRanks,/news/stocks/maintaining-hold-on-edwards-lifesciences-amid-strategic-expansion-and-product-development-1033559342,positive,0.5782631635665894
617,7/16/2024 12:40:27 PM,"Analysts’ Top Healthcare Picks: Accolade (ACCD), Envista Holdings (NVST)",TipRanks,/news/stocks/analysts-top-healthcare-picks-accolade-accd-envista-holdings-nvst-1033560139,positive,0.5790750980377197
618,7/18/2024 6:48:16 AM,Edwards Lifesciences: A Strategic Hold Amid Expansion and Anticipated Clinical Trials,TipRanks,/news/stocks/edwards-lifesciences-a-strategic-hold-amid-expansion-and-anticipated-clinical-trials-1033567601,positive,0.7557513117790222
619,7/18/2024 3:34:12 PM,Med-tech and healthcare stocks with upside during 2Q earnings - Baird,Seeking Alpha,https://seekingalpha.com/news/4125556-med-tech-and-healthcare-stocks-with-upside-during-2q-earnings-baird?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8237015008926392
620,7/22/2024 11:16:37 AM,TD Cowen Reaffirms Their Buy Rating on Edwards Lifesciences (EW),TipRanks,/news/stocks/td-cowen-reaffirms-their-buy-rating-on-edwards-lifesciences-ew-1033578396,neutral,0.8180097341537476
621,7/23/2024 3:01:13 PM,Here's what Wall Street expects from Edwards Lifesciences's earnings report,Markets Insider Automation,/news/stocks/edwards_lifesciences-q2-quarterly-earnings-preview-1033582531,neutral,0.9049685597419739
622,7/23/2024 5:44:07 PM,Edwards Lifesciences Q2 2024 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/4127004-edwards-lifesciences-q2-2024-earnings-preview?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9009416103363037
623,7/23/2024 9:35:48 PM,Notable earnings after Wednesday's close,Seeking Alpha,https://seekingalpha.com/news/4126771-notable-earnings-after-wednesdays-close?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8919200301170349
624,7/24/2024 7:13:32 PM,"US Stocks Tumble, Magnificent 7 Wipe Out $570 Billion As Mega-Tech Earnings Disappoint, VIX Spikes: What's Driving Markets Wednesday?",Benzinga,/news/stocks/us-stocks-tumble-magnificent-7-wipe-out-570-billion-as-mega-tech-earnings-disappoint-vix-spikes-what-s-driving-markets-wednesday-1033590385,negative,0.9039115905761719
625,7/24/2024 8:19:15 PM,"Edwards Lifesciences Non-GAAP EPS of $0.70 beats by $0.01, revenue of $1.63B misses by $20M",Seeking Alpha,https://seekingalpha.com/news/4127869-edwards-lifesciences-non-gaap-eps-of-0_70-beats-0_01-revenue-of-1_63b-misses-20m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7327848672866821
626,7/24/2024 8:21:03 PM,Edwards Lifesciences expands structural heart portfolio with 1.2B investment,Seeking Alpha,https://seekingalpha.com/news/4127874-edwards-lifesciences-expands-structural-heart-portfolio-with-12b-investment?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7345474362373352
627,7/24/2024 8:55:55 PM,Edwards Lifesciences down 14% on lower 2024 sales growth for transcatheter valves,Seeking Alpha,https://seekingalpha.com/news/4127953-edwards-lifesciences-down-14-lower-2024-sales-growth-transcatheter-valves?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9729353785514832
628,7/24/2024 10:46:09 PM,"Edwards Lifesciences Corp. Q2 Profit Increases, Beats Estimates ",RTTNews,/news/stocks/edwards-lifesciences-corp-q2-profit-increases-beats-estimates-1033590888,positive,0.9369561672210693
629,7/25/2024 12:54:31 AM,"EW Stock Earnings: Edwards Lifesciences Beats EPS, Misses Revenue for Q2 2024",InvestorPlace,/news/stocks/ew-stock-earnings-edwards-lifesciences-for-q2-of-2024-1033591265,positive,0.6372172236442566
630,7/25/2024 10:06:38 AM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Edwards Lifesciences (EW), Molina Healthcare (MOH) and Community Health (CYH)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-edwards-lifesciences-ew-molina-healthcare-moh-and-community-health-cyh-1033594719,negative,0.69083571434021
631,7/25/2024 10:36:13 AM,Edwards Lifesciences: Hold Rating Amidst TAVR Slowdown and Operational Challenges,TipRanks,/news/stocks/edwards-lifesciences-hold-rating-amidst-tavr-slowdown-and-operational-challenges-1033594916,negative,0.866978108882904
632,7/25/2024 10:37:21 AM,RBC Capital Keeps Their Buy Rating on Edwards Lifesciences (EW),TipRanks,/news/stocks/rbc-capital-keeps-their-buy-rating-on-edwards-lifesciences-ew-1033594906,neutral,0.9204249978065491
633,7/25/2024 10:50:30 AM,Analysts Offer Insights on Healthcare Companies: Natera (NTRA) and Edwards Lifesciences (EW),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-natera-ntra-and-edwards-lifesciences-ew-1033594966,neutral,0.9125542044639587
634,7/25/2024 11:02:09 AM,Analysts Offer Insights on Healthcare Companies: CervoMed (CRVO) and Edwards Lifesciences (EW),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-cervomed-crvo-and-edwards-lifesciences-ew-1033595350,neutral,0.9049204587936401
635,7/25/2024 11:21:43 AM,Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW) and Tenet Healthcare (THC),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-edwards-lifesciences-ew-and-tenet-healthcare-thc-1033595387,neutral,0.9131205081939697
636,7/25/2024 11:26:27 AM,Stifel Nicolaus Sticks to Its Hold Rating for Edwards Lifesciences (EW),TipRanks,/news/stocks/stifel-nicolaus-sticks-to-its-hold-rating-for-edwards-lifesciences-ew-1033595377,neutral,0.7418672442436218
637,7/25/2024 11:31:35 AM,Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday,InvestorPlace,/news/stocks/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-july-25th-1033594085,negative,0.4803552031517029
638,7/25/2024 11:32:09 AM,Analysts Conflicted on These Healthcare Names: Edwards Lifesciences (EW) and LivaNova (LIVN),TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-edwards-lifesciences-ew-and-livanova-livn-1033595485,negative,0.5518258810043335
639,7/25/2024 11:37:01 AM,Oppenheimer Remains a Buy on Edwards Lifesciences (EW),TipRanks,/news/stocks/oppenheimer-remains-a-buy-on-edwards-lifesciences-ew-1033595463,neutral,0.9454246163368225
640,7/25/2024 12:30:56 PM,Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF) and Edwards Lifesciences (EW),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-roche-holding-ag-otherrhhvf-and-edwards-lifesciences-ew-1033595741,neutral,0.9112405180931091
641,7/25/2024 12:36:29 PM,Why Is Edwards Lifesciences (EW) Stock Down 22% Today?,InvestorPlace,/news/stocks/why-is-edwards-lifesciences-ew-stock-down-22-today-1033594456,negative,0.9676373600959778
642,7/25/2024 12:54:05 PM,LINE Stock: 7 Things to Know as Lineage Starts Trading Today,InvestorPlace,/news/stocks/line-stock-7-things-to-know-as-lineage-starts-trading-today-1033594531,neutral,0.9430667757987976
643,7/25/2024 1:09:28 PM,Viking Therapeutics (VKTX) Stock Pops on Plans to Start Late-Stage Weight Loss Drug Trials,InvestorPlace,/news/stocks/viking-therapeutics-vktx-stock-pops-on-plans-to-start-late-stage-weight-loss-drug-trials-1033594779,neutral,0.498765766620636
644,7/25/2024 1:20:27 PM,"Analysts Are Bullish on These Healthcare Stocks: Option Care Health (OPCH), Edwards Lifesciences (EW)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-option-care-health-opch-edwards-lifesciences-ew-1033595977,neutral,0.553352952003479
645,7/25/2024 4:52:44 PM,"Edwards Lifesciences downgraded at JPM, Truist on slower transcatheter valve growth",Seeking Alpha,https://seekingalpha.com/news/4128469-edwards-lifesciences-downgraded-jpm-truist-slower-transcatheter-valve-growth?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9244226813316345
646,7/26/2024 5:56:02 AM,Hold Rating on Edwards Lifesciences Amid TAVR Challenges and Competitive Pressures,TipRanks,/news/stocks/hold-rating-on-edwards-lifesciences-amid-tavr-challenges-and-competitive-pressures-1033599108,negative,0.8790450096130371
647,7/26/2024 8:37:29 AM,Barclays Keeps Their Buy Rating on Edwards Lifesciences (EW),TipRanks,/news/stocks/barclays-keeps-their-buy-rating-on-edwards-lifesciences-ew-1033599788,neutral,0.9182630181312561
648,7/29/2024 8:41:16 AM,"Analysts Offer Insights on Healthcare Companies: Aclarion, Inc. (ACON), Edwards Lifesciences (EW) and Sanofi (OtherSNYNF)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-aclarion-inc-acon-edwards-lifesciences-ew-and-sanofi-othersnynf-1033605671,neutral,0.9140982031822205
649,7/29/2024 11:00:00 AM,3 Healthcare Stocks to Buy at a 52-Week Low in July,InvestorPlace,/news/stocks/3-healthcare-stocks-to-buy-at-a-52-week-low-in-july-1033605600,negative,0.8792893886566162
650,7/30/2024 10:52:03 AM,"Analysts’ Top Healthcare Picks: Edwards Lifesciences (EW), AbbVie (ABBV)",TipRanks,/news/stocks/analysts-top-healthcare-picks-edwards-lifesciences-ew-abbvie-abbv-1033612401,positive,0.6506854891777039
651,7/31/2024 6:30:32 PM,7 Leading MedTech Stocks for Next-Gen Health Solutions,InvestorPlace,/news/stocks/7-leading-medtech-stocks-for-next-gen-health-solutions-1033620457,neutral,0.5478200912475586
652,8/9/2024 12:16:55 PM,Strategic Acquisitions Bolster Edwards Lifesciences’ Growth in Valvular Disease Market,TipRanks,/news/stocks/strategic-acquisitions-bolster-edwards-lifesciences-growth-in-valvular-disease-market-1033669951,positive,0.9240520000457764
653,8/16/2024 10:45:12 AM,RBC Capital Reaffirms Their Buy Rating on Edwards Lifesciences (EW),TipRanks,/news/stocks/rbc-capital-reaffirms-their-buy-rating-on-edwards-lifesciences-ew-1033700519,neutral,0.8246037364006042
654,8/19/2024 11:00:22 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Edwards Lifesciences (EW), Immunovant (IMVT) and Q32 Bio (QTTB)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-edwards-lifesciences-ew-immunovant-imvt-and-q32-bio-qttb-1033704506,negative,0.9195970892906189
655,8/20/2024 9:10:11 AM,"Analysts Are Bullish on These Healthcare Stocks: Liquidia Technologies (LQDA), Edwards Lifesciences (EW)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-liquidia-technologies-lqda-edwards-lifesciences-ew-1033707062,neutral,0.49318167567253113
656,8/22/2024 6:06:08 AM,Edwards Lifesciences: A Strong Buy on Market Expansion and Innovative Cardiovascular Solutions,TipRanks,/news/stocks/edwards-lifesciences-a-strong-buy-on-market-expansion-and-innovative-cardiovascular-solutions-1033713899,positive,0.8631689548492432
657,8/26/2024 10:35:41 AM,Balanced Outlook: Hold Rating on Edwards Lifesciences Amidst Market Uncertainties and Growth Potential,TipRanks,/news/stocks/balanced-outlook-hold-rating-on-edwards-lifesciences-amidst-market-uncertainties-and-growth-potential-1033722089,neutral,0.49654585123062134
658,9/3/2024 11:35:27 AM,Wells Fargo Sticks to Its Buy Rating for Edwards Lifesciences (EW),TipRanks,/news/stocks/wells-fargo-sticks-to-its-buy-rating-for-edwards-lifesciences-ew-1033744244,neutral,0.7819001078605652
659,9/4/2024 4:31:46 PM,"Edwards completes unit sale to BD, expands stock buyback",Seeking Alpha,https://seekingalpha.com/news/4146930-edwards-completes-unit-sale-to-bd-expands-stock-buyback?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7465933561325073
660,9/9/2024 6:15:53 AM,Edwards Lifesciences: Hold Rating Amidst 2025 Earnings Uncertainty and Market Dynamics,TipRanks,/news/stocks/edwards-lifesciences-hold-rating-amidst-2025-earnings-uncertainty-and-market-dynamics-1033756560,neutral,0.6916258931159973
661,9/12/2024 11:30:14 AM,"Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), MoonLake Immunotherapeutics (MLTX) and Protara Therapeutics (TARA)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-edwards-lifesciences-ew-moonlake-immunotherapeutics-mltx-and-protara-therapeutics-tara-1033767653,neutral,0.910374641418457
662,9/13/2024 11:16:31 AM,Truist Financial Sticks to Its Hold Rating for Edwards Lifesciences (EW),TipRanks,/news/stocks/truist-financial-sticks-to-its-hold-rating-for-edwards-lifesciences-ew-1033770731,neutral,0.5126044750213623
663,9/16/2024 10:56:14 AM,Hold Rating on Edwards Lifesciences Amidst Uncertain Growth and Market Dynamics,TipRanks,/news/stocks/hold-rating-on-edwards-lifesciences-amidst-uncertain-growth-and-market-dynamics-1033774358,negative,0.5043264627456665
664,9/16/2024 4:54:08 PM,Edwards Lifesciences gains amid takeover speculation,Seeking Alpha,https://seekingalpha.com/news/4150042-edwards-lifesciences-gains-amid-takeover-speculation?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8644934892654419
665,9/18/2024 8:45:38 AM,Edwards Lifesciences: Hold Rating Amid TAVR Sector Challenges and Growth Constraints,TipRanks,/news/stocks/edwards-lifesciences-hold-rating-amid-tavr-sector-challenges-and-growth-constraints-1033779973,negative,0.9549163579940796
666,9/18/2024 10:36:25 AM,Wells Fargo Sticks to Their Buy Rating for Edwards Lifesciences (EW),TipRanks,/news/stocks/wells-fargo-sticks-to-their-buy-rating-for-edwards-lifesciences-ew-1033780377,neutral,0.8368936777114868
667,9/18/2024 1:51:02 PM,Edwards Lifesciences downgraded at Jefferies on lower TAVR growth,Seeking Alpha,https://seekingalpha.com/news/4150628-edwards-lifesciences-downgraded-jefferies-lower-tavr-growth?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9357792735099792
668,9/21/2024 2:38:00 PM,"Deals this week: Smartsheet, AT&T, BP, Cleveland-Cliffs, Vistra and more",Seeking Alpha,https://seekingalpha.com/news/4151441-deals-this-week-smartsheet-att-bp-cleveland-cliffs-vistra-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9311981201171875
669,10/1/2024 9:39:53 PM,"BDX upped to buy by Citi, TNDM put on Negative Catalyst Watch",Seeking Alpha,https://seekingalpha.com/news/4155278-bdx-upped-to-buy-by-citi-tndm-put-on-negative-catalyst-watch?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9199478626251221
670,10/2/2024 2:07:00 PM,Bristol-Myers tops growth chart among S&P 500 healthcare stocks in Q3,Seeking Alpha,https://seekingalpha.com/news/4155316-bristol-myers-tops-growth-chart-among-sp-500-healthcare-stocks-in-q3?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9400187730789185
671,10/4/2024 8:20:49 AM,"Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Tandem Diabetes Care (TNDM) and BioMarin Pharmaceutical (BMRN)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-edwards-lifesciences-ew-tandem-diabetes-care-tndm-and-biomarin-pharmaceutical-bmrn-1033820873,neutral,0.9079384803771973
672,10/4/2024 9:32:03 AM,"Analysts Conflicted on These Healthcare Names: TransMedics Group (TMDX), Vertex Pharmaceuticals (VRTX) and Edwards Lifesciences (EW)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-transmedics-group-tmdx-vertex-pharmaceuticals-vrtx-and-edwards-lifesciences-ew-1033821124,negative,0.6997400522232056
673,10/7/2024 10:45:42 AM,Maintaining Hold on Edwards Lifesciences Amid Transition and Earnings Adjustment,TipRanks,/news/stocks/maintaining-hold-on-edwards-lifesciences-amid-transition-and-earnings-adjustment-1033824830,positive,0.5560497045516968
674,10/8/2024 10:45:32 AM,Piper Sandler Reaffirms Their Hold Rating on Edwards Lifesciences (EW),TipRanks,/news/stocks/piper-sandler-reaffirms-their-hold-rating-on-edwards-lifesciences-ew-1033828253,neutral,0.8381720781326294
675,10/14/2024 6:40:15 AM,"Analysts Conflicted on These Healthcare Names: Allakos (ALLK), Edwards Lifesciences (EW) and NewAmsterdam Pharma Company (NAMS)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-allakos-allk-edwards-lifesciences-ew-and-newamsterdam-pharma-company-nams-1033842312,negative,0.6882631778717041
676,10/23/2024 9:35:40 PM,Edwards Lifesciences Q3 2024 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/4196985-edwards-lifesciences-q3-2024-earnings-preview?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8932930827140808
677,10/24/2024 2:00:00 PM,Here are the major earnings after the close today,Seeking Alpha,https://seekingalpha.com/news/4195372-here-are-the-major-earnings-after-the-close-today?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9299408793449402
678,10/24/2024 5:35:09 PM,Edwards Lifesciences options imply 8.1% move in share price post-earnings,TipRanks,/news/stocks/edwards-lifesciences-options-imply-8-1-move-in-share-price-post-earnings-1033888976,positive,0.5645599961280823
679,10/24/2024 5:51:28 PM,Notable companies reporting after market close,TipRanks,/news/stocks/notable-companies-reporting-after-market-close-1033889041,neutral,0.8840794563293457
680,10/24/2024 8:24:57 PM,"Edwards Lifesciences Non-GAAP EPS of $0.67 beats by $0.08, revenue of $1.35B misses by $30M",Seeking Alpha,https://seekingalpha.com/news/4201994-edwards-lifesciences-non-gaap-eps-of-0_67-beats-0_08-revenue-of-1_35b-misses-30m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7256303429603577
681,10/24/2024 8:25:47 PM,"Edwards Lifesciences sees Q4 EPS 53c-57c, consensus 62c",TipRanks,/news/stocks/edwards-lifesciences-sees-q4-eps-53c-57c-consensus-62c-1033889319,neutral,0.8938606977462769
682,10/24/2024 8:26:11 PM,"Edwards Lifesciences backs FY24 revenue growth view 8%-10%, consensus $1.44B",TipRanks,/news/stocks/edwards-lifesciences-backs-fy24-revenue-growth-view-8--10-consensus-1-44b-1033889316,positive,0.9477646350860596
683,10/24/2024 8:26:26 PM,"Edwards Lifesciences reports Q3 adjusted EPS 67c, consensus 64c",TipRanks,/news/stocks/edwards-lifesciences-reports-q3-adjusted-eps-67c-consensus-64c-1033889314,neutral,0.8292984366416931
684,10/24/2024 10:38:43 PM,Edwards Lifesciences Corp. Reveals Rise In Q3 Profit ,RTTNews,/news/stocks/edwards-lifesciences-corp-reveals-rise-in-q3-profit-1033888968,positive,0.9425933957099915
685,10/24/2024 11:20:19 PM,Closing Bell Movers: Deckers up 12% after earnings beat,TipRanks,/news/stocks/closing-bell-movers-deckers-up-12-after-earnings-beat-1033889730,positive,0.9446895718574524
686,10/25/2024 2:45:10 AM,Mixed Signals Maintain Hold Rating for Edwards Lifesciences Amid Modest Q3 Performance,TipRanks,/news/stocks/mixed-signals-maintain-hold-rating-for-edwards-lifesciences-amid-modest-q3-performance-1033890692,positive,0.5951117873191833
687,10/25/2024 10:30:36 AM,Cautious Hold on Edwards Lifesciences Amid TAVR Challenges and Valuation Concerns,TipRanks,/news/stocks/cautious-hold-on-edwards-lifesciences-amid-tavr-challenges-and-valuation-concerns-1033892883,negative,0.7952832579612732
688,10/25/2024 10:33:18 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Legend Biotech (LEGN), Molina Healthcare (MOH) and Edwards Lifesciences (EW)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-legend-biotech-legn-molina-healthcare-moh-and-edwards-lifesciences-ew-1033892859,negative,0.899138867855072
689,10/25/2024 11:07:59 AM,Hold Rating for Edwards Lifesciences Amid Short-Term Challenges and Long-Term Potential,TipRanks,/news/stocks/hold-rating-for-edwards-lifesciences-amid-short-term-challenges-and-long-term-potential-1033893369,positive,0.8615724444389343
690,10/25/2024 11:12:31 AM,Edwards Lifesciences price target lowered to $68 from $73 at Baird,TipRanks,/news/stocks/edwards-lifesciences-price-target-lowered-to-68-from-73-at-baird-1033893352,negative,0.5828194618225098
691,10/25/2024 11:21:25 AM,Edwards Lifesciences price target raised to $78 from $72 at JPMorgan,TipRanks,/news/stocks/edwards-lifesciences-price-target-raised-to-78-from-72-at-jpmorgan-1033893479,positive,0.9455631375312805
692,10/25/2024 11:23:28 AM,Truist Financial Sticks to Their Hold Rating for Edwards Lifesciences (EW),TipRanks,/news/stocks/truist-financial-sticks-to-their-hold-rating-for-edwards-lifesciences-ew-1033893442,neutral,0.7466525435447693
693,10/25/2024 11:50:06 AM,Piper Sandler Sticks to Their Hold Rating for Edwards Lifesciences (EW),TipRanks,/news/stocks/piper-sandler-sticks-to-their-hold-rating-for-edwards-lifesciences-ew-1033893739,neutral,0.8857382535934448
694,10/25/2024 11:51:41 AM,Stifel Nicolaus Keeps Their Hold Rating on Edwards Lifesciences (EW),TipRanks,/news/stocks/stifel-nicolaus-keeps-their-hold-rating-on-edwards-lifesciences-ew-1033893708,neutral,0.9173479080200195
695,10/25/2024 11:53:18 AM,Hold Rating on Edwards Lifesciences Amidst Growth Constraints and Transition Year Projections,TipRanks,/news/stocks/hold-rating-on-edwards-lifesciences-amidst-growth-constraints-and-transition-year-projections-1033893689,neutral,0.47514307498931885
696,10/25/2024 12:01:45 PM,RBC Capital Reaffirms Their Buy Rating on Edwards Lifesciences (EW),TipRanks,/news/stocks/rbc-capital-reaffirms-their-buy-rating-on-edwards-lifesciences-ew-1033893877,neutral,0.8246037364006042
697,10/25/2024 12:04:45 PM,Cautious Hold Rating for Edwards Lifesciences Amid Mixed Growth Prospects and Strategic Challenges,TipRanks,/news/stocks/cautious-hold-rating-for-edwards-lifesciences-amid-mixed-growth-prospects-and-strategic-challenges-1033893845,negative,0.7461568117141724
698,10/25/2024 12:05:58 PM,Edwards Lifesciences (EW) Gets a Buy from Oppenheimer,TipRanks,/news/stocks/edwards-lifesciences-ew-gets-a-buy-from-oppenheimer-1033893830,neutral,0.5749952793121338
699,10/25/2024 12:35:16 PM,Edwards Lifesciences (EW) Gets a Hold from Jefferies,TipRanks,/news/stocks/edwards-lifesciences-ew-gets-a-hold-from-jefferies-1033894109,neutral,0.87562096118927
700,10/25/2024 12:55:26 PM,Edwards Lifesciences price target raised to $63 from $60 at Canaccord,TipRanks,/news/stocks/edwards-lifesciences-price-target-raised-to-63-from-60-at-canaccord-1033894185,positive,0.9443721771240234
701,10/25/2024 12:55:44 PM,Edwards Lifesciences price target lowered to $70 from $71 at Truist,TipRanks,/news/stocks/edwards-lifesciences-price-target-lowered-to-70-from-71-at-truist-1033894183,neutral,0.4896821677684784
702,10/25/2024 1:07:17 PM,Edwards Lifesciences price target lowered to $70 from $73 at Piper Sandler,TipRanks,/news/stocks/edwards-lifesciences-price-target-lowered-to-70-from-73-at-piper-sandler-1033894362,negative,0.5404527187347412
703,10/25/2024 3:16:06 PM,"Edwards Lifesciences Faces Challenges Amidst TAVR Market Maturity and Rising Competition, Leading to Hold Rating",TipRanks,/news/stocks/edwards-lifesciences-faces-challenges-amidst-tavr-market-maturity-and-rising-competition-leading-to-hold-rating-1033894911,negative,0.9550952315330505
704,10/25/2024 4:17:12 PM,Edwards Lifesciences: Promising Growth in TAVR and TMTT Amidst Near-Term Uncertainties,TipRanks,/news/stocks/edwards-lifesciences-promising-growth-in-tavr-and-tmtt-amidst-near-term-uncertainties-1033895065,positive,0.95401930809021
705,10/26/2024 3:56:28 PM,Strong Growth and Promising Outlook: Buy Rating for Edwards Lifesciences,TipRanks,/news/stocks/strong-growth-and-promising-outlook-buy-rating-for-edwards-lifesciences-1033896017,positive,0.8414214849472046
706,10/26/2024 4:05:07 PM,Edwards Lifesciences price target raised to $85 from $80 at Barclays,TipRanks,/news/stocks/edwards-lifesciences-price-target-raised-to-85-from-80-at-barclays-1033896039,positive,0.9411154389381409
707,10/28/2024 10:25:45 AM,Edwards Lifesciences upgraded to Market Perform from Underperform at Bernstein,TipRanks,/news/stocks/edwards-lifesciences-upgraded-to-market-perform-from-underperform-at-bernstein-1033901673,positive,0.9502806067466736
708,10/28/2024 1:47:09 PM,"Coinbase initiated, Edwards Lifesciences upgraded: Wall Street’s top analyst cal",TipRanks,/news/stocks/coinbase-initiated-edwards-lifesciences-upgraded-wall-street-s-top-analyst-cal-1033903187,neutral,0.79985111951828
709,10/28/2024 2:05:54 PM,Early notable gainers among liquid option names on October 28th,TipRanks,/news/stocks/early-notable-gainers-among-liquid-option-names-on-october-28th-1033903294,positive,0.9138472676277161
710,10/28/2024 3:05:07 PM,Edwards Lifesciences announces results from EARLY TAVR trial,TipRanks,/news/stocks/edwards-lifesciences-announces-results-from-early-tavr-trial-1033903526,neutral,0.8687286376953125
711,10/28/2024 3:30:47 PM,Edwards Lifesciences upgraded to outperform by Bernstein,Seeking Alpha,https://seekingalpha.com/news/4214083-edwards-lifesciences-upgraded-to-outperform-by-bernstein?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9411011934280396
712,10/28/2024 3:40:07 PM,"Edwards Lifesciences TAVR data better than expected, says Citi",TipRanks,/news/stocks/edwards-lifesciences-tavr-data-better-than-expected-says-citi-1033903571,positive,0.9504261016845703
713,10/28/2024 3:45:23 PM,Promising EARLY TAVR Trial Results Boost Edwards Lifesciences’ Outlook with 16.7% Projected Share Price Growth,TipRanks,/news/stocks/promising-early-tavr-trial-results-boost-edwards-lifesciences-outlook-with-16-7-projected-share-price-growth-1033903610,positive,0.9564783573150635
714,10/28/2024 4:05:51 PM,JPMorgan views Edwards Lifesciences TAVR data positively,TipRanks,/news/stocks/jpmorgan-views-edwards-lifesciences-tavr-data-positively-1033903640,neutral,0.9180507659912109
715,10/28/2024 4:25:08 PM,Edwards Lifesciences call volume above normal and directionally bullish,TipRanks,/news/stocks/edwards-lifesciences-call-volume-above-normal-and-directionally-bullish-1033903668,positive,0.7974042296409607
716,10/28/2024 6:25:27 PM,"Raymond James says Edwards’ EARLY TAVR data also positive for Medtronic, Abbott",TipRanks,/news/stocks/raymond-james-says-edwards-early-tavr-data-also-positive-for-medtronic-abbott-1033904067,positive,0.9422356486320496
717,10/29/2024 10:25:23 AM,Hold Rating on Edwards Lifesciences Amid Uncertainties in TAVR Data,TipRanks,/news/stocks/hold-rating-on-edwards-lifesciences-amid-uncertainties-in-tavr-data-1033909126,neutral,0.5424578785896301
718,10/29/2024 10:37:02 AM,Promising EARLY TAVR Trial Results Bolster Buy Rating for Edwards Lifesciences,TipRanks,/news/stocks/promising-early-tavr-trial-results-bolster-buy-rating-for-edwards-lifesciences-1033909299,positive,0.953180730342865
719,10/29/2024 10:39:19 AM,Piper Sandler Reaffirms Their Hold Rating on Edwards Lifesciences (EW),TipRanks,/news/stocks/piper-sandler-reaffirms-their-hold-rating-on-edwards-lifesciences-ew-1033909268,neutral,0.8381720781326294
720,10/29/2024 10:46:47 AM,Hold Rating Maintained on Edwards Lifesciences Amid Uncertain Immediate Financial Impact of EARLY TAVR Trial Results,TipRanks,/news/stocks/hold-rating-maintained-on-edwards-lifesciences-amid-uncertain-immediate-financial-impact-of-early-tavr-trial-results-1033909414,negative,0.7966712713241577
721,10/29/2024 11:18:34 AM,Truist Financial Releases a Hold Rating on Edwards Lifesciences (EW),TipRanks,/news/stocks/truist-financial-releases-a-hold-rating-on-edwards-lifesciences-ew-1033909657,neutral,0.9130065441131592
722,10/29/2024 11:45:54 AM,Oppenheimer Keeps Their Buy Rating on Edwards Lifesciences (EW),TipRanks,/news/stocks/oppenheimer-keeps-their-buy-rating-on-edwards-lifesciences-ew-1033909892,neutral,0.9214683175086975
723,10/30/2024 3:05:37 PM,Edwards Lifesciences Evoque demonstrated superiority vs. medical therapy alone,TipRanks,/news/stocks/edwards-lifesciences-evoque-demonstrated-superiority-vs-medical-therapy-alone-1033920209,positive,0.9425886273384094
724,10/30/2024 7:30:10 PM,Edwards Life says pivotal study for Evoque hit one-year goal,Seeking Alpha,https://seekingalpha.com/news/4225583-edwards-lifesciences-hit-main-goal-evoque?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7029523253440857
725,10/31/2024 6:25:13 PM,Edwards Lifesciences call volume above normal and directionally bullish,TipRanks,/news/stocks/edwards-lifesciences-call-volume-above-normal-and-directionally-bullish-1033931564,positive,0.7974042296409607
726,11/8/2024 7:05:12 PM,Edwards Lifesciences call volume above normal and directionally bullish,TipRanks,/news/stocks/edwards-lifesciences-call-volume-above-normal-and-directionally-bullish-1033985124,positive,0.7974042296409607
727,11/15/2024 7:15:09 PM,"Medtech shouldn't be greatly impacted by RFK Jr. at HHS, Wells Fargo says",Seeking Alpha,https://seekingalpha.com/news/4296173-medtech-shouldnt-be-greatly-impacted-by-rfk-jr-at-hhs-wells-fargo-says?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9096674919128418
728,11/19/2024 5:45:42 PM,Trump Trade: President-elect seeks to kill Biden fuel-efficiency rules,TipRanks,/news/stocks/trump-trade-president-elect-seeks-to-kill-biden-fuel-efficiency-rules-1034038710,negative,0.7241330742835999
729,11/25/2024 10:15:28 AM,Edwards Lifesciences announces presentation of one-year SAPIEN 3 data,TipRanks,/news/stocks/edwards-lifesciences-announces-presentation-of-one-year-sapien-3-data-1034060257,neutral,0.8991404175758362
730,11/25/2024 11:47:29 AM,Piper Sandler Reaffirms Their Hold Rating on Edwards Lifesciences (EW),TipRanks,/news/stocks/piper-sandler-reaffirms-their-hold-rating-on-edwards-lifesciences-ew-1034060814,neutral,0.8381720781326294
731,11/25/2024 3:45:28 PM,Hold Rating Maintained on Edwards Lifesciences Despite Positive SAPIEN 3 Ultra RESILIA Valve Data,TipRanks,/news/stocks/hold-rating-maintained-on-edwards-lifesciences-despite-positive-sapien-3-ultra-resilia-valve-data-1034062461,positive,0.5526629090309143
732,11/27/2024 11:50:58 AM,Edwards Lifesciences price target raised to $80 from $75 at RBC Capital,TipRanks,/news/stocks/edwards-lifesciences-price-target-raised-to-80-from-75-at-rbc-capital-1034071650,positive,0.9451586604118347
733,11/27/2024 11:55:16 AM,RBC Capital Sticks to Their Buy Rating for Edwards Lifesciences (EW),TipRanks,/news/stocks/rbc-capital-sticks-to-their-buy-rating-for-edwards-lifesciences-ew-1034071641,neutral,0.5799916386604309
734,11/28/2024 9:25:32 AM,Edwards Lifesciences (EW) Receives a Hold from Leerink Partners,TipRanks,/news/stocks/edwards-lifesciences-ew-receives-a-hold-from-leerink-partners-1034075876,neutral,0.8436751365661621
735,11/29/2024 5:00:00 PM,"Catalyst Watch: November jobs, OPEC+ meeting, Marvell, Salesforce earnings",Seeking Alpha,https://seekingalpha.com/news/4340728-catalyst-watch-november-jobs-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8812248110771179
736,12/2/2024 11:45:15 AM,Positive Growth and Strategic Expansion Justify Buy Rating for Edwards Lifesciences,TipRanks,/news/stocks/positive-growth-and-strategic-expansion-justify-buy-rating-for-edwards-lifesciences-1034086402,positive,0.8601175546646118
737,12/2/2024 12:41:07 PM,Edwards Lifesciences price target raised to $88 from $85 at Barclays,TipRanks,/news/stocks/edwards-lifesciences-price-target-raised-to-88-from-85-at-barclays-1034086988,positive,0.9427720904350281
738,12/4/2024 11:10:07 AM,Edwards Lifesciences backs FY24 constant currency sales growth of 8%-10%,TipRanks,/news/stocks/edwards-lifesciences-backs-fy24-constant-currency-sales-growth-of-8--10-1034096817,positive,0.9343650341033936
739,12/4/2024 11:11:14 AM,"Edwards Lifesciences sees FY25 adjusted EPS $2.40-$2.50, consensus $2.47",TipRanks,/news/stocks/edwards-lifesciences-sees-fy25-adjusted-eps-2-40--2-50-consensus-2-47-1034096809,neutral,0.8379645347595215
740,12/4/2024 12:17:58 PM,Edwards Lifesciences Projects 2025 Constant Currency Sales Growth Of 8% - 10% ,RTTNews,/news/stocks/edwards-lifesciences-projects-2025-constant-currency-sales-growth-of-8-10-1034096011,positive,0.9240756630897522
741,12/4/2024 2:55:11 PM,Early notable gainers among liquid option names on December 4th,TipRanks,/news/stocks/early-notable-gainers-among-liquid-option-names-on-december-4th-1034098346,positive,0.90422523021698
742,12/5/2024 12:12:07 PM,Edwards Lifesciences price target raised to $68 from $63 at Canaccord,TipRanks,/news/stocks/edwards-lifesciences-price-target-raised-to-68-from-63-at-canaccord-1034102498,positive,0.9457364678382874
743,12/5/2024 12:30:50 PM,Edwards Lifesciences price target raised to $75 from $70 at TD Cowen,TipRanks,/news/stocks/edwards-lifesciences-price-target-raised-to-75-from-70-at-td-cowen-1034102735,positive,0.9449726343154907
744,12/5/2024 1:00:20 PM,Edwards Lifesciences price target raised to $82 from $75 at BofA,TipRanks,/news/stocks/edwards-lifesciences-price-target-raised-to-82-from-75-at-bofa-1034102927,positive,0.9464399814605713
745,12/5/2024 1:45:59 PM,Edwards Lifesciences price target raised to $78 from $70 at Truist,TipRanks,/news/stocks/edwards-lifesciences-price-target-raised-to-78-from-70-at-truist-1034103283,positive,0.9445658326148987
746,12/5/2024 1:46:15 PM,Edwards Lifesciences price target raised to $75 from $70 at Stifel,TipRanks,/news/stocks/edwards-lifesciences-price-target-raised-to-75-from-70-at-stifel-1034103281,positive,0.9450516104698181
747,12/5/2024 5:02:05 PM,"Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Evolent Health (EVH) and Palisade Bio (PALI)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-edwards-lifesciences-ew-evolent-health-evh-and-palisade-bio-pali-1034104369,neutral,0.9137740731239319
748,12/5/2024 5:13:17 PM,Edwards Lifesciences: Stable Growth Amidst Mixed Financial Outlook Justifies Hold Rating,TipRanks,/news/stocks/edwards-lifesciences-stable-growth-amidst-mixed-financial-outlook-justifies-hold-rating-1034104316,neutral,0.6520462036132812
749,12/5/2024 5:20:21 PM,Hold Rating for Edwards Lifesciences: Balancing Risks and Opportunities Amidst Market Variability,TipRanks,/news/stocks/hold-rating-for-edwards-lifesciences-balancing-risks-and-opportunities-amidst-market-variability-1034104447,neutral,0.8146532773971558
750,12/5/2024 5:31:15 PM,"Analysts Offer Insights on Healthcare Companies: Patterson Companies (PDCO), Edwards Lifesciences (EW) and Nuvalent (NUVL)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-patterson-companies-pdco-edwards-lifesciences-ew-and-nuvalent-nuvl-1034104581,neutral,0.9180559515953064
751,12/5/2024 5:34:31 PM,Balanced Outlook with Strategic Potential: A Hold Rating for Edwards Lifesciences,TipRanks,/news/stocks/balanced-outlook-with-strategic-potential-a-hold-rating-for-edwards-lifesciences-1034104560,neutral,0.4997095465660095
752,12/5/2024 5:41:31 PM,Edwards Lifesciences Poised for Growth with Strategic Initiatives and Robust Financial Outlook,TipRanks,/news/stocks/edwards-lifesciences-poised-for-growth-with-strategic-initiatives-and-robust-financial-outlook-1034104514,positive,0.9230291247367859
753,12/5/2024 5:46:14 PM,Edwards Lifesciences: Hold Rating Amidst Transitional Growth Prospects and Market Challenges,TipRanks,/news/stocks/edwards-lifesciences-hold-rating-amidst-transitional-growth-prospects-and-market-challenges-1034104687,negative,0.7113612294197083
754,12/5/2024 5:55:15 PM,TD Cowen Sticks to Its Hold Rating for Edwards Lifesciences (EW),TipRanks,/news/stocks/td-cowen-sticks-to-its-hold-rating-for-edwards-lifesciences-ew-1034104631,neutral,0.8278491497039795
755,12/5/2024 6:12:25 PM,"Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS), Biogen (BIIB) and Edwards Lifesciences (EW)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-alkermes-alks-biogen-biib-and-edwards-lifesciences-ew-1034104745,neutral,0.914422869682312
756,12/5/2024 6:16:22 PM,Bank of America Securities Keeps Their Hold Rating on Edwards Lifesciences (EW),TipRanks,/news/stocks/bank-of-america-securities-keeps-their-hold-rating-on-edwards-lifesciences-ew-1034104982,neutral,0.923050582408905
757,12/5/2024 6:17:38 PM,Edwards Lifesciences (EW) Receives a Buy from RBC Capital,TipRanks,/news/stocks/edwards-lifesciences-ew-receives-a-buy-from-rbc-capital-1034104971,neutral,0.5992449522018433
758,12/5/2024 6:20:59 PM,"Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Context Therapeutics (CNTX) and Xenetic Biosciences (XBIO)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-edwards-lifesciences-ew-context-therapeutics-cntx-and-xenetic-biosciences-xbio-1034104942,neutral,0.9082372188568115
759,12/5/2024 6:23:55 PM,Truist Financial Gives a Hold Rating to Edwards Lifesciences (EW),TipRanks,/news/stocks/truist-financial-gives-a-hold-rating-to-edwards-lifesciences-ew-1034104922,neutral,0.8590555787086487
760,12/5/2024 6:26:00 PM,Oppenheimer Remains a Buy on Edwards Lifesciences (EW),TipRanks,/news/stocks/oppenheimer-remains-a-buy-on-edwards-lifesciences-ew-1034104906,neutral,0.9454246163368225
761,12/6/2024 5:55:47 AM,Edwards Lifesciences: Balancing Optimism and Caution with a Hold Rating Amidst TAVR Uncertainties,TipRanks,/news/stocks/edwards-lifesciences-balancing-optimism-and-caution-with-a-hold-rating-amidst-tavr-uncertainties-1034106513,neutral,0.7111368775367737
762,12/10/2024 2:55:14 PM,Early notable gainers among liquid option names on December 10th,TipRanks,/news/stocks/early-notable-gainers-among-liquid-option-names-on-december-10th-1034120756,positive,0.9014385938644409
763,12/11/2024 2:26:22 AM,Edwards Lifesciences (EW) Receives a Hold from Truist Financial,TipRanks,/news/stocks/edwards-lifesciences-ew-receives-a-hold-from-truist-financial-1034122152,neutral,0.8259607553482056
764,12/11/2024 11:46:00 AM,Edwards Lifesciences price target raised to $83 from $81 at Citi,TipRanks,/news/stocks/edwards-lifesciences-price-target-raised-to-83-from-81-at-citi-1034124792,positive,0.9430011510848999
765,12/16/2024 2:05:37 PM,Edwards Lifesciences upgraded to Buy from Neutral at BofA,TipRanks,/news/stocks/edwards-lifesciences-upgraded-to-buy-from-neutral-at-bofa-1034142032,positive,0.902402937412262
766,12/18/2024 11:26:50 AM,Edwards Lifesciences: Competitive Pressures and Valuation Concerns Lead to Sell Rating,TipRanks,/news/stocks/edwards-lifesciences-competitive-pressures-and-valuation-concerns-lead-to-sell-rating-1034151057,negative,0.8972178101539612
767,12/18/2024 6:05:05 PM,Deutsche Bank  Sticks to Its Buy Rating for Edwards Lifesciences (EW),TipRanks,/news/stocks/deutsche-bank-sticks-to-its-buy-rating-for-edwards-lifesciences-ew-1034153179,neutral,0.7967730164527893
768,1/2/2025 11:46:31 AM,Edwards Lifesciences price target raised to $75 from $69 at Evercore ISI,TipRanks,/news/stocks/edwards-lifesciences-price-target-raised-to-75-from-69-at-evercore-isi-1034186888,positive,0.9458346962928772
769,1/6/2025 5:52:14 PM,"FDA issues first draft guidance on use of AI in drug, medical device development",Seeking Alpha,https://seekingalpha.com/news/4392790-fda-issues-first-draft-guidance-use-ai-drug-medical-device-development?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9278177618980408
770,1/8/2025 1:47:19 AM,RBC Capital Reaffirms Their Buy Rating on Edwards Lifesciences (EW),TipRanks,/news/stocks/rbc-capital-reaffirms-their-buy-rating-on-edwards-lifesciences-ew-1034202961,neutral,0.8246037364006042
771,1/8/2025 11:30:55 PM,Edwards Lifesciences price target raised to $74 from $72 at Bernstein,TipRanks,/news/stocks/edwards-lifesciences-price-target-raised-to-74-from-72-at-bernstein-1034208059,positive,0.9445124268531799
772,1/10/2025 1:25:42 PM,Pulse Biosciences announces Paul LaViolette as CEO,TipRanks,/news/stocks/pulse-biosciences-announces-paul-laviolette-as-ceo-1034215460,neutral,0.9028624892234802
773,1/10/2025 7:45:37 PM,Edwards Lifesciences call volume above normal and directionally bullish,TipRanks,/news/stocks/edwards-lifesciences-call-volume-above-normal-and-directionally-bullish-1034216666,positive,0.7974042296409607
774,1/15/2025 11:19:03 AM,Bernstein Reaffirms Their Hold Rating on Edwards Lifesciences (EW),TipRanks,/news/stocks/bernstein-reaffirms-their-hold-rating-on-edwards-lifesciences-ew-1034230561,neutral,0.8662063479423523
775,1/15/2025 11:46:03 AM,Citi Reaffirms Their Buy Rating on Edwards Lifesciences (EW),TipRanks,/news/stocks/citi-reaffirms-their-buy-rating-on-edwards-lifesciences-ew-1034230764,neutral,0.8144055604934692
776,1/16/2025 10:20:24 AM,Edwards Lifesciences downgraded to Underperform at Wolfe Research,TipRanks,/news/stocks/edwards-lifesciences-downgraded-to-underperform-at-wolfe-research-1034235102,negative,0.9243662357330322
777,1/16/2025 1:43:42 PM,Edwards Lifesciences downgraded at Wolfe on TAVR worries,Seeking Alpha,https://seekingalpha.com/news/4395634-edwards-lifesciences-stock-downgraded-wolfe?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7860831022262573
778,1/16/2025 5:10:37 PM,"UnitedHealth, BofA report Q4 earnings beats: Morning Buzz",TipRanks,/news/stocks/unitedhealth-bofa-report-q4-earnings-beats-morning-buzz-1034237400,neutral,0.7674577832221985
779,1/17/2025 7:55:28 PM,Buy/Sell: Wall Street’s top 10 stock calls this week,TipRanks,/news/stocks/buy-sell-wall-street-s-top-10-stock-calls-this-week-1034241751,neutral,0.8970736861228943
780,1/24/2025 8:05:12 PM,Edwards Lifesciences call volume above normal and directionally bullish,TipRanks,/news/stocks/edwards-lifesciences-call-volume-above-normal-and-directionally-bullish-1034267984,positive,0.7974042296409607
781,1/29/2025 10:15:40 PM,Edwards Lifesciences upgraded to Buy from Hold at Stifel,TipRanks,/news/stocks/edwards-lifesciences-upgraded-to-buy-from-hold-at-stifel-1034285062,neutral,0.6504528522491455
782,1/29/2025 10:45:26 PM,Edwards Lifesciences upgraded to Buy from Hold at Stifel,TipRanks,/news/stocks/edwards-lifesciences-upgraded-to-buy-from-hold-at-stifel-1034285146,neutral,0.6504528522491455
783,1/30/2025 4:41:31 PM,Edwards Lifesciences upped to Buy at Stifel on TAVR growth,Seeking Alpha,https://seekingalpha.com/news/4400870-edwards-lifesciences-upped-to-buy-at-stifel-on-tavr-growth?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5402666330337524
